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8Abstract
heart rate (HR), heart rate variability (HRV), 
frontal electromyogram (fEMG) power, EEG-, 
and pulse plethysmography (PPG)-derived 
variables with surgery-induced movement re-
sponses was explored during propofol–N2O–
alfentanil (82 patients, study IV) or sevoflurane 
anesthesia (26 patients, study V).
ECG electrode impedances after both abra-
sion paste and alcohol swab skin pretreatment 
were lower compared to EEG electrodes after 
alcohol swab (p ≤ 0.001). ECG electrode im-
pedances after alcohol swab alone were higher 
than EEG electrode impedances (p ≤ 0.001). 
Impedances decreased during anesthesia with 
all electrode-skin preparation combinations 
(p ≤ 0.002). The BIS values registered with 
ECG electrodes were higher than those reg-
istered simultaneously with EEG electrodes 
(grand average BIS value difference 5.2, 95 % 
CI [3.5; 7.0], p < 0.001 vs. 0). The BIS values 
registered simultaneously with two sets of EEG 
electrodes were similar (grand average BIS val-
ue difference 1.7, 95 % CI [–0.1; 3.4]; p = 0.061 
vs. 0). Epileptiform EEG activity was detected 
in eight of 15 sevoflurane patients during the 
rapid increase in the inspired volatile concen-
tration, and in none of the 16 desflurane pa-
tients (incidences 0.53 vs. 0, p < 0.001; differ-
ence in incidences 0.53, 95 % CI [0.23; 0.75]). 
Heart rate increased transiently following the 
rapid increase in the inhaled desflurane con-
centration ([F(5,18) = 16.39, p < 0.001]). In 
the sevoflurane group, the increase was slower 
and more subtle [F(5,18) = 3.05, p = 0.037]. No 
statistically or clinically significant difference 
in the time to home-readiness between the 
isoflurane and sevoflurane groups was found 
(331 min and 347 min, difference –38 min, 
95 % CI [–106; 29]). All other early and inter-
mediate recovery parameters were also similar. 
A propofol bolus of 0.7 mg / kg i.v. was more 
effective than an alfentanil bolus of 0.5 mg i.v. 
in preventing the recurrence of movement 
Beginning in the 1990’s, several commercial 
hypnosis monitoring systems based on the 
processed electroencephalogram (EEG) have 
been developed for use during general anesthe-
sia. The assessment of the analgesic component 
(antinociception) of general anesthesia is an 
emerging field of research. This study investi-
gated the interaction of hypnosis and antinoci-
ception, the association of several physiologi-
cal variables with the degree of intraoperative 
nociception, and aspects of Bispectral Index 
Scale (BIS) monitoring during general anes-
thesia. In addition, EEG features and heart rate 
responses during desflurane and sevoflurane 
anesthesia were compared.
A total of 418 relatively healthy female pa-
tients were recruited; 344 were included in the 
analysis. The skin-electrode impedance values 
of EEG electrodes and electrocardiography 
(ECG) electrodes after different skin pretreat-
ment methods were compared in 51 patients. 
The difference in BIS values obtained with ECG 
electrodes and EEG electrodes was studied in 26 
patients. The difference in BIS values obtained 
with two sets of EEG electrodes was studied in 
eight patients. 31 patients were randomized to 
receive either sevoflurane or desflurane at the 
highest possible inspired vaporizer concentra-
tion (7 % or 18 %). The incidence of epilepti-
form EEG and the degree of tachycardia dur-
ing a five-minute study period were compared. 
120 ambulatory surgery patients were ran-
domized to receive either sevoflurane–nitrous 
oxide (N2O) or isoflurane–N2O anesthesia. BIS 
was maintained between 50 and 60 by adjust-
ing the concentration of the volatile agent. The 
times to home-readiness and to other recovery 
milestones, and the quality of recovery were 
compared. 82 patients were randomized to re-
ceive a bolus of either propofol or alfentanil in 
the event of movement during uterine dilata-
tion and curettage. The incidence of recurring 
movement was compared. The association of 
9during uterine dilatation and curettage. The 
incidences of recurring movement were 73 % 
and 38 % in the alfentanil and propofol groups 
(difference 35 %, 95 % CI [9 %; 56 %], p = 0.014). 
According to logistic regression analysis, both 
the group assignment and the time from the 
administration of the group drug to the end 
of the procedure were significantly associated 
with the probability of recurring movement. 
HR and several HRV-, fEMG-, PPG-, and 
EEG-derived variables were associated with 
surgery-induced movement responses. Movers 
were discriminated from non-movers mostly 
by the post-stimulus values per se or normal-
ized with respect to the pre-stimulus values. In 
logistic regression analysis, the best classifica-
tion performance, evaluated by leave-one-out 
cross-validation, was achieved with the com-
bination of normalized fEMG power and HR 
in study IV (overall accuracy 81 %, sensitivity 
53 %, specificity 95 %), and with the combina-
tion of normalized EEG Response Entropy, 
R-to-R interval (RRI), and PPG dicrotic notch 
amplitude in study V (overall accuracy 96 %, 
sensitivity 90 %, specificity 100 %).
In conclusion, designated EEG electrodes 
may be superior to ECG electrodes in BIS 
monitoring. Desflurane may be a safer volatile 
agent than sevoflurane in patients with a low-
ered seizure threshold. The tachycardia induced 
by a rapid increase in the inspired desflurane 
concentration may present a risk for patients 
with heart disease. When the administration of 
isoflurane or sevoflurane is adjusted to main-
tain BIS values at 50–60 in healthy ambulatory 
surgery patients, the speed and quality of re-
covery are similar after both isoflurane–N2O 
and sevoflurane–N2O anesthesia. When anes-
thesia is maintained by the inhalation of N2O 
(67 %) and bolus doses of propofol and alfenta-
nil in healthy unparalyzed patients, movement 
responses may be best avoided by ensuring a 
relatively deep hypnotic level with propofol. 
In the present studies, autonomic and fEMG 
responses were superior to EEG responses in 
discriminating movers from non-movers dur-
ing surgical stimulation. HR / RRI, fEMG, and 
PPG dicrotic notch amplitude are potential 
indicators of nociception during anesthesia, 
but their performance needs to be validated in 
future studies. Combining information from 
different sources may improve the discrimina-
tion of the level of nociception.
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DSST Digit Symbol Substitution Test
EC50 / 95 effective concentration in 50 % 
or 95 % of patients 
ECG electrocardiography
ED50 / 95 effective dose in 50 % or 95 % of 
patients
EEG electroencephalography
e.g. for example
EMG electromyography
fEMG frontal electromyography
EPSP / EPSC excitatory postsynaptic 
potential / current
FDA United States Food and Drug 
Administration
FFT fast Fourier transform
GABA γ-amino butyric acid
h hours
HBI heart beat interval
HR heart rate
HRV heart rate variability
HF high frequency; used in HRV 
analysis of the frequency range 
0.15–0.4 Hz
Hz herz
i.e. id est; that is
i.m. intramuscularly
IPSP / IPSC inhibitory postsynaptic 
potential / current
i.v. intravenously
kΩ kilo-ohms
LC locus coeruleus
AAI A-Line Autoregressive Index
ACC anterior cingulate cortex
AEP auditory evoked potential
Ag / AgCl silver / silver-chloride
AMPA α-amino-3-hydroxy-5-methyl-
4-isoxazolepropionic acid 
(glutamate receptor)
ANOVA analysis of variance
ANS autonomic nervous sytem
AOA adequacy of anesthesia
ApEn approximate entropy
ASA American Society of 
Anesthesiologists
AU arbitrary units
BIS Bispectral Index Scale
BSR burst suppression ratio
CBF cerebral blood flow
CMR cerebral metabolic rate
CNS central nervous system
Corp. corporation
Cp50 effective plasma concentration 
in 50 % of patients
CSSA Clinical Signs – Stimulus – 
Antinociception score
dB decibels
DC direct coupling (capacitor-free 
coupling) between the stages 
of amplification; direct current; 
ultraslow potentials
DFT discrete Fourier transform
Div. division
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LF low frequency; used in HRV 
analysis of the frequency range 
0.04–0.15 Hz
LOC loss of consciousness
MAC minimum alveolar concentration
MAP mean arterial pressure
MF median frequency
µV microvolts
min minutes
MLAEP middle latency auditory evoked 
potentials
MRF midbrain reticular formation
NCF nucleus cuneiformis
NLEO nonlinear energy operator
NMB neuromuscular blockade; 
neuromuscular blocking
NMDA N-methyl-D-aspartate 
(glutamate receptor)
NNT number needed to treat
N2O nitrous oxide
NRM nucleus raphe magnus
NRPG nucleus reticularis 
paragigantocellularis
NTS nucleus tractii solitarii
OAA / S Observer’s Assessment of 
Alertness / Sedation scale
mOAA / S modified Observer’s Assessment 
of Alertness / Sedation scale
OR operating room; odds ratio
PK prediction probability
PACU post-operative care unit
PAG periaqueductal grey
PBN parabrachial nucleus
PD pharmacodynamic
PK pharmacokinetic
PPG pulse plethysmography
PSD power spectral density
PSW polyspike wave
PTT pulse transit time
PWR pulse wave reflex
RE Response Entropy (in time-
frequency balanced spectral 
entropy)
RMSSD root of mean squared difference 
between successive R-to-R 
intervals
ROC return of consciousness; Receiver 
Operating Characteristic
RN Response index of Nociception 
RRI R-to-R interval; time between 
two successive beats in ECG
RSA respiratory sinus arrhythmia
RVM rostral ventromedial medulla
s seconds
SD standard deviation
SD1 SD of the residual against the line 
y = x in Poincaré analysis
SD2 SD of the residual against the 
line y’ = (–x)+2m, where m is the 
mean of the variable during the 
epoch of interest, in Poincaré 
analysis
SDNN standard deviation of normal-to-
normal intervals
SE State Entropy (in time-frequency 
balanced spectral entropy)
SEF95 spectral edge frequency; the 
frequency below which lies 95 % 
of the total EEG power
SEP somatosensory evoked potentials
SSI Surgical Stress Index
SVmR skin vasomotor reflex
sVRP slow ventral root potential
SW slow wave
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TOF train-of-four neuromuscular 
stimulation
TSS total surgical stress
ULF ultralow frequency; used in 
HRV analysis of the frequency 
range < 0.003 Hz
v. version
VAS Visual Analog Scale
VLF very low frquency; used in HRV 
analysis of the frequency range 
0.003–0.04 Hz
VLM ventrolateral medulla
vs. versus
ZXF zero crossing frequency
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Introduction
thetic concentrations are required to produce 
immobility than when systemic administra-
tion is used. The dose-response curve of opioid 
analgesics for reducing hypnotic requirements 
is steepest for blocking autonomic responses, 
somewhat less steep for blocking movement 
responses, and the most shallow for inducing 
unconsciousness (Antognini and Carstens 
2002).
The interaction of hypnotic agents and opi-
oid analgesics during general anesthesia can 
be schematically described by a hierarchical 
model introduced by Bouillon and colleagues. 
Initially, a noxious stimulus is processed at 
subcortical levels of the central nervous system 
(CNS), where opioids attenuate the nociceptive 
signal. The attenuated signal is then projected 
to the cortical level, where hypnotic agents act 
to suppress arousal (Bouillon et al 2004).
The incidence of awareness in the general 
surgical population is 0.1 %–0.2 %, and tends 
to be greater in patients with neuromuscular 
blockade during surgery. Recollection of in-
traoperative events may be delayed beyond 
the immediate perioperative period, or may 
fade with time. Intraoperative awareness may 
lead to sustained psychological symptoms 
(Sandin et al 2000). Beginning in the 1990’s, 
several commercial hypnosis monitoring sys-
tems based on processed EEG have been de-
veloped, including the Bispectral Index Scale® 
(Aspect Medical Systems, Inc., MA, USA) and 
time-frequency balanced spectral entropy 
(M-Entropy®, GE Healthcare). Consciousness 
may in itself be more of an on-off phenomenon 
than a continuous variable. Hypnosis monitors 
have the potential to improve the quality of an-
esthesia by decreasing the probability of both 
unintentional consciousness and overdosing 
of anesthetics and by improving the recovery 
profile. The information they provide must be 
interpreted in the light of the technical basis 
of the devices, the technical and physiological 
Multiple anesthetic agents, individually vari-
able pharmacokinetic and pharmacodynamic 
phenomena and the continuously changing 
intensity of surgical stimulation interact in 
a complex way to determine the adequacy of 
general anesthesia. The goal of balanced gen-
eral anesthesia is to safely provide a state of un-
consciousness with lack of memory formation 
and unresponsiveness to noxious stimuli, thus 
maintaining good conditions for surgery. In 
order to maximize patient safety and comfort 
and to facilitate an uncomplicated recovery it is 
necessary to avoid both underdosing and over-
dosing of anesthetic agents. To this end, devel-
opment of methods for monitoring anesthetic 
effect with respect to different components of 
general anesthesia is needed.
The concept of balanced anesthesia, which 
refers to the achievement of different anes-
thetic goals by the administration of specific 
drugs in suitable proportions, originated in 
the first half of the 20th century. The triad of 
hypnosis, analgesia (antinociception), and 
muscle relaxation was first presented by Rees 
and Gray (Rees and Gray 1950). Different an-
esthetic end-points result from actions at dif-
ferent sites. The cortex, thalamus, and reticular 
formation probably participate in producing 
consciousness and are depressed by anesthet-
ics. The amount of ascending afferent sensory 
information influences the arousal level of the 
brain. Analgesic agents are more effective than 
hypnotic agents in blocking cardiovascular re-
sponses. Low concentrations of hypnotics may 
even be hyperalgesic. Movement is blocked 
largely via anesthetic action in the spinal cord. 
Cortical electrical activity is more sensitive 
to anesthetic agents than subcortical activity. 
Movement responses to noxious stimulation 
may occur despite marked cortical electroen-
cephalogram (EEG) depression. If the brain 
is selectively anesthetized and concentrations 
in the torso are low, much higher brain anes-
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sources of error, the prevailing drug concentra-
tions, the physiology of the electrical activity in 
the brain, consciousness and nociception, and 
the interactions of the components of anesthe-
sia (Bonhomme and Hans 2004). Monitoring 
the hypnotic state via processed EEG may alert 
clinicians to equipment malfunction or other 
discontinuities in anesthetic delivery ear-
lier than changes in vital signs (Luginbühl and 
Schnider 2002, Mathews et al 2005).
The stress response to surgery comprises 
the secretion of pituitary and adrenal cortical 
hormones, the activation of the sympathetic 
nervous system, and an immunological acute 
phase reaction with production of cytokines by 
activated leucocytes, fibroblasts and endothe-
lial cells, and acute phase proteins by the liver. 
The endocrine response leads to salt and water 
retention and mobilization of energy substrates 
via catabolism. The stress response is activated 
by afferent neural input from the site of injury 
to the hypothalamus. The magnitude and du-
ration of the stress response is proportional to 
the extent of the surgical injury. Opioids and 
especially neuraxial blockade attenuate the 
stress response, although the neuroendocrine 
responses to upper abdominal and thoracic 
surgery have not been abolished reliably by 
any anesthetic technique. Also, anesthesia has 
little effect on the cytokine response to surgery 
(Desborough 2000).
Thus, even in the unconscious anesthetized 
patient nociception induces several physiologi-
cal responses, which may have persistent effects 
post-operatively, leading to hyperdynamic cir-
culation, hypermetabolism, catabolism, im-
munosuppression, hypercoagulability, and dis-
turbances in pulmonary and gastrointestinal 
function (Carr and Goudas 1999, Kehlet and 
Dahl 2003). A multimodal approach to reduce 
perioperative stress may have several advanta-
geous effects on recovery, with the potential to 
reduce the risks of cardiac, pulmonary, throm-
boembolic and infective complications, gastro-
intestinal and cerebral dysfunction, catabolism 
and decreased functional capacity (Kehlet 
1997, Wilmore 2002).
In addition to autonomic and endocrine 
reactions, surgical stimulation may elicit mo-
tor responses, despite unconsciousness. The 
assessment of the antinociceptive component 
of general anesthesia is an emerging field of re-
search. Possible indicators of the nociceptive-
antinociceptive balance during anesthesia are 
the EEG arousal reactions (Wilder-Smith et 
al 1995, Guignard et al 2000, Hagihira et al 
2004b), fEMG activation responses (Viertiö-
Oja et al 2004), the middle latency auditory 
evoked potentials (MLAEP) (Nishiyama and 
Hanaoka 2004, Bonhomme et al 2006), the so-
matosensory evoked potentials (SEP) (Kochs 
et al 1990), changes in the palmar skin electri-
cal conductance (Storm et al 2002, Storm et 
al 2005, Gjerstad et al 2007), reflex pupillary 
dilation responses (Larson et al 1993, Larson 
et al 1997, Barvais et al 2003, Constant et al 
2006), changes in the superficial skin perfusion 
(Shimoda et al 1998a, Shimoda et al 1998b) and 
changes in the pulse plethysmography (PPG) 
waveform (Luginbühl et al 2002). Recently, 
an index for the assessment of surgical stress, 
based on a linear weighted combination of 
the normalized PPG amplitude and the heart 
beat interval, has been introduced (Huiku et 
al 2007) and is currently undergoing clinical 
validation.
The aim of the present study was to inves-
tigate the technical constraints and benefit of 
EEG BIS monitoring in ambulatory surgical 
patients. In addition, possibilities to monitor 
the nociceptive-antinociceptive balance during 
general anesthesia, and the interaction between 
hypnosis and antinociception were explored 
in order to contribute to the development of 
the assessment of the adequacy of anesthesia. 
Finally, the relationship between hemody-
namic responses and EEG changes during the 
administration of high concentrations of sevo-
flurane or desflurane was investigated. 
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Review of the literature
tions and feedback in neural networks. A de-
pressant anesthetic action on the molecular 
level can result in inhibition, excitation, or no 
effect at higher levels of integration within the 
CNS. Also, at the subcellular level it is difficult 
to predict the effect of agonist binding on long 
second-messenger cascades (Urban 2002). 
Anesthesia may be associated with both de-
creased and increased activity of and decreased 
and increased coherence between neurons 
(John et al 2001, Århem et al 2003, Hameroff 
2006).
General anesthetics increase the sensitiv-
ity of GABA receptors to bind agonist and 
prolong the inhibitory postsynaptic currents 
induced by GABA. Conversely, they reduce 
excitatory postynaptic currents by causing fre-
quent closure or blockade of the opening of the 
acetylcholine receptor ion channel. Neuronal 
nicotinic acetylcholine receptors are inhib-
ited by inhaled anesthetics at low concentra-
tions which cause amnesia but not immobil-
ity (Campagna et al 2003). Whereas propofol, 
pentobarbital and midazolam decrease the re-
lease of noradrenaline and acetylcholine from 
the rat brain, ketamine, N2O, and xenon, which 
are potent N-methyl-D-aspartate (NMDA) re-
ceptor inhibitors, increase the release of these 
neurotransmitters. Ketamine and N2O stimu-
late the sympathetic system, whereas xenon 
is sympatholytic. Ketamine and N2O increase 
the cerebral metabolic rate (CMR) and cere-
bral blood flow (CBF). Xenon also seems to 
increase CBF (Hirota 2006).
Acetylcholine and glutamate receptor ago-
nists are excitatory at the locus coeruleus (LC), 
a major noradrenergic nucleus located in the 
midbrain (pons). Antagonists at these receptors 
act as hypnotics. GABA, opioid and α2-receptor 
agonists are inhibitory when injected to the 
LC. These agents have sedative properties and 
reduce the requirements for volatile anesthet-
ics (Rosow 1997). Different anesthetic agents 
General anesthesia
The idea that general anesthetics act on brain 
lipids was presented as early as 1847 by von 
Bibra and Harless. In 1901 Meyer and Overton 
independently observed that the potency of 
volatile agents depends on their lipid solubility 
(Mashour 2006). In 1984 Franks and Lieb dis-
covered that several anesthetic agents inhibited 
an enzyme, a protein compound, by a competi-
tive mechanism and concluded that general 
anesthetics bind to specific receptors (Franks 
and Lieb 1984).
Based on current knowledge, the structur-
ally very different general anesthetics act on 
ligand-gated (γ-amino butyric acid (GABA)A, 
glycine, glutamate, nicotinic acetylcholine and 
serotonin receptors) and voltage-gated K+, Na+ 
and Ca++ channels on neuronal membranes. 
Some non-voltage gated K+ channels, such as 
those responsible for maintaining the rest-
ing membrane potential, are also sensitive 
to anesthetics. They may also act directly on 
cytoplasmic proteins. Metabotropic recep-
tors, which partly bind the same ligands as 
the ligand-gated ion channels and modulate 
synaptic transmission, may also be affected by 
anesthetic agents. In addition to postsynaptic 
effects, anesthetics can act on presynaptic tar-
gets such as the voltage-gated Ca++ channels, 
which regulate transmitter release. In addition, 
it is possible that anesthetics change the lipid 
micro-environment of ion channel proteins, 
and thus their function. Anesthetic action on 
synaptic transmission is clinically much more 
important than their effect on axonal conduc-
tion. Neurons are not exclusive targets to anes-
thetic agents. Glia, skeletal and cardiac muscle 
cells and cells of the endocrine and immune 
systems are also affected (Urban 2002, Århem 
et al 2003, Mashour et al 2005, Hameroff 
2006).
Anesthetic effects depend on the connec-
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can act preferentially in specific regions of the 
central nervous system or on specific subsets of 
neurons to achieve the anesthetic end-points, 
despite the interaction between different areas 
of the central nervous system. The mechanism 
of general anesthesia may be related to the 
disruption of the so-called cognitive binding, 
an integration process thought to occur in the 
brain within and across sensory modalities. 
Anesthesia-induced unbinding would occur 
from the cellular level to the neural network 
level, with loss of connectivity between differ-
ent brain structures (John and Prichep 2005, 
Mashour et al 2005, Mashour 2006).
Induction of anesthesia is associated with 
reduced CBF and CMR both globally and in 
various specific regions of the cortex, thalamus 
and brainstem (Urban 2002, Campagna et al 
2003, John and Prichep 2005). It seems that 
low doses of anesthetic agents primarily affect 
sensory and association cortices, whereas with 
higher doses subcortical structures, notably the 
thalamus and MRF, are suppressed (Alkire et 
al 2000, Heinke and Schwarzbauer 2002). The 
thalamus and the brainstem reticular activat-
ing system are key structures in the regulation 
of vigilance. During sedation and transition 
to unconsciousness, propofol preferentially 
decreases blood flow in areas linked to the 
control of consciousness, sensory (especially 
visual) associative functions and autonomic 
control (Fiset et al 1999).
Episodic memory is lost at lower anesthetic 
concentrations than those which induce uncon-
sciousness (Glass et al 1997, John and Prichep 
2005). At low anesthetic concentrations im-
plicit memory formation may be present, while 
explicit memory is blocked (Antognini and 
Carstens 2002).
Perceptual tasks are associated with wide-
spread phase-locked EEG γ oscillations. 
Anesthesia may interrupt the coherent cortico-
thalamocortical resonance, as exemplified by 
the disappearance of the auditory steady-state 
40 Hz response (John and Prichep 2005). Loss 
of consciousness seems to involve disruption 
of EEG γ band phase synchrony between fron-
tal and posterior brain regions (John et al 2001, 
Hameroff 2006). The processing of fragmen-
tary sensory data may continue, whereas the 
formation of complex representations is lost 
(John and Prichep 2005, Mashour et al 2005).
The NMDA receptor, which strengthens 
the synapses between simultaneously active 
neurons, has been hypothesized to be the ul-
timate target of all anesthetic agents. States of 
consciousness would emerge automatically in 
sufficiently large neural networks containing 
active NMDA receptors, resulting in coherent 
neuronal assemblies (Flohr 2006).
Alkire and colleagues suggested that a hy-
perpolarization block of the thalamus may 
underlie loss of consciousness, resulting in a 
burst-firing pattern of thalamocortical cells 
and high voltage, slow wave cortical electri-
cal activity. Anesthetics may exert direct hy-
perpolarizing effects on thalamocortical cells, 
decrease excitatory input (cholinergic, gluta-
matergic, aminergic), or enhance inhibitory 
input, interfering with the reticular-thalamic 
activating system. Subcortical structures may 
be required for wakefulness, whereas cortical 
areas may provide the perceptual content of 
consciousness (Alkire et al 2000).
Nociception and anesthesia
In peripheral tissues, noxious stimuli (me-
chanical, thermal, or chemical) activate no-
ciceptors, which transmit electrical signals 
along thinly myelinated Aδ- or unmyelinated 
C-fibers to the dorsal horn of the spinal cord. 
The primary afferents synapse with either as-
cending projection neurons or interneurons. A 
simple spinal reflex arc is formed by a primary 
afferent, one or more excitatory interneurons, 
and a motoneuron. Information is conveyed 
from the spinal nociceptive neurons to the 
thalamus and to the brainstem via the spinotha-
lamic, spinoreticular, and spinomesencephalic 
tracts, situated in the anterolateral quarter of 
the spinal cord. The reticular formation, a key 
structure in the modulation of arousal, in turn 
is connected with the thalamus. Also, spinal 
projections to the periaqueductal gray (PAG) 
in the mesencephalon, the parabrachial nucle-
us (PBN) in the pons and to the ventrolateral 
medulla (VLM) exist (Brooks and Tracey 2005, 
Tracey 2005). Direct connections between the 
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spinal cord and the hypothalamus form the 
spinohypothalamic tract (Giesler et al 1994, 
Brooks and Tracey 2005). The thalamic nuclei 
project to numerous cortical areas. Roughly, 
the lateral thalamocortical system is involved 
in the sensory-discriminative aspect of nocice-
ption, whereas the medial system is involved 
in the affective and motivational integration of 
nociceptive information (Kalso 2002).
Both visceral and somatic nociceptive in-
put activate the nucleus cuneiformis (NCF), a 
nucleus of the reticular formation, the adjacent 
PAG, and areas in the dorsolateral pons, con-
sistent with the LC medially and PBN laterally. 
The NTS, the nucleus gracilis, and the dorsal 
reticular nucleus of the medulla, situated in 
the left dorsolateral medulla, are activated 
predominantly by visceral nociceptive signals 
(Dunckley et al 2005). Spinal and trigeminal 
nociceptive input and visceral afferent infor-
mation converge on the central autonomic 
network including the insular cortex and the 
anterior cingulate cortex (ACC), the central 
nucleus of the amygdala, several areas of the 
hypothalamus, PAG, PBN, VLM, the nucleus 
of the solitary tract (NTS) and the raphe nuclei 
(rostroventromedial medulla, RVM). These ar-
eas have numerous interconnections and gen-
erate stimulus-specific autonomic, endocrine, 
motor, and arousal responses. They project 
to preganglionic sympathetic and parasym-
pathetic neurons, which also receive direct 
input from nociceptive afferents of the same 
spinal segment. They also project to the spinal 
cord dorsal horn and participate in modulat-
ing nociceptive processing (Benarroch 2006). 
The sympathetic and parasympathetic preau-
tonomic neurons are functionally specialized, 
but may coexist in the same hypothalamic and 
brainstem nuclei (Buijs et al 2003).
Nociceptive input induces an increase in 
blood pressure, which is mediated by neurons 
in the rostral ventrolateral medulla (Stornetta 
et al 1989, Allen and Pronych 1997). They proj-
ect to the sympathetic preganglionic neurons 
in the intermediolateral nucleus of the thoracic 
spinal cord and also provide tonic excitation, 
which serves to maintain resting blood pres-
sure (Morrison et al 1988, Stornetta et al 1989). 
The pressor response may be dominant over a 
simultaneous depressor response (Allen and 
Pronych 1997). The depressor response, medi-
ated by the ventrolateral PAG, is characteristic 
of deep somatic or visceral nociception (Keay 
et al 2000).
The brainstem is critically involved in the 
immediate reactions to noxious stimulation. 
During tonic stimulation, the autonomic re-
sponse may habituate (Petrovic et al 2004). The 
neurons in the brainstem reticular formation 
project to the nucleus facialis, which provides 
motor innervation to the facial muscles (Sun 
and Panneton 2005). The neurons in the me-
dial reticular formation, along with the raphe 
nuclei and nucleus retroambiguus, also project 
to motoneurons innervating the abdominal 
muscles (Billig et al 2001). The PAG may par-
ticipate in integrating the somatic and cardio-
vascular defense reactions. The hypothalamus 
coordinates complex response patterns effected 
by other areas of the basal forebrain, the brain-
stem, and the spinal cord (Saper 2002).
Increased circulating catecholamines are as-
sociated with increased arousal (Andrzejowski 
et al 2000). This may be the result of β-receptor 
activation in the medial septal region of the 
basal forebrain (Berridge and Foote 1996, 
Berridge et al 1996), but increased clear-
ance or redistribution of anesthetics due to 
increased cardiac output may also play a role 
(Andrzejowski et al 2000).
 The activation of the noradrenergic LC by 
nociceptive input, as well as sudden noises or 
other non-noxious stimuli, is associated with 
increased attention and arousal (Kalso 2002, 
Leone et al 2006). Opioid analgesics inhibit 
the LC. They stimulate the PAG and nucleus 
reticularis paragigantocellularis (NRPG). 
These in turn activate the nucleus raphe mag-
nus (NRM), a key structure in the descending 
modulation of nociceptive transmission in the 
dorsal horn (serotonin, encephalin). The LC is 
also involved in descending modulation (no-
radrenalin) (Kalso 2002). The descending pain 
modulatory system causes either inhibition or 
facilitation of nociceptive processing, depend-
ing on circumstances. The PAG, NCF, RVM, 
PBN, and the dorsal reticular nucleus of the 
medulla may be involved in the generation and 
maintenance of central sensitization states and 
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hyperalgesia (Tracey 2005, Leone et al 2006).
The μ opioid receptors are widely distrib-
uted in the forebrain, brainstem and the super-
ficial layers of the spinal cord dorsal horn. They 
are located both pre- and postsynaptically, and 
in both extrasynaptic and synaptic regions. 
They may be involved in the modulation of 
both transmitter release and the firing pattern 
of postsynaptic neurons, resulting in inhibition 
of nociceptive neurotransmission (Glaum et al 
1994, Grudt and Williams 1994, Cheng et al 
1996, Ding et al 1996, Zhang et al 1996, Kohno 
et al 2005). The μ opioid agonists preferentially 
inhibit the calcium channels on small unmy-
elinated nociceptors (Taddese et al 1995). They 
directly hyperpolarize cells in the substantia 
gelatinosa by increasing potassium conduc-
tance (Yoshimura and North 1983, Grudt and 
Williams 1994).
In a study on the superficial layer of the rat 
cervical spinal cord, the relative proportions 
of μ, δ and κ opioid receptors were 70 %, 23 %, 
and 7 %. It was estimated that 76 %, 61 %, and 
53 % of these were located presynaptically in 
the afferent fibers (Besse et al 1990). Different 
opioid receptor subtypes may be involved in 
the modulation of different nociceptive mo-
dalitites (Schmauss and Yaksh 1984). Both μ 
and δ opioid agonists inhibit the responses of 
spinal cord dorsal horn nociceptive neurons 
to electrical stimulation of the Aδ-fibers and 
C-fibers. The responses mediated by C-fibers 
are more markedly and consistently depressed 
than those mediated by Aδ-fibers (Wang et al 
1996).
Opioids depress the slow ventral root po-
tential, which is associated with nociception, 
especially the late component mediated by me-
tabotropic receptors. Their effects on fast glu-
tamate mediated neurotransmission (AMPA 
receptors are responsible for the monosynaptic 
reflex, and NMDA receptors mediate the early 
component of the slow ventral root potential) 
in the ventral horn are small. Opioids slightly 
depress the inhibitory (antinociceptive) dorsal 
root potential (Feng and Kendig 1995). The 
spinal cord is an important site for opioid ac-
tion (Yaksh and Rudy 1977). Opioids also act 
on supraspinal targets (Vigouret et al 1973, 
Yaksh et al 1976, Takagi et al 1978, Wagner 
et al 2001). Endogenous opioid peptides par-
ticipate in mediating the descending inhibition 
of nociceptive transmission (Budai and Fields 
1998). Opioids may also have peripheral an-
tinociceptive effects on local opioid receptors 
(Stein et al 1990a, Stein et al 1990b).
Increasing opoid concentrations attenuate 
the hemodynamic response to tracheal intuba-
tion. The same applies to increasing propofol 
concentrations, although to a lesser degree 
(Luginbühl et al 2006). Rantanen and colleagues 
found that during anesthesia with propofol 
titrated to state entropy (SE) 50 and 1 ng / ml 
(effect-site) remifentanil, a 30 s tetanic electri-
cal stimulus induces a significantly greater RRI 
decrease than a 5 s stimulus, comparable to 
that induced by skin incision. At remifentanil 
concentrations 3 ng / ml and 5 ng / ml the RRI 
responses to a 30 s tetanic stimulus and skin 
incision are very small (Rantanen et al 2006b). 
A modest dose of fentanyl decreases the con-
centration of isoflurane or desflurane, com-
bined with N2O, required to block adrenergic 
responses to skin incision by approximately 
60 % (Daniel et al 1998).
The concentration of inhaled anesthetics 
required to block cardiovascular responses is 
much higher than that required to block move-
ment responses to noxious stimulation. Also, 
more interindividual variability in the level 
of anesthesia needed to block cardiovascular 
responses than in that needed to block move-
ment responses exists. In general, the higher 
the sympathetic activity in the awake state, the 
greater the change in cardiovascular variables 
(and plasma noradrenalin levels) at induction 
of anesthesia (Roizen et al 1981). Similarly to 
movement responses, anesthetic effects at the 
level of the spinal cord are probably important 
in mediating the attenuation of cardiovascular 
responses (Antognini and Berg 1995).
 Anesthetic actions in the spinal cord in-
clude the suppression of the excitability of 
motoneurons, either directly or indirectly, and 
the suppression of the responses of nociceptive 
neurons, with varying molecular targets. In ad-
dition to immobility, antinociception is largely 
produced at the spinal level but is subject to 
supraspinal influences. The thalamus and the 
anterior cingulate cortex appear to be targets 
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for opioid and N2O analgesia (Urban 2002).
Increasing isoflurane concentrations in the 
brain attenuate the noxious-stimulus evoked 
activity in spinal dorsal horn nociceptive neu-
rons in the presence of relatively low spinal 
cord isoflurane concentrations, possibly by 
changing the balance of descending inhibi-
tion and facilitation. With high spinal cord 
isoflurane concentrations, the supraspinal ef-
fects are masked by the direct spinal isoflurane 
effect (Antognini et al 1998, Jinks et al 1999). 
Isoflurane depresses the nociception-related 
slow ventral root potential in the isolated rat 
spinal cord. At concentrations close to those 
required for general anesthesia, the mono-
synaptic reflex is also depressed (Savola et al 
1991).
Subanesthetic concentrations of propofol 
are hyperalgesic by heat stimulation (Hofbauer 
et al 2004) and mechanical pressure stimula-
tion (Petersen-Felix et al 1996). Subanesthetic 
concentrations of propofol do not increase the 
threshold of the nociceptive motor reflex to 
repeated electrical stimulation. The sedation 
produced by propofol can influence nocicep-
tive electrophysiological responses (Petersen-
Felix et al 1996). After loss of consciousness 
during propofol sedation, noxious stimulation 
may still activate the insular cortex, involved in 
autonomic and homeostatic regulation, even 
though increased activity in the thalamus is 
lost (Hofbauer et al 2004).
Propofol decreases the metabolic activity in 
both the rat brain and spinal cord (Cavazzuti et 
al 1991). Propofol has a direct depressing effect 
on the activity of spinal cord dorsal horn noci-
ceptive neurons at noxious mechanical stimula-
tion (Antognini et al 2000c). It blunts the EEG 
and midbrain responses to noxious mechani-
cal stimulation by both a direct brain effect 
and an indirect spinal effect (Antognini et al 
2001). In the isolated rat spinal cord, propofol 
inhibits nociceptive-related neurotransmission 
at concentrations near the general anesthetic 
level, acting like a GABAA agonist (Jewett et al 
1992).
It has been suggested that the δ opioid re-
ceptor (Nadeson and Goodchild 1997) and 
the glycine receptor (Dong and Xu 2002) are 
involved in propofol-induced antinociception 
in the spinal cord in addition to the GABAA 
receptor. Propofol seems to have a suppressive 
effect on the L-type calcium channel, which 
may play a role in spinal nociceptive and mo-
tor circuits (Guertin and Hounsgaard 1999). 
Spinal neuronal responses to both noxious 
mechanical and heat stimuli and non-noxious 
mechanical stimuli are depressed by propofol 
in rats (Sun et al 2004) and cats (Uchida et al 
1995). In a rat model, propofol attenuated spi-
nal sensitization (O’Connor and Abram 1995). 
Propofol and alfentanil both have the capacity 
to depress the sVRP, and subclinical concen-
trations of propofol significantly enhance the 
effect of alfentanil (Feng and Kendig 1997).
Propofol does depress nociceptive signal 
transmission in the spinal cord, but to a signifi-
cantly lesser extent than sevoflurane (Matute et 
al 2004). In clinically relevant concentrations, 
the capacity of propofol to depress spinal neu-
ronal activity is less than that of sevoflurane, 
possibly due to more restricted molecular 
targets (Grasshoff and Antkowiak 2004). 
Suppression of spinal cord reflex function by 
propofol may occur more slowly than sup-
pression of forebrain function, and with doses 
insufficient to produce unresponsiveness to 
noxious stimulation (Baars et al 2006a, Baars et 
al 2006b). Apparently propofol causes complex 
dose-dependent effects in different parts of the 
CNS. These may also vary between different 
stimulus modalitites.
Surgical nociception may lead to both spi-
nal sensitization and descending inhibition 
of nociceptive processing. A rebound central 
sensitization may occur after the cessation of 
post-operative opioid analgesia in patients 
who receive nonanalgesic anesthesia. Objective 
changes in sensory processing after surgery are 
only weakly correlated with subjective pain 
intensity or analgesic consumption (Wilder-
Smith 2000).
The adequacy of anesthesia
Eger and Sonner argue that the anesthetic state 
caused by inhaled agents is defined by revers-
ible amnesia and immobility. They hold that 
unconsciousness cannot be directly measured, 
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unless it is accepted that the loss of awareness 
(loss of responses to command) implies un-
consciousness. Autonomic reflexes are often 
functional at clinically relevant anesthetic con-
centrations and muscle relaxation is not always 
present. Analgesia, a subjective experience, 
cannot be verified (Eger and Sonner 2006). 
A similar view was presented by Antognini 
and Carstens, who define general anesthesia 
as a combination of unconsciousness, amne-
sia, and immobility. In their opinion, analge-
sia may indirectly contribute to the state of 
general anesthesia and may be important for 
patient management, but since no conscious 
perception is normally present during general 
anesthesia, analgesia is not an essential compo-
nent. Likewise, hemodynamic stability may be 
important for certain patient groups, but is not 
an essential component of general anesthesia 
(Antognini and Carstens 2002).
Autonomic, endocrine and motor reflex 
responses during anesthesia, however, are 
linked to nociception, which can be defined as 
the unconscious processing of noxious stimuli 
during anesthesia. They can be suppressed 
by analgesic drugs, most commonly opioids, 
without using exceedingly large doses of hyp-
notic drugs. Hypnotic drugs are used to achieve 
loss of consciousness and recall, whereby the 
patient is unable to respond to or remember 
a non-noxious (or noxious) stimulus. Muscle 
relaxation, which may be necessary for certain 
surgical procedures, is sometimes regarded as 
a component of balanced anesthesia. It can 
be achieved with either a sufficient amount of 
hypnotic and analgesic drugs, or by neuromus-
cular blocking agents.
Tammisto and colleagues were among the 
pioneers in establishing the optimal combina-
tion of hypnotic and analgetic agents in terms 
of not only unconsciousness, but also anti-
nociception, i.e. tolerance of surgical stimuli 
(Tammisto et al 1980, Tammisto and Aromaa 
1982). Tammisto and Olkkola demonstrated 
the negative linear relationship between the 
end-tidal enflurane concentration and the 
level of neuromuscular blockade necessary to 
produce adequate surgical muscle relaxation 
during upper abdominal surgery (Tammisto 
and Olkkola 1995).
Opioids alone do not reliably produce un-
consciousness, even at high doses, although 
increasing opioid doses reduce the require-
ments for hypnotic agents (Jhaveri et al 1997). 
Unresponsiveness to verbal or other stimuli 
does not always imply unconsciousness. The 
level of opioid analgesia affects the level of 
hypnosis at loss of responsiveness (Jensen et al 
2004).
The level of hypnosis during surgery is de-
termined by the interaction of hypnotic drugs, 
analgetic drugs, and the intensity of noxious 
stimulation (Bouillon et al 2004, Hagihira et al 
2004b). Increasing surgical stimulation shifts 
the individual dose-response curve toward 
higher anesthetic concentrations (Heier and 
Steen 1996). Hagihira and colleagues have ad-
vocated the maintenance of unconsciousness 
during surgery with steady concentrations of 
hypnotic agents and adjusting the level of an-
tinociception to the changing levels of surgical 
stimulation (Hagihira et al 2004b).
Different anesthetic agents have varying 
potencies to produce each of the components 
of anesthesia (Heier and Steen 1996). Kissin 
concluded that the components of anesthesia, 
whether produced by a single agent or multiple 
drugs, represent different pharmacological 
actions. Ideally, the level of each component 
should be separately assessed (Kissin 1993).
In unparalyzed patients, the observation 
of movement responses to surgery is the best 
clinical measure for detecting impending 
awareness. Hemodynamic responses do not 
correlate well with end-tidal concentrations 
of volatile anesthetic agents, and the relation-
ship between autonomic and movement re-
sponses during inhalation anesthesia is poor. 
Autonomic responses are not only affected by 
the depth of anesthesia but also by cardiovas-
cular drugs, the circulating blood volume, ac-
id-base status, and cardiac contractility (Heier 
and Steen 1996). Thus, the correlation between 
the hypnotic level and somatic and hemody-
namic responses during anesthesia is not very 
good (Gan et al 1997, Luginbühl et al 2003).
In an effort to improve the objective as-
sessment of the adequacy of anesthesia, sev-
eral different hypnosis monitoring techniques 
based on processed EEG have been developed 
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and are commercially available. Apart from 
BIS® (Aspect Medical Systems, Inc., MA, USA) 
and M-Entropy® (GE Healthcare), these in-
clude the Patient State Index (PSA®, Hospira 
Inc., IL, USA), SNAP II® (Everest Biomedical 
Instruments Company, MO, USA), Narcotrend® 
(Hannover, Germany), and the Cerebral 
State Index (CSM®, Danmeter A / S, Odense, 
Denmark). Earlier EEG monitoring systems 
included the Anesthesia and Brain Activity 
Monitor (ABM®, Datex / Instrumentarium 
Corp., Helsinki, Finland), the Cerebral 
Function Analysing Monitor (CFAM®) and 
the Advanced Depth of Anaesthesia Monitor 
(ADAM®) (Sebel et al 1983, Edmonds and 
Paloheimo 1985, Thomsen et al 1989).
The A-Line Autoregressive Index (AAI®, 
Danmeter A / S, Odense, Denmark) is based 
on the analysis of the middle latency auditory 
evoked potential waveforms. The composite 
AAI index combines information from both 
MLAEP and the spontaneous EEG. Gajraj and 
colleagues proposed that the AEPIndex , also 
derived from the morphology of the MLAEP 
waveform, provides a measure of the overall 
balance between surgical stimulation, analge-
sia, and hypnosis (Gajraj et al 1999). Recently 
ocular microtremor, a high-frequency, low-
amplitude physiological tremor driven by oc-
ulomotor neurons embedded in the brainstem 
reticular formation, has been suggested to re-
flect the adequacy of anesthesia (Heaney et al 
2004).
In general, the curves relating EEG and 
MLAEP variables to clinical end-points are 
relatively shallow, with large interindividual 
variability and suboptimal sensitivity and 
specificity (Heier and Steen 1996). Schwilden 
noted that in addition to the strength of asso-
ciation between a monitoring measure and the 
clinical end-points, the signal-to-noise ratio is 
important for the applicability of that measure. 
He suggested that in the future the intensity of 
surgical stimulation needs to be incorporated 
into pharmacokinetic (PK)-pharmacodynamic 
(PD) models to describe the relationship be-
tween electrophysiological variables and clini-
cal anesthesia (Schwilden 2006).
Electroencephalography
The physiological basis of the 
electroencephalogram
The neocortex consists of six neuronal layers 
or lamina, histologically differentiated accord-
ing to the dominant cell type. Two prevalent 
cell types are the large pyramidal cells and the 
smaller granular cells, the relative density of 
which varies in different cortical regions. In 
addition to this laminar arrengement, the cells 
are organized into vertical functional units or 
columns. The pyramidal cells have prominent 
apical dendrites, which extend to the cortical 
surface. Other cell types also display long den-
dritic and axonal arborizations (Kahle 1986). 
The neurons interact via synapses which cover 
the somata, the dendrites, and the axon hill-
ocks in large numbers (Speckmann and Elger 
1999).
Synaptic activity causes alterations in the 
resting cell membrane potentials: either ex-
citatory (depolarizing, EPSP) or inhibitory 
(hyperpolarizing, IPSP) postsynaptic poten-
tials. Primary transmembrane ionic currents 
induce secondary ionic currents along the 
cell membrane both intra- and extracellu-
larly. Extracellular potentials are called field 
potentials. The glia cells may amplify the 
field potentials (Speckmann and Elger 1999). 
Ionic currents spread from the source neurons 
throughout an essentially liquid medium to the 
skin (volume conduction). The spatial and tem-
poral summation of numerous EPSPs or IPSPs 
result in field potentials large enough to be de-
tected on the surface of the skull (Creutzfeldt 
et al 1966). Conduction through the cerebro-
spinal fluid, the skull and the scalp leads to 
weakening and spatial smearing of the regional 
voltage differences (Rampil 1998). Summation 
of asynchronous potentials tends to result in a 
relatively low-amplitude EEG signal, whereas 
synchronous oscillations are associated with 
a higher amplitude. Under normal metabolic 
conditions, the dominant frequency and the 
amplitude of the EEG signal are inversely cor-
related (Edmonds et al 2004a).
Cortical dendrites are also interconnected 
via electrical gap junctions, which may partici-
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pate in mediating γ frequency synchronization 
in membrane potentials. Coordinated activity 
in dendritic proteins may support γ synchro-
ny, thought to be critical for consciousness 
(Hameroff 2006). 
Signal transduction and registration  
of the electroencephalogram
Electrodes are needed to transduce the biopo-
tentials into voltage changes recordable with 
electronic equipment. Typically, the gap be-
tween the metal conductor of the recording ap-
paratus and the skin is bridged with electrolyte 
jelly. A continuous exchange of ions takes place 
at the metal-electrolyte and skin-electrolyte in-
terfaces, with an excess charge in the solution. 
This results in the formation of an electrical 
double layer, with a steady DC potential and 
a certain capacitance. These DC potentials 
may interfere with the recording of the EEG 
signal (Kamp and Lopes da Silva 1999). The 
DC potentials formed at the metal-electrolyte 
and skin-electrolyte interfaces are connected 
in series. Ideally, the DC potentials of separate 
electrodes should be equal. In practice, a cer-
tain potential difference, the DC offset voltage, 
exists between different electrodes. When us-
ing similar, good quality electrodes, attached 
in the same way, the DC offset voltage is rela-
tively small. The DC potential, resistance, and 
capacitance of the metal-electrolyte interface 
depend on the metal used, the electrolyte com-
position, the temperature, and the magnitude 
and frequency of the current. The stability of 
the metal-electrolyte interface can be increased 
by a suitable salt coating. The Ag / AgCl elec-
trode is frequently used for EEG recordings 
due to its favorable electrical properties.
At the skin-electrolyte interface, the resis-
tance and capacitance are strongly influenced 
by the width of the epidermis and the magni-
tude of the current. The dry outermost layer of 
the skin is a poor conductor. The resistance of 
the skin-electrolyte junction can be reduced by 
using a high concentration of NaCl (5 %-10 %), 
and by scraping off the stratum corneum of the 
skin. Careful preparation of the skin and the 
use of electrode jelly also serve to reduce elec-
trode movement artifacts. The resistance and 
capacitance in different parts of the body fluid-
skin-electrolyte-electrode complex are com-
ponents of the impedance (figure 1), which 
characterizes the relationship between applied 
voltage and resulting current. The frequency-
dependent component of the impedance is 
inversely proportional to the square root of 
frequency (Kamp and Lopes da Silva 1999).
The most commonly used method of elec-
trode placement is the International 10–20 
System (figure 2) (Report of the committee on 
methods of clinical examination in electroen-
cephalography 1958), where specific relative 
distances between bony landmarks (nasion, in-
ion, and preauricular points) are used to make 
the electrode placement comparable between 
patients and separate measurements. The 
electrodes are designated with a number (odd 
numbers on the left, even numbers on the right) 
and a letter (or letters) referring to the anatom-
ical area. Either referential or bipolar recording 
can be used. In the former, all electrodes are re-
ferred to a single common electrode, one com-
mon electrode on each side of the head, or the 
electrically combined activity of two or more 
electrodes. The particular choice of reference 
influences the resulting signal. For example, 
temporal cortical activity may be reflected on 
the earlobe reference. Bipolar recordings mea-
sure voltage between specified electrode pairs. 
A voltage, which is negative at input one (ac-
tive electrode in referential montage) relative 
Figure 1. A simplified diagram of the impedance 
of a metal-electrolyte interface. R1 = electrolyte 
resistance, R2 = electrical double layer resistance, C2 
= electrical double layer capacitance, R3 and C3 = 
time- and frequency-dependent diffusion impedance. 
Modified from Kamp and Lopes da Silva 1999. 
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to input two, is presented as an upward deflec-
tion of the EEG tracing. If a transient signal is 
similar in both recording electrodes, it may be 
cancelled out. The electrode pairs, which the 
amplifier compares, are channels that together 
comprise the montage. In general, the differen-
tial voltage increases as the distance between 
the two electrodes increases (Reilly 1999). The 
ground electrode provides a return path for 
mains leakage current (Kamp and Lopes da 
Silva 1999).
In order to avoid significant signal attenua-
tion at the amplifier, the electrode impedance 
must be sufficiently small compared to the am-
plifier input impedance and the cable imped-
ance. The optimal amplifier input impedance 
in EEG recordings is around 10 megaohms. 
Differential amplifiers are designed to measure 
the voltage difference between input termi-
nals and reject the common mode potential 
present in both terminals. External electrical 
sources cause an alternating common mode 
potential, which depends on the impedance of 
the ground electrode, between the electrodes 
and the earth. For this mains power interfer-
ence (or high frequency signal from electrical 
devices) to be effectively attenuated the differ-
ence between the electrode impedances must 
be as small as possible and the amplifier input 
impedance must be large. An unbalance in 
the impedances of the recording electrodes 
restricts the accuracy of measurement (Kamp 
and Lopes da Silva 1999). Generally the im-
pedance of EEG electrodes should be less than 
5 kΩ. The appearance of mains power interfer-
ence in the recording may be a sign of deterio-
rating impedance values (Reilly 1999).
The amplification or sensitivity of the sys-
tem can be varied according to the amplitude 
of the recorded signal. Sensitivity is the mag-
nitude of input voltage required to produce an 
output of standard amplitude. Gain is defined 
as the ratio of output voltage to input voltage. 
The relationship between the output and input 
is linear over the dynamic range of the ampli-
fier (Edmonds et al 2004a).
The frequency response of the amplifier is 
adjusted by the high and low pass filters. The 
cut-off frequencies correspond to the frequen-
cies at which the signal amplitude is attenuated 
to 70.7 % of the original (–3 decibels, dB). The 
high- and low-pass filters represent a compro-
mise between the reduction of noise and the 
preservation of fidelity in reproducing the sig-
nal. Low-pass filters may round off spikes and 
prevent their clear identification. The frequen-
cy response of the high-pass filter is related to 
its time constant, determined by the resistance 
Figure 2. Schematic diagram of the modified international 10–20 electrode placement system. Modified from 
Guideline thirteen: guidelines for standard electrode position nomenclature 1994 and Edmonds et al 2004a.
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and capacitance of the filter. The time constant 
and the cut-off frequency are inversely related. 
A time constant of one second results in the 
suppression of slow oscillations of less than 
0.16 Hz (Kamp and Lopes da Silva 1999, Reilly 
1999).
In digital EEG recordings, broad-band 
filters (commonly 0.1–70 Hz for scalp re-
cordings) are used in the analog amplifica-
tion stage. Subsequently, digital filters can be 
applied according to specific measurement 
purposes and situations. The high-pass filter, 
ranging from 0.01 to 5 Hz, stabilizes baseline 
drift. The low-pass filter, usually ranging from 
30 to 100 Hz, is used to remove noise that oc-
curs above the frequencies of interest and to 
prevent aliasing during signal digitization. In 
addition, a sharply attenuating notch filter at 
50 Hz (power mains frequency) can be used 
(Krauss and Webber 1999).
The analog to digital converter measures the 
continuous analog signal at discrete time inter-
vals. The amplitude resolution of digital EEG 
equipment can be expressed in bits (usually 
8–16 bits). Recording with 12 bits means that 
the full-scale voltage deflection is represented 
in 212 ( = 4096) increments. Approximately 
5–10 samples per cycle are needed to accu-
rately represent a waveform. An insufficient 
sampling rate results in loss of information of 
high frequency events and the distortion of 
lower frequency signals. In extracranial EEG 
recordings sampling rates of 200–400 Hz are 
commonly used (Krauss and Webber 1999).
The EEG artifact caused by QRS complexes 
is often intermittent, which complicates its 
detection. The ECG should always be moni-
tored in parallel with EEG, and changes in 
heart rate compared with the frequency of a 
suspected transient. The ECG artifact is most 
pronounced in channels oriented transversely 
to the primary ECG vector. Cardiac pacemak-
ers can produce brief, regular spikes in all EEG 
channels. Pulsating vessels can induce localized 
artifacts expressed either as smooth rhythmic 
slow waves or triangular waves of higher fre-
quency. The beating of the heart may produce 
an actual movement artifact. The electro-
oculographic artifact, caused by the rotating 
eyeball, can be recognized by the characteristic 
pattern of transient slow wave activity in awake 
or lightly sedated subjects or by formal eye 
movement monitoring. The frequency bands 
of ocular potentials overlap those of the EEG. 
A residual powerline or high-frequency signal, 
picked up by the body from the surrounding 
electromagnetic field, and fEMG, may be at-
tenuated to some extent by filtering. Significant 
overlap, however, exists between frequencies of 
EEG and fEMG activity. Also, the fEMG in it-
self may provide valuable information. Mouth 
and tongue movements may produce relatively 
large amplitude signals in the frontal channels. 
In addition, the movement of fluids in plastic 
tubing produces electric potentials. A roller 
pump may cause a sinusoidal artifact mainly in 
the frontal channels (Rampil 1998, Reilly 1999, 
Edmonds et al 2004a).
The difficulties arising from different arti-
facts are illustrated in the study by Wennervirta 
and colleagues, in which EEG was monitored 
during solid organ harvest from brain dead 
donors. For a significant portion of the total 
recording time both BIS and time-frequency 
balanced spectral entropy differed from zero, 
even when the donors with non-isoelectric 
EEG (4 / 16) were excluded from analysis 
(Wennervirta et al 2007).
Electroencephalogram rhythms  
and synchronization
EEG rhythms consist of regularly recurring 
waveforms of similar shape and duration 
(Steriade 1999). The α rhythm has a frequency 
range of 8–13 Hz. It is associated with the wak-
ing state, and is pronounced over the occipital 
cortex in the eyes closed state. The α rhythm 
mainly spreads through cortico-cortical path-
ways, but thalamocortical interaction is also 
involved (Steriade et al 1990). δ waves (1–4 
Hz) appear normally during deep sleep. They 
are probably generated by pyramidal cells 
during partial cortical deafferentation, and 
reflect sequencies of excitatory and inhibitory 
processes. Cholinergic stimulation from the 
basal forebrain during arousal suppresses the δ 
waves. Limbic θ waves (4–8 Hz) are more pro-
nounced in lower mammals than in humans. 
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The septal area is a pacemaker for this rhythm. 
EEG waves in the θ frequency range may oc-
cur during reduced cerebral metabolism and 
blood flow, representing a slowing down of α 
waves or precursors of δ waves (Steriade et al 
1990). According to John and Prichep, strong 
activation of the limbic areas with cortical pro-
jections can generate widespread θ rhythms 
(John and Prichep 2005). Fast waves (γ or fast 
β) occur during states of increased alertness. 
The term β rhythm is commonly used of 13–30 
Hz activity, and the term γ rhythm of activity 
faster than 30 Hz. Fast rhythms expressed on 
the EEG are generated by synchronized activ-
ity in cortical neuronal networks. Subcortical 
structures, particularly the thalamus, also 
participate in the generation of fast rhythms 
(Steriade 1999). On the other hand, fast oscil-
lations seem to characterize the spontaneous 
or background activity of cortical and thal-
amic cells during depolarization (Steriade et al 
1996b). Patterns of γ band synchrony and de-
synchrony have been linked to active cognitive 
integration during perception (Desmedt and 
Tomberg 1994, Rodriguez et al 1999).
The reticular thalamic nucleus, a key struc-
ture in the generation of spindle oscillations, 
is an important pacemaker in the brain. The 
GABA-ergic thalamic reticular neurons pro-
duce inhibition of the thalamocortical neu-
rons, which in turn provide feedback excitation 
to the reticular cells during rebound activity. 
The thalamocortical cells project to the corti-
cal neurons, which in turn project back to the 
thalamus, completing a second oscillatory loop. 
Spindle waves appear during unconsciousness 
and are associated with interruption of synap-
tic transmission through the thalamus. They 
are characterized by waxing and waning 1.5–2 
s sequencies of 7–14 Hz activity recurring at 
a 0.1–0.2 Hz rhythm. In deeper sleep stages, 
the incidence of spindles diminishes, and 
slower EEG rhythms progressively emerge. In 
addition to cortically generated δ waves, thal-
amic cells also display an intrinsic δ rhythm 
associated with membrane hyperpolarization. 
Spindles and δ waves are grouped by a very 
slow (< 1 Hz) cortical oscillation. During wak-
ing and rapid eye movement sleep or arousal, 
spindles and slow waves are blocked and they 
are replaced by low-amplitude fast waves in 
the thalamocortical circuit, associated with 
diffusely increased synaptic excitability. Brain 
activation is associated with focally synchro-
nized fast activity (Steriade et al 1990, Steriade 
et al 1996a, Steriade et al 1996b, Steriade 1999). 
The blockage of spindling and slow waves is ef-
fected by mainly cholinergic projections from 
the brainstem (reticular formation of the teg-
mentum) and basal forebrain to the thalamus 
and cortex. The thalamocortical projection 
neurons are stimulated and the inhibitory thal-
amic reticular cells are hyperpolarized, result-
ing in a switch from burst firing mode to tonic 
firing mode of thalamic and cortical neurons. 
Tonic firing is associated with enhanced infor-
mation processing. The brainstem monoamin-
ergic neurons are also involved in regulating 
behavioral states (Steriade et al 1990).
Hyper- or hyposynchronous brain states 
are associated with impaired consciousness. 
Perceptual or cognitive processing may either 
increase or decrease the level of synchroniza-
tion in the brain (Stam 2005).
Frequency domain analysis
The Fourier transform is used to represent a 
time-varying signal as a sum of sinusoids, each 
having a characteristic frequency, amplitude, 
and phase. The Fourier transform gives the 
complex amplitudes, containing information 
of both the magnitude and phase angle, as a 
function of frequency. The inverse Fourier 
transform returns the original signal. The pow-
er spectrum can be estimated by the squared 
magnitudes of the complex amplitudes of the 
frequency components, and can be calcu-
lated by multiplying the Fourier transform of 
a signal by its complex conjugate. The power 
spectrum does not contain phase information 
(Rampil 1998, Viertiö-Oja et al 2004).
The Fourier transform assumes that the 
signal is stationary, i.e. its statistical properties 
do not vary with time. In reality, physiologi-
cal signals are nonstationary. They are divided 
into quasi-stationary segments or epochs be-
fore processing, either overlapping or continu-
ous. In the case of digitized data, the discrete 
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Fourier transform (DFT) can be applied. Fast 
Fourier transform (FFT) algorithms allow ef-
ficient computation of the DFT. In order for 
the digitized signal to be fully representative of 
the original signal, the sampling rate must be 
greater than twice the highest frequency con-
tained in the original signal (Shannon 1949, 
Krauss and Webber 1999). The power spectral 
density function (PSD) can be estimated by us-
ing the squared magnitude values of the results 
of the DFT, also called the periodogram. In 
the Welch periodogram method, the periodo-
grams of short partly overlapping epochs are 
averaged to generate a smoother PSD. 
Power spectral variables
Variables used to characterize the PSD include 
the median frequency (MF), which divides 
the power spectrum into two equal halves, the 
spectral edge frequency (SEF), below which 
lies a certain percentage (most often 95 %; 
SEF95) of the total power, and either the ab-
solute or relative power in different frequency 
bands. The frequency bands most often used in 
EEG analysis are called δ (1–4 Hz), θ (4–8 Hz), 
α (8–13 Hz) and β (13–30 Hz). Occasionally, 
a high frequency band γ (or β2) (30–55 Hz) 
is recognized. The δ waves are characterized 
by a high amplitude. The β (γ) waves consist 
of low amplitude irregular activity. It may be 
that the dominant frequency of EEG activity is 
determined by the level of sensory processing, 
which is controlled separately from the level of 
vigilance (Edmonds et al 2004a).
The interindividual variability in the dis-
tribution of EEG power among the different 
frequency bands is large. Different drugs have 
different effects on the EEG (Billard et al 1997). 
The power spectral variables are highly de-
pendent on the filter settings of the amplifier. 
Major shifts in the lower frequency bands can 
occur without a change in SEF95 (Tonner and 
Bein 2006). The spectral content of awake EEG 
varies with age. The total EEG power decreases 
with age. During deep propofol anesthesia the 
amplitude of δ waves is smaller in elderly pa-
tients than in younger individuals (Schultz et 
al 2004).
The power spectral variables do not change 
in a monotonic fashion during changing anes-
thetic depth. They also depend on the specific 
anesthetic agent used. Thus they do not convey 
explicit information of the anesthetic depth 
(Todd 1998). During anesthetic induction, the 
power in the α and β bands first increases and 
then decreases with increasing sedation. The 
change in δ activity is also biphasic, but the 
decrease in δ power occurs at deeper levels of 
anesthesia. The values of different EEG vari-
ables at the moment of loss of consciousness 
vary widely between individuals (Kuizenga 
et al 2001). Correspondingly, the response of 
SEF95 and MF to increasing anesthetic con-
centrations is biphasic: with deepening seda-
tion these variables first increase compared to 
awake values and then decrease (Katoh et al 
1998, Kuizenga et al 2001). Thus, for example, 
a certain value of SEF may be associated with 
different anesthetic depths within a patient, 
or represent different anesthetic depths with 
different drugs. When burst suppression oc-
curs, many spectral calculation methods fail, 
or SEF may paradoxically increase, reflecting 
the high frequency bursts. The univariate EEG 
descriptors may be useful as trend monitors 
regarding changes in hypnotic depth, espe-
cially during surgical anesthesia as opposed to 
light sedation. Power spectral variables can be 
used to assess the pharmacodynamic effect of 
some single-agent infusions, especially opioids 
(Todd 1998, Tonner and Bein 2006).
Katoh and colleagues found the SEF95 and 
MF to predict the level of sedation better than 
chance alone, but significantly worse than BIS 
or end-tidal sevoflurane concentration (Katoh 
et al 1998). Although better than the MF or 
power in different EEG frequency bands, the 
SEF95 was found to be a less accurate measure 
of midazolam-induced sedation than BIS (Liu 
et al 1996). In a study by Sleigh and Donovan 
the sensitivity, specificity and negative and 
positive predictive values of SEF95 for dis-
criminating between awake and anesthetized 
conditions during propofol induction were 
around 70 %. They reported that the overlap in 
SEF values between different stages of anesthe-
sia was greater than that in BIS values (Sleigh 
and Donovan 1999).
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When interpreting processed EEG vari-
ables, it is important to refer to the raw signal. 
The waveform of the raw EEG and transient 
phenomena are lost with transformation to 
frequency domain (Yli-Hankala et al 1993b). 
Also, the basic requirements of correct signal 
acquisition must be met, for example, the im-
pedance of the electrodes must be acceptable 
(van Gils et al 1997).
Dynamics of the  
electroencephalogram signal
In a linear dynamical system, changes in the 
state of the system can be modeled by linear 
equations. In a nonlinear system nonlinear 
equations are required. In a linear system, the 
output is proportional to the input, whereas in 
a nonlinear system, small changes in the input 
may have a large effect, which is not directly 
proportional to the change in input (Stam 
2005). A dynamical system is deterministic if 
its state changes can be described by linear or 
nonlinear equations, otherwise it is stochas-
tic.
In healthy, waking subjects most EEG ep-
ochs cannot be distinguished from a linear 
stochastic process, but occasionally significant 
nonlinearity can be detected (Stam et al 1999, 
Stepien 2002). In contrast to the normal EEG 
signal, epileptic seizures often display strongly 
nonlinear dynamics (Pijn et al 1997, Ferri et al 
2001, Burioka et al 2005). Watt and Hamerof 
were the first to suggest that EEG analysis 
based on nonlinear dynamics could be used 
to assess the depth of anesthesia (Watt and 
Hameroff 1988).
Higher order spectra
In the time domain, the first moment or ex-
pected value of a time series is the mean. The 
second moment of a discrete, zero-mean signal 
is the autocorrelation function, the expected 
value of the signal multiplied by the same 
signal with a certain time lag. If the time lag 
is zero, this is the variance of the signal. A 
Gaussian signal can be fully characterized by 
its mean and variance (McLaughlin et al 1995, 
Schwilden 2006).
Higher order moments are the expected 
values of functions with progressively more lag 
terms, e.g. the third moment depends on two 
independent lags. Higher than second-order 
moments are needed to describe the prob-
ability distribution of non-gaussian signals. 
If the time series is generated by a Gaussian 
process, the higher-order moments are either 
zero (e.g. the third-order moment) or contain 
redundant information. Also, if the phases of 
the signal are random, the higher moments are 
zero (McLaughlin et al 1995, Schwilden 2006).
In the frequency domain, the power spec-
trum (second-order spectrum) can be calcu-
lated by performing a DFT of the autocorre-
lation function or by multiplying the Fourier 
transform of the signal by its complex conju-
gate. Similarly, the Fourier transform of the 
higher moments of a time series define higher-
order spectra. The bispectrum (third-order 
spectrum) can be calculated by taking a two-
dimensional DFT of the third-order cumulant 
(a function of the first to third moments) or by 
forming the product of the Fourier transforms 
at two different frequencies and the complex 
conjugate at their sum (McLaughlin et al 1995, 
Schwilden 2006).
The bispectra of the original signals and sur-
rogate signals with identical power spectra, but 
random phases, can be compared to investigate 
whether the original signal contains informa-
tion in the phase spectrum. Schwilden and col-
leagues found that in over 90 % of stationary 
EEG segments the normalized bispectrum, the 
bicoherence, was zero or a constant (Schwilden 
2006).
Whereas the power spectrum is related to 
the variance, the bispectrum is related to the 
skewness of the probability distribution func-
tion of the signal. When the distribution of the 
signal is skewed, the bispectrum differs from 
zero. For stochastic wide-band signals, the bi-
coherence is a measure of the signal skewness. 
For deterministic signals, a peak in bicoherence 
may indicate the presence of quadratic phase 
coupling, a type of nonlinearity (McLaughlin 
et al 1995, Schwilden 2006). Nonlinear systems 
typically display phase coupling. That is, the 
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phases of certain frequency components are 
dependent on the phases of other frequency 
components in the signal (Sigl and Chamoun 
1994). Quadratic phase coupling between the 
frequency components f1 and f2 implies that 
the phase of f1 + f2 equals the phase of f1 + the 
phase of f2 (Bullock et al 1997).
The magnitude of the bispectrum is given 
by the magnitude of the product of the com-
plex amplitudes of f1 and f2 and the complex 
conjugate of f1 + f2, averaged over several ep-
ochs. If one of the three frequency components 
is small or absent, or if the phase angles are 
not aligned, this average product will be small 
and the bispectral energy will be low. Thus in 
the absence of phase coupling the bispectrum 
will tend toward zero. The real triple product is 
calculated as the product of the squared mag-
nitudes of the complex amplitudes of the three 
frequency components, averaged over the ep-
ochs. Its square root is an analog of the bispec-
trum with maximal phase coupling. Both the 
bispectrum and the real triple product depend 
on the signal power. The ratio of the magnitude 
of the bispectrum and the square root of the 
real triple product gives the bicoherence, which 
is independent of the amplitude or power of 
the signal. The bicoherence varies from zero to 
one according to the degree of phase coupling 
among the three frequency components (Sigl 
and Chamoun 1994, Rampil 1998).
Electroencephalography during anesthesia
In the practise of anesthesia, EEG may be used 
to evaluate the adequacy of oxygen delivery to 
the brain, to monitor therapeutic metabolic 
suppression in the cortex, or to assess the level 
of functional CNS suppression induced by 
anesthetic agents (Rampil 1998). One to four 
channels are commonly registered for these 
purposes. Gibbs and colleagues were the first 
to suggest that EEG patterns could be used as 
a measure of anesthetic depth. They reported 
that EEG changes during sedation resembled 
those during natural sleep and EEG patterns 
of very deep anesthesia were similar to those 
observed during a coma from whatever cause 
(Gibbs et al 1937).
Awareness is associated with desynchro-
nized, low voltage, high frequency EEG pat-
terns. Depression of consciousness leads to 
slower EEG patterns with increased cortical 
synchrony (Rampil 1998). General anesthesia 
interferes with synaptic function (el-Beheiry 
and Puil 1989). Interestingly, by modifying the 
probability of activation of adjacent units in a 
cellular automaton model, and using the num-
ber of active units as a surrogate of EEG am-
plitude, Sleigh and Galletly were able to simu-
late the amplitude and frequency changes that 
occur in the EEG during changing anesthetic 
depth. Above a critical connection probability 
the activity of the network tended to be self-
sustaining, whereas below the critical thresh-
old almost all induced signals rapidly died out 
(Sleigh and Galletly 1997).
Alkire demonstrated that during increas-
ing anesthetic effect and decreasing CMR, the 
EEG total power and relative δ power tend to 
increase, whereas relative β, α and θ powers, 
SEF95, and MF tend to decrease. In that study, 
BIS was the strongest predictor of CMR reduc-
tion during propofol and isoflurane anesthesia. 
The study was performed on volunteers, and 
the CMR reductions mostly varied from 40 % 
to 60 % (Alkire 1998).
John and colleagues investigated quantita-
tive EEG during various different anesthetic 
techniques (induction with propofol, thiopen-
tal, or etomidate, maintenance with isoflurane, 
sevoflurane, desflurane, propofol with or with-
out N2O, and opioids). They observed that a 
general increase in EEG power occurred at loss 
of consciousness (LOC), together with a shift 
toward anterior predominance. The increase in 
power was most marked in the δ and θ bands. 
In contrast, power in the γ band decreased 
sharply at LOC (after increasing during seda-
tion) and decreased further during the main-
tenance of anesthesia, most markedly around 
40 Hz. With induction, the coupling between 
left and right prefrontal cortices and between 
the prefrontal and frontal cortices within each 
hemisphere increased, consistent with the oc-
currence of large amplitude slow waves. On the 
other hand, the coherence between the frontal 
and occipital cortices within each hemisphere 
and between left and right frontal and oc-
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cipital cortices decreased. During emergence 
the decreased coherence in the δ and θ bands 
failed to reverse. In contrast, recoupling was 
observed in the γ band during emergence and 
at return of consciousness (ROC) the γ power 
and coherence was increased in all areas. The 
power in the δ and θ bands decreased at ROC 
(John et al 2001). Recoupling in δ and α bands 
occurred only several minutes after respon-
siveness was restored (John and Prichep 2005). 
The inferred anatomical regions displaying the 
most marked slow wave changes included the 
prefrontal cortex, the superior frontal gyrus, 
the limbic system, the basal ganglia, and the 
thalamus. The authors concluded that the ob-
served electrophysiological changes are associ-
ated with blockade of perception at induction 
(John et al 2001).
Ketamine produces a frontally dominant 
rhythmic θ EEG activity. With increasing 
dose, polymorphic large amplitude δ activity 
and interspersed low amplitude β activity in-
crease (Hirota 2006). In addition to prominent 
increases in θ activity, ketamine anesthesia is 
associated with the appearance of γ spindles. 
Increasing the ketamine dose also increases α 
and β power (Maksimow et al 2006). N2O in-
creases fast β activity, associated with analgesia 
and depressed consciousness. The EEG effects 
of xenon resemble those of the potent volatile 
agents, with an increased β activity at low doses 
and then gradual increases in rhythmic θ and 
δ activity with loss of consciousness (Hirota 
2006).
The main EEG effect of opioids is a shift of 
the frequency spectrum to the δ band (Billard 
et al 1997). Olofsen and colleagues found that 
in the unstimulated state, the overall effect of 
remifentanil on the pharmacodynamic rela-
tionship between end-tidal sevoflurane con-
centrations and EEG effect, as estimated by BIS, 
a canonical univariate parameter, and SEF, was 
minor. Of these variables, BIS seemed to most 
closely reflect the effect-site concentration of 
sevoflurane. During surgery, the prediction of 
EEG effect based on end-tidal sevoflurane con-
centrations was poor when the pharmacody-
namic parameters derived in the unstimulated 
state were used (Olofsen et al 2002).
Bouillon and colleagues found that the in-
teraction of propofol and remifentanil on BIS 
and approximate entropy (ApEn) was additive, 
but with concentrations less than 8 ng / ml the 
effect of remifentanil on either EEG measure 
was modest. Due to a strong synergistic inter-
action between propofol and remifentanil for 
suppression of responsiveness to noxious and 
non-noxious stimulation, the EEG state (as 
measured by e.g. BIS or ApEn) at loss of re-
sponsiveness depends on the particular com-
bination of hypnotic and analgetic concentra-
tions. ApEn may be more sensitive to opioid 
effects than BIS (Bouillon et al 2004).
The total EEG power was the first processed 
EEG variable used in assessing and controlling 
the depth of anesthesia (Bickford 1950). It is 
insensitive to significant changes in the fre-
quency distribution, however, and it is affected 
by electrode location (Rampil 1998).
Burst suppression
Burst suppression is an EEG pattern char-
acterized by alternating periods of high and 
variable amplitude, mixed frequency activity, 
and periods of partial or complete attenuation 
of cortical electrical activity. In the context of 
anesthesia, this is a fully reversible phenom-
enon indicative of excessively deep anesthesia, 
whereas in the context of brain damage it is 
a sign of irreversible damage associated with 
a very poor prognosis (van Gils et al 1997). 
During deepening anesthesia, the suppres-
sion periods become progressively longer, 
until continuous suppression occurs. The ex-
act morphology of bursts varies with different 
anesthetic agents (Yli-Hankala and Jäntti 1990, 
Jäntti et al 1993, Särkelä et al 2002). The burst 
onset and offset are associated with DC shifts 
(Jäntti et al 1993). These shifts are abrupt dur-
ing isoflurane and sevoflurane induced bursts, 
whereas during propofol anesthesia the onset 
and offset of bursts are smooth (Huotari et 
al 2004). Occasionally, bursts may turn into 
epileptic discharges (Jäntti and Yli-Hankala 
1990). The bursts share several features of epi-
leptic discharges: sharp spikes, a negative DC 
shift during the burst, and an increase in heart 
rate at burst onset.
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Before the onset of burst suppression, the 
cortical neurons are hyperpolarized, and the 
slow rhythm of intracellular depolarizations 
(< 1 Hz) associated with anesthesia is progres-
sively disorganized. The cortical cells begin to 
display transient, shorter depolarizations sepa-
rated by periods of complete electrical silence. 
The electrocorticography closely follows the 
intracellular events, as does the mass electrical 
activity of the brainstem. The synaptic excit-
ability of cortical neurons is reduced, but some 
stimuli may induce sustained recovery from 
burst suppression. Some thalamic neurons 
may retain rhythmic electrical activity during 
periods of electrocorticography suppression, 
reflecting their intrinsic pacemaker properties. 
With very deep burst suppression, however, 
the thalamic cells become silent. It was ob-
served that the frequency of thalamic intrac-
ellular depolarizations during a burst closely 
corresponded to the frequency of spiky waves 
in the EEG. Increased K+ conductance may 
be important for the initial hyperpolarization 
(Steriade et al 1994).
During isoflurane anesthesia, deep enough 
to induce EEG suppression, bursts can be 
evoked by non-noxious and noxious stimuli. 
The spontaneous bursts may represent re-
sponses to some internal stimuli, or they may 
reflect properties of a burst pacemaker (Yli-
Hankala et al 1993a, Hartikainen et al 1995b, 
Hartikainen et al 1995a). Different stimulation 
modalities induce different burst waveforms, 
the morphology of which is stable within the 
same individual at a constant anesthetic level. 
Noxious stimulation is the most effective in 
activating the EEG, and may restore the con-
tinuous EEG pattern. During deepening an-
esthesia, the probability of stimulus-evoked 
bursts decreases. Also, stimulus-offset evoked 
bursts may predominate over stimulus-onset 
evoked bursts during deeper anesthetic levels. 
Deepening anesthesia is probably associated 
with both increasing inhibition and increas-
ing neuronal excitability (Hartikainen et al 
1995b). During propofol anesthesia, deep 
enough to induce EEG suppression, bursts can 
be evoked by noxious electrical stimulation. 
The sharp evoked negative wave and the burst 
wave, which during isoflurane or sevoflurane 
anesthesia seem to be merged, are temporally 
separate during propofol anesthesia and may 
occur independently. Deep propofol anesthesia 
is characterized by the occurrence of spindles 
both during bursts and during suppressions 
(Huotari et al 2004).
Time-domain analysis techniques can 
be used in burst suppression detection. 
Suppression can be defined as a period of EEG 
longer than 0.5 s, during which the EEG am-
plitude is less than ±5 µV. A frequently used 
quantitative measure of burst suppression is 
the burst suppression ratio (BSR), that is the 
fraction of the epoch length where suppression 
is present. Because burst suppression is a very 
variable phenomenon, the BSR should be aver-
aged over at least 60 s (Rampil 1998). Several 
different approaches to burst suppression de-
tection and quantification have been reported. 
Särkelä and colleagues suggested that the av-
erage energy present in the bursts should also 
be quantified. They compared an amplitude-
based burst suppression detection method 
with a method based on the Nonlinear Energy 
Operator (NLEO). They found that after high-
pass (> 47 Hz) and low-pass (< 8 Hz) filtering 
and applying agent-specific decision threshold 
values for classification, the NLEO method 
resulted in more sensitive artifact detection 
and in the case of propofol more sensitive sup-
pression detection compared to the amplitude-
based method (Särkelä et al 2002). The NLEO 
method is used for burst suppression detection 
in time-frequency balanced spectral entropy 
(M-Entropy®) monitoring.
Arousal reactions
Event-related desynchronization corresponds 
to a decrease of power in certain EEG frequen-
cy bands during cortical sensory or cognitive 
information processing, or motor behavior. 
It reflects increased cellular excitability in the 
thalamocortical circuits. Event-related syn-
chronization refers to an increase of power in 
certain EEG frequency bands. γ band synchro-
nization reflects active information processing, 
perhaps related to sensorimotor integration 
(Pfurtscheller 1999).
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Kuramoto and colleagues demonstrated in 
anesthetized dogs that during noxious stimu-
lation the CMR and EEG desynchronization 
responses were closely coupled (Kuramoto et 
al 1979).
Röpcke and colleagues showed that com-
pared to the unstimulated state, in the presence 
of surgical stimulation considerably higher des-
flurane concentrations were required to main-
tain a certain level of EEG activity, as measured 
by BIS (v. 2.5), SEF95, and MF. Surgery was 
thus associated with an EEG arousal response 
(Röpcke et al 2001).
A noxious mechanical stimulus caused de-
creases in the total EEG power and the δ, θ and 
α band power in goats under 0.6 or 0.9 MAC 
isoflurane anesthesia, whereas no significant 
change in EEG activity was observed after the 
stimulus at 1.1 or 1.4 MAC. The β power was 
unchanged at all anesthetic concentrations. At 
the lower isoflurane concentrations, desyn-
chronization was observed in thalamic and 
MRF areas as well (Antognini and Carstens 
1999).
In a rodent study, Orth and colleagues 
found that propofol infused at a rate around 
that needed to prevent a movement responses 
to tail clamping blunted the EEG arousal reac-
tion to repetitive and supramaximal noxious 
stimuli, whereas halothane at a concentration 
around one MAC did not. EEG desynchroni-
zation and increases in SEF95 and MF were 
observed at 1.2 MAC halothane with electrical 
stimulation and tail clamping. With 1.2 ED50 
propofol a decrease in SEF95 was seen after the 
supramaximal stimuli (Orth et al 2005).
Electrical stimulation of the midbrain re-
ticular formation induced EEG activation in 
rats during 1.2 MAC halothane anesthesia, 
but not during 1.2 ED50 propofol anesthesia. 
At some stimulation intensities, a decrease of 
SEF95 / MF at 1.2 ED50 propofol anesthesia 
occurred. Noxious mechanical or electrical 
stimulation of the tail caused some EEG ac-
tivation at 0.8 ED50 propofol, but little at 1.2 
ED50 propofol. The EEG activation induced 
by tail stimulation was considerably greater 
during 0.8–1.2 MAC halothane anesthesia. 
Thus, propofol and halothane have different 
electrophysiological effects on cortical activity 
and generation of movement (Antognini et al 
2006).
Bimar and Belleville described the occur-
rence of both EEG desynchronization respons-
es and sudden shifts of the power spectrum to 
lower frequencies with increased amplitude 
during relatively light levels of halothane–N2O 
or opioid–N2O anesthesia (Bimar and Bellville 
1977). Kochs and colleagues also reported 
increases in δ and decreases in α and β band 
activity after surgical stimulation during iso-
flurane–N2O anesthesia, especially in frontal 
leads. The changes were pronounced during 
0.6 % isoflurane and attenuated during 1.2 % 
isoflurane. The authors concluded that different 
doses of anesthetics and different states of the 
reticular activating system may lead to varying 
EEG arousal responses (Kochs et al 1994).
Kiyama and Takeda showed an EEG arousal 
response to abdominal skin incision during 
isoflurane–N2O anesthesia in patients without 
an epidural blockade, whereas no EEG changes 
were noted in patients who had received an 
epidural blockade before incision. In the for-
mer group, SEF95, MF, and relative θ, α, and β 
band powers decreased after the skin incision, 
and relative δ power increased, accompanied 
by an increase in blood pressure. The authors 
emphasized the importance of considering the 
adequacy of analgesia when interpreting intra-
operative EEG changes (Kiyama and Takeda 
1997).
Isoflurane effect in the spinal cord influenc-
es the probability of EEG desynchronization 
caused by peripheral noxious stimulation or 
electrical MRF stimulation, in the presence of 
constant brain isoflurane concentrations. The 
increase in MRF single unit activity in response 
to peripheral noxious stimulation is also inhib-
ited by increasing isoflurane concentrations in 
the spinal cord. Isoflurane action in the spinal 
cord thus affects the arousal state of the brain, 
presumably by dose-dependent blocking of as-
cending somatosensory neuronal transmission 
(Antognini et al 2000b, Antognini et al 2003). 
The direct brain effect and the indirect spinal 
cord effect of isoflurane on the EEG desynchro-
nization and thalamic single unit response to 
noxious stimulation seem to be approximately 
equally important (Antognini et al 2000a).
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Menigaux and colleagues showed that es-
molol attenuated the somatic, hemodynamic 
and BIS arousal reactions to laryngoscopy 
and tracheal intubation. Esmolol did not af-
fect BIS values before noxious stimulation. 
The authors speculated that esmolol might in-
hibit an EEG arousal response by blocking the 
β-adrenoreceptors in the reticular activating 
system (Menigaux et al 2002). In a relatively 
small, placebo-controlled study Johansen ob-
served that during propofol–alfentanil anes-
thesia an infusion of esmolol was associated 
with a decrease in BIS values and an increase 
in the suppression ratio. Surgical stimuli were 
not controlled (Johansen 2001).
Wilder-Smith and colleagues reported an 
EEG arousal reaction with laryngoscopy and 
intubation after propofol–N2O or thiopen-
tone–N2O induction. The relative EEG θ, α 
and β band powers increased, and the relative 
δ power decreased, together with an increase 
in blood pressure. The EEG changes were more 
pronounced after thiopentone induction, de-
spite similar pre-stimulus EEG profiles. The 
authors concluded that even though prediction 
of the response to nociception based on pre-
stimulus EEG patterns may not be possible, 
the arousal reactions themselves could be used 
to study intraoperative nociception (Wilder-
Smith et al 1995).
Epileptiform activity and seizures
Epileptiform discharges may be reflected in 
the surface EEG as monophasic negative, 
monophasic positive, or polyphasic waves. A 
negative DC shift occurs during the seizure 
(Speckmann and Elger 1999).
Spikes and sharp waves are closely related 
paroxysmal discharges, suggestive of epileptic 
activity. A spike is a pointed, multiphasic EEG 
transient with a variable amplitude and a dura-
tion of 20–70 ms, which is clearly distinguish-
able from the background activity. They may 
represent hypersynchronous neural discharges. 
Spikes may be followed by a slow negative com-
ponent. A sharp wave is a pointed, multiphasic 
EEG transient with a duration of 70–200 ms. 
They usually appear as random focal discharg-
es. Multiple spike complexes or polyspikes are 
bursts of closely associated diphasic spikes 
occurring more or less rhythmically. On the 
scalp, they usually occur as bilateral or gen-
eralized synchronous discharges. Discharges 
consisting of spike and slow wave complexes 
may represent the alternation of excitation and 
inhibition. Periodic discharges usually occur 
in severe CNS disease such as encephalitis, 
infarction, acute anoxia, metabolic disorders, 
or neoplasia, associated with paroxysmal or 
epileptogenic properties. They may also oc-
cur during complex partial status epilepticus. 
The periodic discharges may present as sharp 
waves or complex patterns with mixed spiky 
and slower components (Brenner and Schaul 
1990, Niedermeyer 1999). The mechanism of 
periodicity is not clear. Periodic lateralized 
discharges may represent an unstable ictal-in-
terictal neurophysiological state (Niedermeyer 
1999). Focal periodic epileptiform discharges 
indicate structural damage. When generalized, 
they are associated with severely impaired con-
sciousness (Edmonds et al 2004b).
Seizure activity is generally associated with 
a marked elevation of HR and blood pres-
sure (Prudic et al 1987). Other sympathetic 
responses such as a decrease in skin resis-
tance (sweating) and vasoconstriction may 
also occur (Johnson and Davidoff 1964). The 
magnitude of HR change may depend on the 
extent of seizure spread and the presence or 
absence of spikes and clinical manifestations. 
Occasionally, transient HR slowing or rhythm 
abnormalities may occur during seizures 
(Johnson and Davidoff 1964, Epstein et al 
1992). A hyperdynamic cardiovascular reac-
tion associated with epileptiform EEG activity 
has also been shown during sevoflurane anes-
thesia (Yli-Hankala et al 1999b, Vakkuri et al 
2000, Vakkuri et al 2001).
Spike-wave (SW) or spike-wave / polyspike-
wave (SW / PSW) seizures, the latter often as-
sociated with fast paroxysmal runs (Lennox-
Gastaut seizures), are likely generated within 
the neocortex. They distribute synaptically to 
other cortical areas and eventually to the thala-
mus. The paroxysmal depolarization shifts in 
cortical neurons during SW / PSW seizures 
are followed by rhythmic spike bursts in the 
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inhibitory thalamic reticular neurons. During 
cortical fast runs, thalamic reticular neurons 
fire spike doublets or triplets, followed by an 
after-depolarization. Reticular neurons in turn 
project to the thalamocortical neurons. The 
majority of the thalamocortical cells display 
sustained hyperpolarization and phasic IPSPs 
during SW / PSW seizures and do not project 
back to the cortex, but instead are “disconnect-
ed” from the outside world. The phasic IPSPs 
show the same frequency as the cortical spikes 
and the reticular cell spike bursts. The remain-
ing minority of thalamocortical cells may have 
a role in enhancing the coherence of activity 
betwen different cortical areas during seizures. 
At the end of cortical seizures thalamocortical 
cells fire at high rates (Timofeev and Steriade 
2004).
The properties of cortical and thalamic 
neurons are modulated by synaptic activity in 
corticothalamic networks and during different 
behavioral states. During sleep, spindles are 
generated by thalamic reticular cells, regular 
δ activity by thalamocortical cells, and slower 
rhythmic oscillations (< 1 Hz) by cortical cells. 
The highly synchronized activity in thalamo-
cortical circuits during slow wave sleep pro-
motes seizure paroxysms. Both local increases 
in excitation and decreases in synaptic activity 
may trigger seizures, as partial deafferentation 
increases synaptic excitability. Ultra-fast oscil-
lations generated by fast rhythmic bursting 
cortical cells have been implicated in the initia-
tion of seizures. If these field potential “ripples” 
reach a critical amplitude, neuronal excitabil-
ity is increased, resulting in recruitment of 
inactive neurons into synchronous firing. This 
feedback amplification may be responsible for 
the initiation and the spread of paroxysmal 
activity. The amplitudes of EPSPs, leading to 
action potentials, progressively increase prior 
to the onset of seizures (Timofeev and Steriade 
2004).
Isolated paroxysmal depolarization shifts 
may evolve into full-blown seizures. The par-
oxysmal depolarization shifts during SW com-
plexes, manifested as EEG spikes, contain an 
important inhibitory component. The wave 
component is associated with hyperpolariza-
tion, probably due to K+ currents and decreased 
excitatory input. Hyperpolarization leads to 
increased excitability and rebound depolar-
ization, inducing the next paroxysmal cycle. 
The neuronal synchrony is increased during 
interictal spikes, and is even higher during 
seizures. During the seizure a progressive de-
polarization, which reaches its maximum dur-
ing fast runs, occurs and the end of the seizure 
is followed by a prolonged hyperpolarization. 
The termination of seizures may be due to 
overwhelming K+ currents and decreased syn-
aptic responsiveness (partly due to decreased 
extracellular Ca2+ concentration), which pre-
vents further recurrent excitation (Timofeev 
and Steriade 2004).
Bispectral index scale monitoring
The development and technique of 
bispectral index scale monitoring
Dumermuth and colleagues and Barnett and 
colleagues were among the first to describe 
the EEG bispectrum in waking and sleeping 
subjects (Barnett et al 1971, Dumermuth et 
al 1971). Bullock and colleagues reported in 
a series of depth EEG recordings in epileptic 
patients during wakefulness, sleep, and sei-
zures that pairs of frequency components with 
prominent bicoherence can appear episodical-
ly between long periods of virtually no signifi-
cant bicoherence. When present, the pattern of 
quadratic phase coupling is very variable and 
changes rapidly along both time and distance. 
EEG bicoherence generally increases during 
sleep and seizure activity. Some seizures dis-
play a “hair-brush” bicoherence pattern, with 
narrow peaks occurring at regular intervals 
in the bifrequency plane. Also, bicoherence 
is generally relatively high in deep temporal 
structures. The authors noted that changes in 
bicoherence may result not only from changes 
in the absolute amount of quadratic phase cou-
pling, but also from changes in the amount of 
non-quadratically coupled power at the cor-
responding frequencies. They also noted that 
transient sharp events appear to be a common 
cause of quadratic phase coupling (Bullock et 
al 1997).
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The development of bispectral index scale 
monitoring was begun by collecting a database 
of artifact-free EEGs from 195 subjects with 
different anesthetic regimens. Of these sub-
jects, 59 were volunteers for whom the clini-
cal end-point was the maximal EEG effect of 
the drug (propofol or alfentanil). For the other 
subjects, data was collected during surgical 
procedures, and movement or hemodynamic 
responses to noxious stimulation were used 
as the clinical end-points. From a large set of 
variables derived from the EEG bispectrum, 
a subset that best predicted the associated 
clinical end-point was selected. Discriminant 
analysis was used to compute coefficients that 
maximized the separation between responders 
and non-responders, for these variables. The 
possible values of the linear combination of 
variables were limited to 0–100 with sigmoidal 
scaling (Kearse et al 1994a). Subsequently, ad-
ditional EEG records (up to roughly 1500 pa-
tients) with time-matched clinical end-points 
and drug concentrations were collected and 
used for updating the BIS algorithm. Different 
time domain, frequency domain, and bispec-
tral EEG descriptors were extracted from the 
artifact-free EEGs and statistically ranked by 
their ability to predict the corresponding clini-
cal condition. The best descriptors were fitted 
to a multivariate logistic regression analysis 
and the derived index was prospectively tested 
(Rampil 1998, Johansen and Sebel 2000).
Bispectral index monitoring was approved 
by the FDA for monitoring of anesthetic effect 
in 1996. BIS is a dimensionless number scaled 
from 100 to 0, 100 representing the awake state 
and 0 representing complete cortical electrical 
silence. Versions 2.0 and higher have been op-
timized to correlate with the level of sedation 
and hypnosis. The latest revisions, 4.0 and 4.1, 
have been designed for use with a four-lead pro-
prietary sensor. They apply enhanced artifact 
recognition and rejection algorithms (fEMG, 
eye movements, electrocautery) (Johansen and 
Sebel 2000, Johansen 2006).
The bispectral index is calculated from digi-
tized and band-pass filtered EEG in 2 s epochs. 
Several algorithms are used to reject artifacts. 
The degree of burst suppression is estimated 
with two different algorithms, BSR, and 
“QUAZI”. The latter improves burst suppres-
sion detection in the presence of a wandering 
baseline by incorporating information of low 
frequency (< 1 Hz) power. A Blackman window 
is applied to the artifact-free epoch, and then 
FFT and the bispectrum are calculated. The 
spectral and bispectral values are smoothed 
by using a moving average. BetaRatio is a vari-
able defined by the logarithm of the ratio of 
power in the frequency bands 30–47 Hz and 
11–20 Hz. SynchFastSlow is calculated as the 
logarithm of the ratio of summed bispectrum 
values in the areas of the bifrequency plane 
defined by 40–47 Hz and 0.5–47 Hz. Due to 
symmetry and the limit imposed by the sam-
pling frequency, only a subset of the associated 
frequency combinations need to be consid-
ered. The bispectral index is computed by a 
nonlinear function combining the variables 
BetaRatio, SynchFastSlow, BSR and QUAZI. 
The different subparameters are weighted ac-
cording to the depth of anesthesia. In contrast 
to power spectral variables, BIS decreases mo-
notonously with increasing depth of anesthesia 
(Rampil 1998).
The association of bispectral index values 
with the sedation level and the loss and 
return of consciousness
BIS correlates well with the observer’s as-
sessment of alertness / sedation (OAA / S) 
scale with various anesthetic agents (Glass et 
al 1997, Katoh et al 1998, Iselin-Chaves et al 
2000, Mourisse et al 2004). Katoh and col-
leagues found that the prediction probability 
(PK) value of BIS (v. 3.2) for predicting OAA / S 
was 0.93 during sevoflurane sedation (Katoh et 
al 2000). Mourisse and colleagues reported a 
similar PK value of 0.88 (v. 3.4) during propo-
fol sedation (Mourisse et al 2004). Stryus and 
colleagues reported that BIS (v. 3.4), the A-line 
Autoregressive Index based on MLAEP, and 
the estimated propofol effect-site concentra-
tion had similarly high PK values (0.87–0.95) 
for predicting the OAA / S level and the loss of 
the lash reflex, and the addition of remifentanil 
2–4 ng / ml did not affect their performance 
(Struys et al 2003).
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Struys and colleagues reported that the BIS 
(v. 3.4) values associated with 50 % and 95 % 
probabilities of LOC during propofol anesthe-
sia were 61 and 55 (Struys et al 2003). Katoh 
and colleagues found the BIS (v. 3.2) values 
associated with 50 % and 95 % probabilities of 
loss of response to a loud verbal command to 
be 73 and 65 during sevoflurane anesthesia. 
As the intensity of non-noxious stimulation 
increases, the BIS-response curve is shifted to 
lower BIS values (Katoh et al 1998). LOC oc-
curred at similar BIS values across different 
adult age groups (from 18 to 85 years) (Katoh 
et al 2000). Glass and colleagues reported 50 % 
and 95 % probabilities of LOC at BIS (v. 3.0) 
values 65 and 51 from combined data of volun-
teers receiving propofol, isoflurane, or mida-
zolam (Glass et al 1997). Overall, loss of con-
sciousness in 50 % and 95 % of patients occurs 
roughly at BIS values 65–70 and 50–60 (Glass 
et al 1997, Iselin-Chaves et al 1998, Vanluchene 
et al 2004a). Return of consciousness tends to 
occur at BIS values approximately 75–85 (Doi 
et al 1997, Liu et al 1997).
In volunteer studies conducted by Iselin-
Chaves and colleagues, the PK of BIS (v. 2.0 and 
3.0) for LOC was better than those of target 
effect-site or measured plasma concentration 
of propofol. The PK of BIS for LOC was simi-
lar (0.94 or more) during propofol monoan-
esthesia and during propofol–alfentanil (100 
ng / ml) anesthesia (Iselin-Chaves et al 1998, 
Iselin-Chaves et al 2000). A similarly high PK 
(0.89–0.98) of BIS (v. 3.0) for LOC was ob-
served by Glass and colleagues (Glass et al 
1997). In contrast, Schneider and colleagues 
found PK values of BIS (v. 3.3) just under 0.70 
for detection of consciousness during sevoflu-
rane–remifentanil or propofol–remifentanil 
anesthesia. A wide variation in BIS values at 
LOC and ROC was observed, although the 
mean values at LOC were lower than at ROC 
(Schneider et al 2003).
The large interindividual variability in BIS 
values (v. 4.0, XP) and overlap between re-
sponders and non-responders to verbal com-
mand during LOC and ROC with rapid wash-
in and wash-out of sevoflurane was emphasized 
by Anderson and colleagues (Anderson et al 
2003). A similar large overlap between BIS val-
ues (v. 3.0) associated with consciousness and 
unconsciousness was reported by Gajraj and 
colleagues during propofol sedation (Gajraj et 
al 1998). 
The association of bispectral index values 
with intraoperative recall
Glass and colleagues reported that BIS (v. 3.0) 
values of 64 and 86 during propofol, isoflurane, 
or midazolam anesthesia or sedation were as-
sociated with a 95 % and 50 % probability of 
loss of free or cued recall (Glass et al 1997). 
In volunteers, during propofol or propofol–
alfentanil sedation, Iselin-Chaves and col-
leagues obtained similar results. In that study, 
the presence of alfentanil did not affect the 
BIS (v. 3.0) values associated with loss of recall 
(Iselin-Chaves et al 1998). Liu and colleagues 
reported that with BIS values less than 80, only 
8 % of pictures presented intraoperatively were 
recalled in patients with regional anesthesia 
and propofol sedation. A considerable inter-
individual variability in recall at different BIS 
values and OAA / S scores was found (Liu et al 
1997).
In a study on trauma patients subjected to 
isoflurane–fentanyl anesthesia, Lubke and col-
leagues found that the intraoperative BIS level 
was a weak but significant predictor of post-
operative memory performance, as measured 
by a word stem completion test with intraoper-
atively presented words and distractor words. 
Memory performance increased with increas-
ing BIS values, and was higher than that caused 
by chance in the BIS range 40–60, but not at 
BIS values less than 40. The data suggested that 
the observed memory performance consisted 
of implicit memory. The authors concluded 
that at anesthetic levels considered adequate by 
BIS monitoring, some patients process audi-
tory information without conscious access to 
this data after recovery (Lubke et al 1999). On 
the other hand, Kerssens and colleagues found 
no explicit or implicit memory formation in 
elective surgical patients during adequately 
controlled propofol hypnosis, with BIS (v. 
3.2) values between 40 and 60 (Kerssens et al 
2001).
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Bispectral index, the adequacy of the level 
of hypnosis, and outcome
BIS values correlate well with the concentra-
tions of hypnotic agents (Doi et al 1997, Katoh 
et al 1998, Lysakowski et al 2001).
In coronary artery bypass surgery patients, 
adjustment of propofol administration to 
achieve BIS (v. XP) 40–50, combined with a 
constant remifentanil infusion, resulted in a 
roughly 30 % decrease of propofol consump-
tion compared to the control group, without 
affecting the neurohumoral or cytokine stress 
response and with no intraoperative recall. An 
unnecessarily deep anesthetic level was ob-
served in 50 % of the control group patients, 
with a fixed propofol infusion rate (Bauer et al 
2004). In a study by Luginbühl and colleagues 
titrating BIS (v. 3.3) between 45–55 (up to 65 
during the last 15 min of the procedure) was 
associated with a reduced hypnotic drug use 
and a faster extubation in propofol patients, 
whereas desflurane patients experienced fewer 
episodes of inadequate hypnosis (BIS value 
above 60), less nausea, and greater subjective 
satisfaction with the anesthetic compared to 
controls (Luginbühl et al 2003).
In a prospective observational study, Monk 
and colleagues found the cumulative deep hyp-
notic time, defined as BIS values less than 45, to 
be an independent predictor of 1-year mortal-
ity after major noncardiac surgery, in addition 
to patient co-morbidity and the cumulative 
systolic hypotension time. The relative risks as-
sociated with these variables were 1.24 (per h), 
16.12 (the Charlson co-morbidity score  ≥ 3 vs. 
0–2), and 1.04 (per min). The authors specu-
lated that a relative overdose of anesthetic 
agents may adversely alter the inflammatory 
response after surgery (Monk et al 2005). The 
study protocol excluded patients with known 
neurological diseases and patients scheduled 
for procedures conferring a high risk of neu-
rological deficits. Even so, it is not certain that 
there exists a causal relationship between the 
observed anesthetic depth and outcome. The 
total anesthetic dose was not assessed. An un-
known risk factor may predispose patients to 
both low BIS values and poor outcome. 
Bispectral index and  
intraoperative awareness
Myles and colleagues showed that BIS moni-
toring reduced the incidence of intraoperative 
awareness in adult patients at high risk for this 
complication during general anesthesia with 
neuromuscular blockade. In this population 
with an approximately 1 % baseline risk of 
intraoperative awareness the number needed 
to treat (NNT) was 138, corresponding to an 
absolute risk reduction of 0.74 % (Myles et al 
2004). Similarly, Ekman and colleagues found 
that compared to a historical control group, 
the implementation of BIS monitoring reduced 
the incidence of awareness in an unselected 
surgical population. Based on the results of 
that study, the NNT in the general population 
would be 714, corresponding to an absolute 
risk reduction of 0.14 %. The authors con-
cluded that the sensitivity of a BIS cut-off value 
of 60 seems to be adequate for prevention of 
awareness, although the specificity is less than 
100 % (Ekman et al 2004). Reducing the inci-
dence of awareness during general anesthesia 
was approved by the FDA as an indication of 
BIS monitoring in 2004 (Johansen 2006).
Regarding the risk of awareness, not only the 
absolute BIS value but also the duration of BIS 
elevation seems to be important (Luginbühl and 
Schnider 2002). Awareness has been observed 
at BIS values at the upper end of the recom-
mended 40–60 range (Bevacqua and Kazdan 
2003). In the study by Myles and colleagues, 
one patient had confirmed awareness during 
an intraoperative episode with registered BIS 
values between 55 and 59 (Myles et al 2004). 
This case demonstrates the inherent individual 
variation in biosignals and the probabilistic in-
terpretation of BIS values.
The electromyogram and other issues in 
interpreting bispectral index values
Sleigh and Donovan demonstrated a hysteresis 
effect both during induction and emergence 
from anesthesia such that the BIS (v. 3.12) 
values at syringe drop were not different from 
awake values, and at recovery a period of clini-
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cal awareness occurred with low BIS values. 
BIS, however, usually increased to more than 
95 within 20–30 s. The authors discussed the 
possibility that in addition to the lag in updat-
ing the BIS values, an intrinsic lag between the 
transition between consciousness and uncon-
sciousness and EEG changes could be involved. 
The sensitivity, specificity, and negative and 
positive predictive values of BIS for discrimi-
nating between awake and anesthetized condi-
tions during propofol induction were around 
95 % or better (Sleigh and Donovan 1999). 
Similarly, Doi and colleagues showed that dur-
ing emergence from propofol–N2O anesthesia, 
BIS (v. 3.0) values, SEF95, or MF immediately 
before and after ROC did not differ, whereas 
AEP index values effectively discriminated be-
tween the awake and anesthetized states. BIS 
values at ROC were lower than before induc-
tion. The transition to consciousness occurred 
at BIS values of 64–80 (Doi et al 1997). Gajraj 
and colleagues have suggested that BIS reflects 
the level of global suppression of cortical activ-
ity, as opposed to the sudden transition from 
unconsciousness to consciousness, which may 
be a threshold event determined by deeper 
brain structures (Gajraj et al 1999).
Katoh and colleagues observed a plateau 
of BIS (v. 3.2) decrease at sevoflurane concen-
trations of around 1.8 % (Katoh et al 1998). 
A similar BIS (v. 3.22) plateau with sevoflu-
rane and isoflurane concentrations above 2 % 
and 1 % was found by Olofsen and colleagues 
(Olofsen and Dahan 1999). Ellerkman and 
colleagues found that in patients anesthetized 
with sevoflurane, with a BSR over 40 % a lin-
ear relationship between BIS (v. XP) and BSR 
existed, with little or no interindividual differ-
ences (Ellerkmann et al 2004). Using various 
anesthetic techniques, Vakkuri and colleagues 
demonstrated a similar linear relationship be-
tween BIS (v. 3.12) and BSR with a BSR over 
50 %. A plateau was observed in BIS values be-
low 40 during desflurane–N2O and propofol–
N2O anesthesia, but not during sevoflurane–
N2O anesthesia, where no burst suppression 
was present. A short plateau was also found 
in BIS values over 60. The authors ascribed 
these plateau phases to transitions between the 
three different algorithms used in computing 
BIS (Vakkuri et al 2004). Similar results were 
reported by Bruhn and colleagues during 
propofol anesthesia. With suppression ratios 
of 5 %–40 % the average BIS value was constant 
(30–40). Suppression ratios over 40 % were lin-
early correlated with BIS (v. 3.22) values from 
30 to 0 (Bruhn et al 2000a).
The frequency ranges of EEG and EMG 
overlap. EMG activity, interpreted by the BIS 
algorithm as high frequency, low amplitude 
waves, may occasionally falsely elevate BIS val-
ues. Efforts have been made to reduce the EMG 
contamination in later BIS versions (Johansen 
2006). The A-2000 EEG monitor discards 
data contaminated by monopolar electrocau-
tery. Bipolar electrocautery generates a low-
amplitude, high frequency signal, which may 
interfere with EEG processing. Other electri-
cal devices and even forced air-flow warming 
blankets used in the operating room may also 
cause subtle signal contamination and result in 
misleadingly high BIS values (Hemmerling and 
Fortier 2002, Dahaba 2005). Falsely elevated 
BIS values may also occur with high electrode 
impedances (Johansen 2006).
Neuromuscular blockade (NMB) does not 
affect BIS (v. 3.3–3.4) values in deeply sedated, 
unstimulated subjects (Greif et al 2002, Vasella 
et al 2005). In patients with increased EMG 
activity, the administration of NMB drugs can 
decrease the BIS values (Dahaba 2005, Liu et al 
2005). Vasella and colleagues found that dur-
ing steady propofol anesthesia in unstimulated 
patients, neuromuscular blockade was associ-
ated with a decrease in frontal EMG power but 
no change in BIS (v. 3.4) values or AAI. The 
administration of neostigmine–glycopyrrolate 
was associated with an increase in both BIS 
and AAI values exceeding those induced by 
glycopyrrolate alone. The authors concluded 
that this effect of neostigmine probably did not 
represent a frontal EMG artifact, but rather a 
genuine arousal resulting from increased af-
ferent signals from muscle stretch receptors 
(Vasella et al 2005). Dahaba and colleagues 
reported that the onset of mivacurium effect 
induced a transient BIS deviation, which had 
opposite directions in the BIS 3.4 and 4.0 algo-
rithms. It was suggested that version 4.0 may 
indicate systematically lower BIS values than 
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previous algorithms (v. 3.4), especially during 
recovery from anesthesia and during periods 
of artifacts (Dahaba et al 2004).
Various cerebral disorders which affect the 
EEG characteristics or brain metabolism are 
reflected in BIS values (Dahaba 2005). A ge-
netically determined low EEG voltage variant 
can result in abnormally low awake BIS values 
(Schnider et al 1998). The very low voltage 
EEG during a phase of emergence from sevo-
flurane, isoflurane, or remifentanil anesthesia 
can be misinterpreted by the BIS algorithm as 
burst suppression, resulting in inappropriately 
low BIS values (Muncaster et al 2003, Hagihira 
et al 2004a). Gunawardane and colleagues have 
shown that a pathological increase in low fre-
quency EEG activity, such as that occurring 
in the post-ictal state, may produce low BIS 
values that are not associated with the level of 
consciousness (Gunawardane et al 2002).
It has been observed that BIS (v. 4.0) values 
tend to be higher during halothane anesthe-
sia than during anesthesia with other potent 
volatile agents at similar anesthetic levels (as 
assessed by MAC multiples). This may be due 
to differences in EEG profiles induced by the 
different agents and differences in relative ef-
fects on the brain and subcortical structures 
(Edwards et al 2003, Davidson and Czarnecki 
2004).
Bispectral index and  
hemodynamic responses
In an early study with thiopental–N2O–opioid 
anesthesia, the pre-laryngoscopy BIS values 
distinguished patients with a significant blood 
pressure response to intubation from non-
responders, whereas none of the investigated 
power spectral variables did. Overlap, how-
ever, occurred in BIS values between respond-
ers and non-responders (Kearse et al 1994b). 
With a later BIS version (v. 3.12), Driessen and 
colleagues reported that pre-stimulus BIS val-
ues did not correlate with the blood pressure 
response to intubation and sternotomy during 
fentanyl–midazolam anesthesia (Driessen et 
al 1999). The correlation between the hemo-
dynamic and BIS responses to noxious stimu-
lation is not good (Mi et al 1998, Driessen et 
al 1999). No correlation between the concen-
trations of various stress hormones and BIS 
during anesthesia has been found (Bauer et al 
2004, Ledowski et al 2005). 
Bispectral index, nitrous oxide, xenon, 
ketamine, and dexmedetomidine
Rampil and colleagues described the changes 
in the spectral content of the EEG during N2O 
sedation (10 %–50 %). In general, higher N2O 
concentrations increased the high-frequency 
EEG activity and EMG activity. Steady-state 
N2O alone did not influence BIS (v. 3.22) val-
ues. A prominent transient EEG slowing, also 
reflected in decreased BIS values, was noted 
upon withdrawal of N2O. The subjects re-
mained awake and alert throughout the study. 
The authors concluded that N2O exerts both 
excitatory and inhibitory actions on the CNS 
(Rampil et al 1998).
N2O does not seem to affect BIS values in the 
absence of noxious stimulation (Barr et al 1999, 
Coste et al 2000). Analgesia induced by N2O 
attenuates the central nervous system arousal 
response to noxious stimulation. Therefore, 
N2O may indirectly affect BIS values during 
noxious stimulation (Hans et al 2001). This ef-
fect has not been found in all studies (Barr et al 
1999, Coste et al 2000). In some patients, N2O 
may increase BIS values, even when combined 
with a potent volatile anesthetic, presumably by 
altering the relative β ratio. In such instances, 
withdrawal of N2O may result in a decrease in 
BIS values (Puri 2001).
Due to increased fast activity in the EEG 
caused by ketamine (Hering et al 1994, 
Maksimow et al 2006), BIS monitoring does 
not track the hypnotic effect of ketamine (Hans 
et al 2005b). In the presence of moderate doses 
of ketamine the loss of responsiveness to verbal 
and noxious stimulation (mechanical stimula-
tion of nasal mucosa) occurs at higher BIS 
values compared to propofol anesthesia alone 
(Sakai et al 1999). In a study by Hirota and 
colleagues, the addition of N2O (20 %–70 %) 
to stable propofol–fentanyl anesthesia had no 
effect on BIS values. The addition of ketamine 
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(bolus 0.4 mg / kg and infusion 1 mg / kg / h) in-
creased both BIS and SEF significantly (Hirota 
et al 1999).
Dexmedetomidine sedation seems to be 
associated with decreased BIS values, compa-
rable to those achieved by propofol sedation 
(Venn and Grounds 2001).
Even though xenon decreases BIS values 
similarly to isoflurane, during emergence from 
xenon anesthesia the EEG pattern and the BIS 
values (v. 3.22) may display greater variability 
than during emergence from isoflurane an-
esthesia, such that some patients regain con-
sciousness with slow EEG patterns and low BIS 
values (Goto et al 2000).
Bispectral index and opioid analgesics
Clinically relevant doses of opioid analgesics 
have relatively little influence on the electro-
encephalogram (Scott et al 1985, Shafer and 
Varvel 1991, Barvais et al 2003, Hagihira et al 
2004b), even though the sedative effect of opi-
oids may be clinically evident (Lysakowski et 
al 2001). Glass and colleagues showed that al-
fentanil concentrations up to 200 ng / ml alone 
did not induce unconsciousness and produced 
minimal decreases in BIS (v. 3.0) values in vol-
unteers (Glass et al 1997).
In a placebo-controlled study, Lysakowski 
and colleagues demonstrated that in the pres-
ence of clinically relevant doses of opioid anal-
gesics LOC occurs at higher BIS (v. 3.12) values 
and lower propofol effect-site concentrations 
than with propofol alone. The correlation be-
tween BIS and effect-site propofol concentra-
tion was preserved in the presence of opioids 
(Lysakowski et al 2001). Mi and colleagues 
found that LOC and the loss of response to 
mechanical stimulation of the nasal mucous 
membrane occurred with lower propofol doses 
and at higher BIS (v. 3.2) values in the presence 
of than in the absence of an analgetic dose of 
fentanyl (2 µg / kg). The reduction of propofol 
requirements was greater for noxious than for 
non-noxious stimuli. In that study, the correla-
tion between BIS values and plasma propofol 
concentrations was weaker in the presence of 
than in the absence of fentanyl (Mi et al 1999). 
Mustola and colleagues reported that the loss 
of response to tetanic electrical stimulation oc-
curred at higher BIS (v. 3.3) values and with 
lower doses of propofol during combined 
propofol and remifentanil infusions than dur-
ing a propofol infusion combined with placebo 
(Mustola et al 2005).
Large doses of opioids, in relation to the 
amount of stimulation, may increase seda-
tion and lower BIS values (Billard et al 1997, 
Strachan and Edwards 2000, Koitabashi et al 
2002). In a study by Guignard and colleagues, 
during propofol anesthesia, no significant 
changes in BIS (v. 3.12) were noted with re-
mifentanil administration before noxious 
stimulation, even with the highest remifentanil 
target effect-site concentration of 16 ng / ml 
(Guignard et al 2000). The arousal reaction of 
the cortex, and thus also the BIS response to 
noxious stimulation is modulated by the level 
of opioid analgesia (Hans et al 1999, Guignard 
et al 2000) and perhaps also by β-adrenergic 
blockade (Menigaux et al 2002). Guignard and 
colleagues found that during propofol anesthe-
sia, the increase in BIS (v. 3.12) at laryngoscopy 
and intubation was inversely correlated with 
the target effect-site concentration of remifen-
tanil (Guignard et al 2000). Iselin-Chaves and 
colleagues found that the BIS (v. 3.0) response 
to a noxious mechanical stimulus was reduced 
by both an increase in propofol concentration 
and the presence of alfentanil (Iselin-Chaves et 
al 1998).
Bispectral index, noxious stimulation and 
movement responses
A substantial increase in noxious stimulation 
during surgery can cause an arousal response 
with clinical signs and an increased BIS value 
even when the pre-stimulus hypnotic effect is 
profound and the corresponding BIS value is 
low. In such instances the BIS lags behind the 
clinical change by 5–10 s (Rosow and Manberg 
2001). Mi and colleagues reported that BIS was 
more sensitive than SEF or MF in detecting 
arousal caused by noxious stimulation during 
propofol or propofol–fentanyl anesthesia (Mi 
et al 1998).
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In the beginning phase of bispectral index 
development, Kearse and colleagues reported 
that the bispectral index was a significant pre-
dictor of movement responses to skin incision 
during propofol–N2O anesthesia (Kearse et al 
1994a). In another early study, pre-incision BIS 
values were different in movers and non-mov-
ers to incision during isoflurane–alfentanil and 
during propofol–alfentanil anesthesia. BIS was 
a significant predictor of movement responses 
(Vernon et al 1995). In a study conducted with 
BIS version 1.1, overall the pre-incision BIS val-
ues were lower in non-movers than in movers 
to skin incision. The correlation between BIS 
values and the probability of movement was 
much less significant when opioids were used 
as anesthetic adjuvants than with hypnotic-
based anesthesia. Thus, opioid analgesia sup-
pressed movement responses at effect-site con-
centrations, which had little effect on the EEG. 
Both BIS and the estimated effect-site opioid 
concentration were independent predictors of 
movement responses in the combined data set 
from patients anesthetized with isoflurane or 
propofol, N2O, and opioids (Sebel et al 1997).
The PK values reported for the pre-stimulus 
values of later BIS versions (v. 3.12–3.22) for 
movement responses to noxious stimulation 
have been low or modest (0.54–0.68) (Katoh 
et al 1998, Doi et al 1999, Kurita et al 2001, 
Bruhn et al 2003, Doi et al 2005). The same 
applies to SEF95 (reported pre-stimulus PK 
values 0.55–0.63) (Katoh et al 1998, Doi et al 
1999, Bruhn et al 2003, Doi et al 2005). Some 
authors, however, have found a statistically 
significant association between BIS (v. 3.0–3.3) 
(Leslie et al 1996, Singh et al 1999) or SEF95 
(Dutton et al 1996, Leslie et al 1996) and move-
ment responses to noxious stimulation.
Bispectral index and recovery from 
anesthesia
Gan and colleagues showed that titrating the 
administration of propofol–alfentanil–N2O 
anesthesia to achieve BIS (v. 3.0) values be-
tween 45 and 60 (60–75 during the final 15 
min of surgery) was associated with a reduced 
consumption of propofol and a faster recovery 
compared to a standard practice group, with-
out an increase in adverse intraoperative re-
sponses (Gan et al 1997). Song and colleagues 
found that titrating desflurane–fentanyl–N2O 
or sevoflurane–fentanyl–N2O anesthesia to a 
target BIS (v. 3.12) value of 60 reduced the con-
sumption of the volatile agents and hastened 
the emergence from anesthesia compared 
to the control groups, where the average BIS 
value was in the range of 40–45. In that study, 
more mivacurium was used in the BIS-titrated 
groups than in the control groups, but the con-
sumption of fentanyl was similar among both 
groups. The times to home-readiness did not 
differ between the groups (Song et al 1997).
In elderly patients undergoing orthope-
dic surgery with isoflurane–fentanyl–N2O 
anesthesia, titration of the isoflurane dose to 
achieve BIS 50–60 during maintenance was as-
sociated with reduced isoflurane consumption 
and faster post-operative orientation compared 
to standard clinical practice, despite similar 
BIS values at the end of anesthesia (Wong et 
al 2002).
Nelskylä and colleagues showed that titrat-
ing sevoflurane–alfentanil–N2O anesthesia to 
maintain BIS (v. 3.21) values at 50–60 was as-
sociated with a decreased incidence of emetic 
symptoms and improvement in some of the 
early recovery parameters, compared to guid-
ing anesthesia with hemodynamic signs. The 
times to achieving home-readiness were simi-
lar in the BIS and the control groups after gy-
necologic laparoscopy (Nelskylä et al 2001). 
Similarly, the incidence of nausea and the anti-
emetic drug requirement 24 h after desflurane 
anesthesia were reduced in BIS (v. 3.3) moni-
tored (target BIS 45–55) patients compared to 
a control group (Luginbühl et al 2003).
White and colleagues found that compared 
to a control group, both early and intermediate 
recovery, including the times to home-read-
iness and actual discharge, were significantly 
faster in both BIS-guided (target 50–60) and 
AAI-guided groups after desflurane–N2O an-
esthesia for gynecological laparoscopic surgery. 
Desflurane consumption was reduced and the 
subjective quality of recovery was improved 
in the EEG monitored groups. The mean BIS 
and AAI values during anesthetic maintenance 
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were significantly lower in the control group 
than in the EEG monitored groups (White et 
al 2004).
Ahmad and colleagues reported very high 
PACU bypass rates after gynecological lap-
aroscopic surgery, regardless of whether sevo-
flurane anesthesia was guided by BIS values 
(50–60) or hemodynamic signs. In that study, 
the mean sevoflurane concentrations in the 
two groups were remarkably similar and in the 
suturing phase only N2O was used as needed. 
No significant differences emerged in any 
other recovery parameters, either (Ahmad et al 
2003). Song and colleagues reported that the 
BIS (v. 3.12) value at the end of laparoscopy did 
correlate with the time to achieving fast-track 
eligibility after both desflurane–fentanyl–N2O 
and propofol–fentanyl–N2O anesthesia. No 
correlation between the BIS values at the end 
of the procedure and the times to home-read-
iness or actual discharge was found (Song et al 
1998).
In a multicenter study using desflurane–
remifentanil anesthesia, Bruhn and colleagues 
did not find significant reductions in recovery 
times with either BIS-guided (target 50, and 
60 during the last 15 min of surgery) or AAI-
guided anesthesia, compared to the standard 
practice. The standard practice group had BIS 
values similar to those of the BIS group (Bruhn 
et al 2005).
In an open, observational study includ-
ing a large number of heterogenous patients, 
Johansen and colleagues found that titration of 
anesthetic administration to achieve a BIS (v. 
3.0) range of 50–65 during maintenance was 
associated with shortened times to extubation, 
OR exit, and PACU discharge, compared to 
unmonitored controls. The frequency of PACU 
extubations was also reduced, as were the av-
erage total doses of desflurane and isoflurane. 
The recovery times of patients maintained 
mostly at BIS values less than 50 were similar 
to those of unmonitored controls (Johansen et 
al 2000).
Pavlin and colleagues investigated a large, 
heterogenous group of surgical inpatients in 
a randomized cross-over design. BIS moni-
toring with a suggested target range of 50–60 
resulted in a mean BIS 47 during anesthetic 
maintenance. BIS values were not available in 
the control group. No significant differences 
in the recovery parameters between the BIS 
monitored group and the control group were 
observed. The authors speculated that there 
may have been a reluctance to use lighter lev-
els of anesthesia in inpatients. They concluded 
that since multiple medical and non-medical 
factors influence the time to discharge, it may 
be impossible to hasten recovery by small ad-
justments in the delivered anesthetic dose, es-
pecially when using anesthetic agents with fast 
kinetics (Pavlin et al 2005).
Cost issues in bispectral index monitoring
Yli-Hankala and colleagues found that the cost 
of BIS monitoring exceeded the savings from 
the decreased consumption of propofol and 
sevoflurane in patients whose anesthesia was 
guided by BIS values. The increase in direct 
costs with BIS monitoring was mainly due to 
expensive designated EEG electrodes. The price 
of drugs has only a marginal role in the total 
costs of operative treatment. The authors con-
cluded that potential financial benefit may be 
gained indirectly from an improved recovery 
profile with BIS-monitoring (Yli-Hankala et al 
1999a). O’Connor and colleagues argued that 
if only the potential prevention of intraopera-
tive awareness is regarded, it may be difficult to 
justify routine BIS monitoring. The cost of pre-
venting a rare event is high and increases with 
less than perfect performance of the monitor-
ing technique. In populations at high risk for 
awareness, however, BIS-monitoring could be 
cost-effective (O’Connor et al 2001). A meta-
analysis by Liu concluded that the use of BIS 
monitoring for ambulatory anesthesia was eco-
nomically inefficient. Even though BIS moni-
toring modestly reduced anesthetic use and the 
risk of post-operative nausea and vomiting, the 
time spent in the PACU was only marginally 
reduced, and the ability to bypass PACU or the 
time spent in the ambulatory surgery unit were 
not changed. Even without the capital costs of 
the monitoring system, the cost of the BIS elec-
trodes exceeded the savings by approximately 
5 US dollars per patient (Liu 2004). 
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Critique on bispectral index monitoring
Miller and colleagues have questioned the 
benefit of bispectral analysis over power spec-
tral analysis of the EEG for differentiating the 
awake and anesthetized states. They found that 
during the induction of anesthesia, an ana-
log of the BIS SyncFastSlow parameter based 
on the amplitude-independent bicoherence 
did not change at all, whereas SyncFastSlow 
was closely tracked by its analog based on the 
power spectrum (instead of the bispectrum). 
Thus, changes in SyncFastSlow during induc-
tion mostly reflected changes in high frequen-
cy spectral power. Both SyncFastSlow and its 
power spectrum analog equally discriminated 
the awake and the anesthetized states. The 
authors concluded that because the EEG is a 
stochastic signal, the bispectral power in fact 
measures the degree of deviation from gaussi-
anity, namely the skewness of the signal, and 
does not necessarily imply the presence of 
quadratic phase coupling. The magnitude of 
the bispectrum depends on the signal power 
(amplitude). Also, short data lengths bias the 
bispectrum and bicoherence away from zero, 
falsely indicating quadratic phase coupling 
(Miller et al 2004). In another study, Sleigh and 
colleagues demonstrated that during the induc-
tion of anesthesia, the BetaRatio performed as 
well as BIS (v. 3.12) in distinguishing the awake 
and anesthetized states. They emphasized the 
importance of the high frequency (γ) band 
in detecting LOC (induced by GABA-ergic 
agents) (Sleigh et al 2001).
Schwilden and Jeleazcov examined the sta-
tistical properties of EEG during isoflurane–
alfentanil anesthesia, and concluded that over 
90 % of the EEG epochs had to be considered 
as representing a linear random signal, where-
by the bicoherence is constant and most of the 
information content of the signal is given by 
the power spectrum (Schwilden and Jeleazcov 
2002). Similar results were obtained during 
propofol–alfentanil anesthesia. The proportion 
of EEG epochs with nontrivial bispectra was 
approximately 10 % (Jeleazcov et al 2005). The 
authors concluded that although the underly-
ing neuronal processes may be nonlinear to 
some extent, the transmission of the electrical 
signal to the scalp may introduce some kind 
of phase randomization. Similarly to Sleigh 
and colleagues, these authors pointed out that 
a non-trivial bispectrum is to be expected 
whenever the amplitude distribution of the 
EEG is skewed (Schwilden and Jeleazcov 2002, 
Jeleazcov et al 2005).
Entropy
The concept of entropy
Entropy is related to the randomness or regu-
larity of a process, but the precise definition 
depends on the setting in which it is applied 
(Pincus 1991). The concept of entropy has been 
used in thermodynamics, statistical mechanics, 
and information theory. As a physical concept, 
entropy is proportional to the logarithm of the 
number of microstates available to a thermo-
dynamical system (Viertiö-Oja et al 2004). 
The Kolmogorov-Sinai entropy is a generaliza-
tion of the probabilistic definition of entropy 
(Shannon entropy) (Pincus et al 1991).
In 1991 Pincus suggested using entropy 
for the analysis of physiological signals. 
Approximate entropy (ApEn), a modification 
of the Kolmogorov-Sinai entropy, measures 
the logarithmic likelihood that runs of pat-
terns that are similar remain similar in the next 
incremental comparisons. It can be applied to 
reasonably short time series, and an appropri-
ately selected filtering parameter decreases its 
sensitivity to noise. ApEn is a relative measure, 
the absolute value of which depends on the 
choice of the input parameters (Pincus et al 
1991). Pincus used the ApEn algorithm for the 
analysis of HRV and Bruhn applied it to EEG 
analysis. Adjacent EEG epochs are not statis-
tically independent, however, so the require-
ments for calculating the approximate entropy 
are not rigorously met (Schwilden 2006).
The Shannon entropy is a measure of uncer-
tainty, originally applied to information theory. 
It is related to the probabilities of system states 
(Shannon 1948a, Shannon 1948b). Shannon 
defined the entropy of a set of probabilities 
p1,...pN as
Η = – Σ pi log pi 
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The range of measured values of a signal can 
be divided into bins, each with a certain prob-
ability of occurrence. From these probabilities 
the Shannon entropy can be calculated. It is in-
dependent of the order of occurrence of values 
of different magnitudes (Schwilden 2006). The 
Shannon entropy is insensitive to infrequently 
occurring values (Bruhn et al 2001b). It is 
largest (equal to logN) when all values have 
the same probability of occurrence, i.e. 1 / N 
(the probability density function is uniform) 
(Shannon 1948a, Shannon 1948b).
If the area under the power spectral density 
function is normalized to one, it can be con-
sidered as the probability density function of 
the frequency components, and the spectral 
entropy can be calculated (Rezek and Roberts 
1998, Schwilden 2006). The spectral entropy, a 
modification of Shannon’s entropy, estimates 
the degree of irregularity or complexity in the 
frequency distribution. It is affected by the 
sampling frequency and windowing (Rezek 
and Roberts 1998). It is independent of the 
absolute magnitudes of the frequency compo-
nents of the signal (Viertiö-Oja et al 2004).
Entropy and anesthesia
Rezek and colleagues demonstrated that both 
ApEn and spectral entropy decrease with in-
creasing anesthetic depth (Rezek and Roberts 
1998). Bruhn and colleagues found that ApEn 
predicted desflurane effect-site concentrations 
as well as or better than spectral parameters 
and BIS. ApEn decreased as the desflurane 
concentration increased (Bruhn et al 2000b). 
They reported that after the onset of burst 
suppression, ApEn indicates the increasing 
pharmacodynamic effect more accurately than 
spectral parameters or BIS (v. 3.22) (Bruhn et 
al 2000c, Bruhn et al 2001a).
In a study by Sleigh and Donovan the sen-
sitivity, specificity and negative and positive 
predictive values of approximate entropy for 
discriminating between the awake and the 
anesthetized conditions during propofol in-
duction were slightly over 70 %, compared to 
over 90 % for BIS (v. 3.12) (Sleigh and Donovan 
1999). Bruhn and colleagues found that the 
overall PK values of ApEn, BIS (v. 3.22), and 
SEF95 for predicting a modified OAA / S score 
during propofol–remifentanil anesthesia were 
0.89, 0.85, and 0.83, respectively. The PK val-
ues for predicting unconsciousness were 0.95, 
0.94, and 0.92. The PK values for predicting 
the response to noxious stimulation (laryngeal 
manipulation) were much lower, namely 0.70, 
0.62 and 0.63 (Bruhn et al 2003).
Bruhn and colleagues found that the 
Shannon entropy of the EEG amplitude val-
ues, ApEn, SEF95 and BIS (v. 3.12) correlated 
equally well with the desflurane effect-site 
concentration. As the probability distribution 
of EEG amplitude values becomes broader and 
more uniform during deepening anesthesia, 
the Shannon entropy of amplitude values in-
creases with increasing desflurane concentra-
tions. The absolute values of the calculated 
Shannon entropy may vary considerably be-
tween individuals despite a similar anesthetic 
state, and thus it is not suitable for anesthetic 
depth monitoring (Bruhn et al 2001b).
Time-frequency balanced spectral entropy
Datex-Ohmeda, now part of GE Healthcare, re-
cently developed a concept called time-frequen-
cy balanced spectral entropy (M-Entropy®), 
intended for on-line monitoring of anesthetic 
effect. The algorithm is based on spectral en-
tropy. To calculate the spectral entropy of a 
particular epoch and frequency range, the 
power spectrum of the epoch is normalized, 
so that the sum of the normalized power spec-
trum over the selected frequency range equals 
one. Then Shannon’s function is applied to the 
normalized power spectrum over the specific 
frequency range. The resulting entropy value 
is adjusted to range between one (correspond-
ing to maximum irregularity) and zero (cor-
responding to complete regularity) by dividing 
with logN, where N is the number of frequency 
components (Viertiö-Oja et al 2004).
By individually changing the time window 
used to assess each frequency component, the 
response time of the algorithm is optimized. 
An epoch of 1.92 s is used for frequencies be-
tween 32 and 47 Hz, whereas for frequencies of 
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less than 2 Hz an epoch of 60.16 s is used. The 
time windows used for frequencies between 2 
and 32 Hz are intermediate between these two 
extremes. The sampling frequency is 400 Hz 
(Viertiö-Oja et al 2004).
The activity of facial muscles produces a 
broad-band, noise-like EMG signal that is 
dominant above roughly 30 Hz, whereas the 
EEG signal dominates at lower frequencies 
and its power decreases exponentially above 
30 Hz. The increase in the fEMG power is a 
key arousal phenomenon, induced by e.g. 
noxious stimuli in the absence of sufficient 
analgesia. Because of the short window length 
used in updating the frequency band 32–47 
Hz, the algorithm of time-frequency balanced 
spectral entropy allows rapid detection of 
impending arousal. The M-Entropy® module 
displays two separate entropy values, RE and 
SE. The former is calculated over the frequen-
cies 0.8–47 Hz, including frequencies associ-
ated with EMG activity, whereas the latter is 
calculated over 0.8–32 Hz and reflects mainly 
cortical EEG activity. The calculation of SE is 
adjusted so that when the power in the range 
32–47 Hz is zero, RE and SE are equal. This 
is achieved by multiplying the normalized en-
tropy value in the 0.8–32 Hz range by the fac-
tor logN[0.8–32 Hz] / logN[0.8–47 Hz]. When 
RE > SE, EMG activity is present (Viertiö-Oja 
et al 2004). Vakkuri and colleagues recom-
mended that the train-of-four (TOF) stimula-
tion count be kept at a minimum of one or two 
in order to benefit from the RE-SE difference 
as an indicator of EMG activation (Vakkuri et 
al 2005). Vanluchene and colleagues demon-
strated that the RE-SE difference decreased 
nonlinearly toward zero with increasing effect-
site concentrations of propofol (Vanluchene et 
al 2004b).
EEG burst suppression is detected by ap-
plying a method described by Särkelä and 
colleagues (Särkelä et al 2002). A one-minute 
time window is used for all frequencies, if sup-
pression periods have been detected during the 
preceding 60 s. A suppressed EEG is consid-
ered to be a perfectly regular signal with zero 
entropy, and entropy associated with bursts is 
computed in the same way as during lighter 
levels of anesthesia. To enhance resolution in 
the clinically interesting range, the original en-
tropy value is subjected to a non-linear trans-
formation with a monotonous spline function. 
The slope of the spline function is highest in 
the range of clinically relevant anesthesia and 
emergence. The output is presented as two-
digit integer values ranging between 0–100 
(RE) or 0–91 (SE) (Viertiö-Oja et al 2004).
Time-frequency balanced spectral entropy 
and anesthesia
Maksimow and colleagues have shown that 
calculated entropy values, corresponding to 
SE, correlate with CBF, and thus presumably 
with neuronal function, during sevoflurane 
and propofol anesthesia. The correlation ex-
tended to deep (1.5–2 MAC / EC50) levels of 
anesthesia (Maksimow et al 2005). McKay and 
colleagues demonstrated a consistent relation-
ship between RE / SE and effect-site sevoflurane 
concentrations. The steepness of the relation-
ship was much larger during deepening than 
during lightening anesthesia. The authors pro-
posed that this might be due to the rapid phase 
transition which occurs at LOC. They found 
that above the sevoflurane concentration of 3 % 
the changes in RE / SE were minimal. A large 
interindividual variability in the RE / SE values 
at LOC was observed (McKay et al 2006).
Ellerkman and colleagues found similar PK 
values for discriminating different effect-site 
sevoflurane concentrations with RE / SE and BIS 
(v. XP) (0.82–0.84 and 0.80). The PK and PD 
parameters obtained by modeling were nearly 
identical for RE / SE and BIS (Ellerkmann et al 
2004). For discriminating different effect-site 
propofol concentrations, the PK value of BIS 
(v. XP) was better than those of RE / SE (0.84 
vs. 0.76–0.77) (Ellerkmann et al 2006). The PK 
values of BIS (v. 4.0), SE and RE for predicting 
effect-site propofol concentrations reported by 
Vanluchene and colleagues were 0.91. 0.86, and 
0.89. The PD model describing the relationship 
of effect-site propofol and the EEG parameters 
was steeper for RE / SE than for BIS. The au-
thors demonstrated a monotonic nonlinear 
decrease in RE / SE during burst suppression 
and concluded that RE / SE was superior to BIS 
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in detecting burst suppression (Vanluchene et 
al 2004b).
During propofol induction, Schmidt and 
colleagues showed a very good correlation 
between the sedation level and RE / SE (PK 
values for modified OAA / S 0.88–0.89). PK 
values for LOC were 1.00 and 0.97 for SE and 
RE. The start of a remifentanil infusion of 0.4 
μg / kg / min in the unstimulated state resulted 
in slight decreases in RE / SE and BIS. The PK 
values of BIS (v. 4.0), SE, and RE for discrimi-
nating the anesthetized state and the first so-
matic response during emergence were 0.91, 
0.82, and 0.85 (Schmidt et al 2004). Vakkuri 
and colleagues found that the PK values of both 
RE / SE and BIS (v. 3.12) for discriminating 
between the conscious and unconscious states 
were 1.0 with a variety of anesthetic techniques. 
The sensitivities and specificities for classifying 
consciousness and unconsciousness were also 
uniformly over 90 %. For both RE / SE and BIS, 
higher indicator values associated with uncon-
sciousness than with consciousness were only 
observed at the transition between conscious-
ness and unconsciousness. During emergence, 
RE / SE were found to recover closer to their 
baseline values than BIS. RE increase preceded 
the increase in SE or BIS by 11–12 s during 
emergence from anesthesia. The authors sug-
gested that in addition to the shorter response 
time of RE compared to SE and BIS, this may 
reflect faster resolution of anesthetic effect at 
the brainstem level than at the cortex (Vakkuri 
et al 2004).
Iannuzzi and colleagues reported that dur-
ing propofol induction, the PK value of SE for 
detecting LOC was even better than that of 
BIS (v. XP), although the difference was not 
statistically significant (0.94 vs. 0.82). The SE 
values associated with a 50 % and 95 % prob-
ability of LOC were 50 and 42 (Iannuzzi et al 
2005). During sevoflurane induction, the PK 
values of BIS (v. 3.4), SE and RE for detecting 
LOC were 0.84, 0.83 and 0.84 (Takamatsu et 
al 2006). White and colleagues reported ROC 
areas for detecting unconsciousness during 
propofol–desflurane anesthesia for BIS (v. XP), 
SE, and RE to be 0.97, 0.93 and 0.98. The de-
gree of interindividual variability was similar 
for all indices. All indices responded consis-
tently to bolus doses of propofol and changes 
in the inspired desflurane concentration. The 
entropy module was significantly less suscep-
tible to interference from electrocautery than 
the BIS monitor (White et al 2006).
 In a study by Takamatsu and colleagues, 
a significant difference in the pre-stimulus 
RE / SE values and the end-tidal sevoflurane 
concentration between movers and non-
movers to skin incision emerged, whereas 
no significant difference in the pre-stimulus 
BIS values was observed. The RE / SE value at 
which 50 % of patients were non-responsive 
to skin incision was 26. The logistic regression 
model gave very low (near zero) estimates for 
RE / SE values associated with a 95 % prob-
ability of non-responsiveness to skin incision. 
Progressively more intense tetanic electrical 
stimuli induced progressively larger increases 
in BIS and RE / SE, which were attenuated by 
increasing sevoflurane concentrations. Tetanic 
electrical stimuli caused increases in the RE-
SE difference, except at 2.5 % sevoflurane. The 
authors encouraged caution in interpreting the 
RE-SE difference during anesthesia. They dis-
cussed the possibility that the fEMG response 
might be part of the overall motor response to 
nociception and be suppressed earlier than the 
adrenergic response. They noted that fEMG 
activation occurs not only during nocicep-
tion but also during other arousal reactions 
(Takamatsu et al 2006).
Wheeler and colleagues showed that clear 
increases in the RE-SE difference in response 
to noxious stimulation, followed by increases 
in SE, occurred more often in patients under 
0.8 % isoflurane anesthesia than in patients 
under 1.4 % isoflurane anesthesia. This was 
observed both with and without neuromus-
cular blockade. RE-SE and SE increases were 
accompanied by increases in the mean arterial 
pressure (MAP) and HR (Wheeler et al 2005). 
Valjus and colleagues observed that during gy-
necological laparoscopic procedures, the RE-
SE difference was small with both propofol–
N2O–esmolol and propofol–N2O–remifentanil 
anesthesia, even during the most stressful pe-
riods. The HR, blood pressure and propofol 
requirement were greater in the esmolol group. 
Also, all of the patients in the esmolol group 
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moved in response to surgical stimulation at 
some point, whereas none of the patients in 
the remifentanil group did. A minority of the 
movements were associated with simultaneous 
increases in SE, RE, and BIS values (Valjus et 
al 2006).
Dierckens and colleagues found a very good 
agreement between RE / SE and BIS during 
laparotomy under isoflurane–N2O anesthesia. 
The RE-SE difference was small throughout the 
procedure. No significant variation in RE / SE 
or BIS was observed at incision, placement of 
retractors, peritoneal lavage, or skin closure, 
despite the occurrence of hemodynamic re-
actions. The areas under the ROC curve for 
predicting the need for sufentanil bolus, based 
on a significant hemodynamic response dur-
ing an adequate hypnotic level (BIS 40–60), 
were 0.71 and 0.69 for RE and SE. Both areas 
were statistically significantly different from 
0.5. The maximal sensitivities and specificities 
were 86 %–88 % and 55 %–57 %. The authors 
used a continuous i.v. infusion of atracurium 
and the level of neuromuscular blockade was 
not reported. They concluded that the results 
do not preclude the possibility that RE might 
be an indicator of nociception in unparalyzed 
patients (Dierckens et al 2007).
Vakkuri and colleagues showed that titra-
tion of propofol–alfentanil–N2O anesthesia 
by using RE / SE monitoring (SE target 45–65, 
RE-SE target < 10) decreased propofol use and 
hastened early recovery without increasing 
adverse intra- or post-operative reactions. The 
average SE value during anesthesia was 50 in 
the experimental group and 44 in the control 
group in which anesthesia was guided by he-
modynamic variables (Vakkuri et al 2005).
Caveats in interpreting time-frequency 
balanced spectral entropy and other 
entropy measures
Anderson and Jakobsson induced unrespon-
sivess to verbal stimulation with N2O and 
found that RE / SE values were unchanged 
compared to the awake state (Anderson and 
Jakobsson 2004). Hans and colleagues found 
that the addition of N2O to sevoflurane an-
esthesia during surgery was associated with 
significant decreases in SE and RE (Hans et 
al 2005a). During stable sevoflurane anesthe-
sia, a ketamine bolus was found to induce an 
increase in both BIS (v. 4.0) and RE / SE. The 
RE-SE difference remained unchanged (Hans 
et al 2005b). Maksimow and colleagues found 
that the inter- and intraindividual variability 
in RE / SE was much higher during S-ketamine 
than during propofol anesthesia. Whereas 
propofol markedly increases δ activity, increas-
es in θ and γ activity were characteristic of ket-
amine anesthesia. More spectral peaks are ob-
served during ketamine than during propofol 
anesthesia. Although very good PK values and 
sensitivites for discriminating the conscious 
and unconscious states during ketamine an-
esthesia were found with RE / SE, the specifici-
ties were modest. High relative powers within 
the high β and γ EEG bands were associated 
with high RE / SE values. The amount of high 
frequency EEG activity increased towards the 
end of ketamine anesthesia, with correspond-
ing increases in RE / SE values (Maksimow et 
al 2006).
During remifentanil–propofol induction 
RE, EMG power, and BIS (v. XP) were lower 
after a bolus of atracurium than after a saline 
bolus. SE and SEF did not differ between the 
atracurium and placebo groups. The authors 
concluded that the light anesthetic level with a 
relatively high baseline EMG activity explained 
these findings (Liu et al 2005). Wennervirta 
and colleagues investigated the usefulness of 
processed EEG in brain-dead donors during 
solid organ harvest. They found that both BIS 
(v. 4.0) and RE / SE differed from zero at times 
during the procedure, but entropy was less vul-
nerable to artifacts than BIS (Wennervirta et al 
2007).
In a study on stress responses to noxious 
stimulation, Gjerstad and colleagues reported 
that two out of twenty patients displayed 
high RE / SE values during surgical propofol–
remifentanil anesthesia, with no other signs of 
stress. Increasing the propofol concentration 
did not result in reduction of RE / SE in these 
cases (Gjerstad et al 2007).
ApEn decreases during epileptic seizures 
(Burioka et al 2005). The spectral entropy of 
electrocorticography in sheep was reported 
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to be falsely elevated during spikes induced 
by deep enflurane and sevoflurane anesthesia 
(Voss et al 2006). Gunawardane and colleagues 
studied patients undergoing electroconvulsive 
therapy, and found that similarly to BIS, the 
broad-band spectral entropy did not increase 
with return of consciousness in post-ictal pa-
tients. High frequency (20–40 Hz) spectral 
entropy was more sensitive to ROC. They 
concluded that in patients with abnormal low-
frequency EEG activity, the spectral entropy or 
BIS values may not correlate with the level of 
consciousness (Gunawardane et al 2002).
Electromyography
The motor nucleus of the seventh cranial nerve 
receives input from the cortex, the extrapyra-
midal system, several brainstem nuclei, and the 
spinal cord. The mimic muscles also receive 
direct sympathetic innervation. The voluntary 
contractions of mimic muscles are under cor-
tical control, whereas emotional expressions 
are generated by the extrapyramidal system. 
Startle reflexes can be elicited by touch, light, 
or sound. The electrical activity of the upper 
facial mimic muscles (m. corrugator supercilii, 
m. frontalis, m. orbicularis oculi, m. pyramida-
lis nasi) is a signal source for the biopotentials 
registered from the forehead. Other facial and 
neck muscles may also contribute to the signal. 
Induction of anesthesia reduces the spontane-
ous facial EMG activity due to reduced efferent 
motor output (Paloheimo 1990).
The motor unit actiopotential is produced 
by the summated action potentials of nearly 
simultaneously firing individual muscle fibers 
in a motor unit (Kamen and Caldwell 1996). 
These spikes produced by single motor units 
can be recorded during weak muscle activity. 
With an increasing firing rate and recruitment 
of additional motor units a complex interfer-
ence pattern is produced (Hopkins and Ellis 
1996). Surface electrodes usually record the 
activity of several motor units simultaneously. 
After amplification and low-pass filtering the 
signal can be integrated and divided by the 
length of the corresponding time window to 
yield a measure of time-dependent changes in 
the signal (time-domain analysis). The power 
spectrum of the EMG signal can be obtained 
by the Fourier transform (frequency domain 
analysis) (Paloheimo 1990).
The morphology, amplitude, and frequency 
content of the recorded potentials depend 
on the number and characteristics of the ac-
tive muscle fibers or motor units, the firing 
rate, the surrounding tissue, the recording 
distance, the placement of the electrodes, and 
the properties of the recording apparatus. The 
action potential conduction velocity along the 
muscle fiber membrane is an important de-
terminant of the surface EMG. For example, 
the power spectrum of the more rapidly con-
ducting fast-twitch fibers is characterized by 
higher frequencies than that of slow-twitch 
fibers. The general increase in high-frequency 
content with increasing muscle force is prob-
ably related to the progressive recruitment of 
motor units with faster conducting properties 
(Kamen and Caldwell 1996). During intensive 
facial muscle contractions, the EMG power 
distributes over frequencies up to 300 Hz 
(Paloheimo 1990).
In 1960, Fink used abdominal EMG to as-
sess the level of muscle relaxation during anes-
thesia. He observed increases in EMG activity 
with skin incision, dissection of abdominal 
muscles or the peritoneum, and traction of 
mesenterial structures (Fink 1960). The use 
of the frontal EMG signal as an indicator of 
arousal reactions to noxious stimuli during 
anesthesia was suggested at the end of 1970’s 
(Harmel et al 1978, Hollmén et al 1982).
The Anesthesia and Brain Monitor® (ABM2, 
Datex / Instrumentarium Corp., Helsinki, 
Finland) was one of the first applications of 
online EEG and EMG monitoring in the field 
of anesthesia. Besides displaying the end-tidal 
carbon-dioxide, non-invasive blood pressure, 
and the TOF stimulation response the device 
provided a graphical (series of ten-second 
averages) and numerical (updated every sec-
ond) display of the mean integrated amplitude 
of one-channel EEG (1.5–25 Hz) and frontal 
EMG (65–300 Hz) signals. The monitor used 
non-linear scaling of the ouput to emphasize 
low-amplitude changes. The frequency content 
of the EEG signal was estimated by the mean 
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zero-crossing frequency (ZXF) (Edmonds and 
Paloheimo 1985).
Edmonds and Paloheimo demonstrated that 
fEMG responded readily to acoustic stimula-
tion even during deep isoflurane anesthesia or 
coma (Edmonds et al 1986). They also showed 
that neuromuscular blocking agents depressed 
the neuromuscular transmission in the frontal 
muscle to a lesser degree than in the hypoth-
enar muscle (Edmonds et al 1986, Paloheimo 
et al 1988). In a study by Greif and colleagues 
on deeply sedated unstimulated subjects, the 
frontal-temporal EMG intensity (power in the 
70–100 Hz range relative to 0.0001 µV2) was 
stable during varying neuromuscular blockade 
(T1 twitch intensity 0 %–80 % of the level be-
fore mivacurium infusion) as measured by su-
pramaximal electrical stimulation of the ulnar 
nerve at the wrist (Greif et al 2002). The data of 
Tammisto and Toikka suggest that monitoring 
the EMG activity of neck muscles might pro-
vide an even more sensitive method to detect 
arousal during anesthesia than the fEMG, at 
least with neuromuscular block levels less than 
90 % (Tammisto and Toikka 1991). Without 
EMG monitoring, subtle movements may go 
undetected during anesthesia. EMG chan-
nels including the mastoid process may reveal 
EMG activation at deeper levels of anesthesia 
than facial channels, but may be more affected 
by neuromuscular blockade than facial chan-
nels (Dutton et al 1998).
In a study by Edmonds and colleagues the 
administration of opiate analgesics decreased 
the fEMG amplitude, although this was not 
uniformly associated with subjective analgesia 
in conscious, post-operative patients (Edmonds 
et al 1986, Edmonds et al 1988). A low fEMG 
amplitude often occurred in the absence of 
moderate or severe pain, however, whereas a 
high fEMG activity was consistently associated 
with moderate or severe pain. A significant 
correlation between the log pain score and 
the log fEMG amplitude existed (Edmonds et 
al 1986). The same authors showed a dose-re-
sponse relationship between fEMG amplitude 
and the intensity of an electrical stimulus to the 
infraorbital nerve (Edmonds et al 1988).
Mathews and colleagues reported that the 
fEMG power displayed by the BIS monitor was 
useful in titrating fentanyl administration to 
an opiate-exposed, unparalyzed patient during 
desflurane anesthesia, resulting in a rapid and 
smooth emergence after surgery (Mathews et 
al 2003).
Heart rate variability
Origin and analysis of heart rate variability 
Heart rate variability (HRV) refers to oscil-
lation in the interval between consecutive 
cardiac cycles or between consecutive instan-
taneous heart rates. This oscillation represents 
the complex interplay of the central and auto-
nomic nervous system regulation, the humoral 
and electrophysiological environment, and 
the cardiovascular and thermal status, which 
modulate the intrinsic rhythmicity of the sinus 
node. Mechanical factors (changes in the lung 
volume) can also influence the HRV (Fleisher 
1996, Heart rate variability: standards of mea-
surement, physiological interpretation and 
clinical use 1996). The first clinical application 
of HRV was the evaluation of fetal well-being 
(Hon and Lee 1963). Since then, important 
fields of HRV research have been risk assess-
ment in patients with myocardial infarction 
or heart failure and the evaluation of diabetic 
neuropathy (Fleisher 1996, Heart rate variabil-
ity: standards of measurement, physiological 
interpretation and clinical use 1996).
HRV can be analyzed in the time domain or 
in the frequency domain. Alternatively, meth-
ods based on the detection of rhythm patterns 
or on nonlinear dynamics can be used. The lat-
ter address the correlation properties and the 
complexity of the signal (Heart rate variability: 
standards of measurement, physiological in-
terpretation and clinical use 1996, Lombardi 
2002). Dynamic beat-to-beat measures may 
be more sensitive than traditional methods of 
HRV analysis during unstable HR dynamics 
such as may occur during accentuated sym-
pathovagal interaction (Tulppo et al 1998).
The time domain methods describe the 
statistical properties of either the cycle length 
(R-to-R or normal-to-normal (N-to-N) in-
terval) or the instantaneous heart rate, or the 
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differences between successive cycle lengths 
or heart rates. Examples include SDNN (the 
standard deviation of N-to-N intervals), an 
estimate of the overall HRV, and RMSSD (the 
root of mean squared successive differences 
in N-to-N intervals), an estimate of the short-
term components of HRV. The overall HRV can 
also be described by the geometrical properties 
of the probability density distribution of cycle 
lengths or their differences. The time domain 
methods are ideal for analysis of long-term 
recordings. Frequency domain measures are 
based on estimation of the power spectral den-
sity (PSD) of the signal by either parametric or 
nonparametric methods. The nonparametric 
fast Fourier transform (FFT) is commonly 
used for this purpose. In short-term record-
ings, two major power peaks can be observed 
in clinical data, the low-frequency (LF) and 
high-frequency (HF) components. These cor-
respond to the bands 0.04–0.15 Hz and 0.15–
0.4 Hz. Frequency domain methods are well 
suited for short-term recordings (Heart rate 
variability: standards of measurement, physi-
ological interpretation and clinical use 1996). 
Similar oscillations can be found in arterial 
pressure and in peripheral flow. The RRI oscil-
lations may be most sensitive to altered physi-
ological states, however. The spectral variables 
show a great interindividual spread of values 
(Mainardi et al 1997).
The HF component of HRV is predomi-
nantly under vagal, or parasympathetic con-
trol, whereas sympathetic activity is a major 
contributor to LF (Pagani et al 1986, Heart 
rate variability: standards of measurement, 
physiological interpretation and clinical use 
1996). It is thought that the slower response 
time of the adrenergic system compared to 
the parasympathetic cholinergic system is re-
sponsible for the characteristic LF frequency 
modulation (van Ravenswaaij-Arts et al 1993, 
Fleisher 1996). Parasympathetic activity may 
also influence LF, especially in the resting su-
pine position (Akselrod et al 1981, Pomeranz 
et al 1985). LF and HF frequency modulation 
can be found in both sympathetic and vagal 
efferent nerve discharge, with LF being pre-
dominant in the sympathetic outflow and HF 
in the vagal outflow (Malliani et al 1991). The 
ratio of LF to HF has been used as an index 
of the sympatho-vagal interaction (Fleisher 
1996, Heart rate variability: standards of mea-
surement, physiological interpretation and 
clinical use 1996). The origin of slower HRV 
rhythms (very low frequency and ultra-low 
frequency), which account for the majority of 
the total power in a 24-h recording, is unclear. 
Thermoregulatory and peripheral vasomotor 
mechanisms, the renin-angiotensin system and 
circadian rhythms may be involved, in addition 
to sympathetic and parasympathetic influences 
(Akselrod et al 1981, Fleisher 1996).
At normal breathing frequencies, parasym-
pathetic outflow is decreased during inspira-
tion and increased during expiration (Gilbey et 
al 1984). Usually the respiration related rhyth-
mic activity in vagal and sympathetic nerves 
is almost completely reciprocal. Co-activation 
of both the vagal and sympathetic systems is 
involved in some adaptive responses (Koizumi 
et al 1983).
Both diminished autonomic input and a 
very high level of sympathetic activity lead to 
decreased variance of R-to-R intervals (RRI) 
and thus to decreased HRV, although in the 
latter case the fraction of total HRV in the LF 
band may increase (Fleisher 1996, Heart rate 
variability: standards of measurement, physi-
ological interpretation and clinical use 1996). 
Similarly, during very high vagal activity fixed 
heart rate dynamics may occur (Tulppo et al 
1998). HRV does not reflect the mean level of 
neural input, but rather how variable the neu-
ral input is (Malik and Camm 1993, Hedman 
et al 1995). It is important to consider the 
changes in HR (RRI) when interpreting chang-
es in HRV (Korhonen et al 2001). Bradycardia 
can amplify the effects of any source of vari-
ability affecting the sinus node. In general, the 
effect of (other than sedative) drugs on HRV 
seems to be small and mostly attributable to 
changes in heart rate (Lombardi 2002). Aging 
and several cardiovascular and neurological 
diseases are associated with reduced HRV (van 
Ravenswaaij-Arts et al 1993, Fleisher 1996).
Normal heart rate dynamics have a fractal 
or scale-free character, i.e. both short-term 
and long-term correlations exist between RR 
intervals. This represents a balance or compro-
51
mise between randomness and order. With ag-
ing and disease the fractal dynamics typically 
degrade into either excessive regularity (loss 
of complexity) or uncorrelated randomness. 
It is thought that this is associated with a re-
duction in adaptive capacity (Laitio et al 2000, 
Goldberger et al 2002).
The Poincaré plot displays the current 
value of a variable against the previous value. 
Normal and abnormal heart rate dynamics can 
be discriminated by the shape of the resulting 
Poincaré plot. The normal pattern resembles a 
comet: an increasing RRI is associated with in-
creasing beat-to-beat dispersion (Tulppo et al 
1998). The form of the plot can be quantitative-
ly described by the SD of the residuals against 
the lines y = x (SD1) and y’ = (–x)+2m (SD2), 
where m is the mean of the variable during 
the epoch of interest (Korhonen et al 2001). 
SD1, a measure of the instantaneous beat-to-
beat variability, quantifies vagal modulation 
of heart rate. SD2 is a measure of the longer-
term RRI variability (Tulppo et al 1996). SD1 is 
strongly correlated with RMSSD and HF. SD2 
is strongly correlated with RRI SD, and slightly 
less with LF (Korhonen et al 2001).
Heart rate variability and anesthesia
Induction of anesthesia causes a marked re-
duction in HRV (Kato et al 1992, Latson and 
O’Flaherty 1993, Galletly et al 1994b). As early 
as in 1985, the degree of respiratory sinus ar-
rhythmia (RSA) was suggested to be a poten-
tial on-line indicator of the level of general 
anesthesia in humans (Donchin et al 1985). 
Pomfrett and colleagues used circular statistical 
analysis to estimate the degree of RSA during 
propofol anesthesia. They found that changes 
in RSA followed changes in anesthetic depth 
and preceded corresponding changes in EEG 
MF. In two lightly anesthetized patients RSA 
also increased at skin incision (Pomfrett et al 
1993). Similar results were obtained during iso-
flurane–N2O anesthesia. RSA increased during 
skin incision, whereas EEG MF or SEF95 did 
not. The authors concluded that as an indicator 
of brainstem activity RSA is ideal for the early 
detection of arousal (Pomfrett et al 1994).
N2O (67 %) does not affect the HRV power 
spectra (Tanaka and Nishikawa 2004). The ef-
fect of opioids may be more readily detected by 
nonlinear measures than time-domain mea-
sures of HRV (Storella et al 1995). Morphine 
has been reported to decrease LF more mark-
edly than HF, consistent with a vagotonic effect 
(Michaloudis et al 1998).
Constant and colleagues demonstrated 
in isoflurane-anesthetized children that the 
residual HRV during anesthesia was mainly 
composed of HF fluctuations (Constant et al 
2000). Similarly, during isoflurane–N2O or 
desflurane–N2O anesthesia in spontaneously 
breathing patients, normalized LF decreased 
and normalized HF increased (Widmark et al 
1998). Korhonen and colleagues demonstrated 
that during deep propofol sedation in cardiac 
surgery patients, the regular peaked RSA re-
lated to mechanical ventilation was practically 
the only modulation of HR (Korhonen et al 
2001). VLF power was found to be relatively 
preserved during propofol anesthesia, possibly 
due to the direct vasodilator effect of propo-
fol (Galletly et al 1994a). This may also be an 
indication of loss of stability of cardiovascular 
control during propofol anesthesia (Keyl et al 
2000).
The onset of burst suppression during iso-
flurane anesthesia was associated with a tran-
sient increase in the total HRV power (Kato et 
al 1992). Yli-Hankala and colleagues demon-
strated that the onset of a burst episode is asso-
ciated with a decrease in the RRI, and the onset 
of a suppression episode is associated with an 
increase in RRI in most patients. The magni-
tude of the RRI changes varies between indi-
viduals. The authors suggested that the onset 
of suppression is associated with an increase 
of vagal inhibitory influence on HR, which is 
abruptly released at burst onset (Jäntti and Yli-
Hankala 1990, Yli-Hankala and Jäntti 1990, 
Yli-Hankala et al 1990). In a later study the au-
thors showed that the EEG related changes in 
RRI were abolished by atropine. Atropine did 
not affect the amplitude of RSA during anes-
thesia with mechanical ventilation. Thus RSA 
does not seem to be exclusively under para-
sympathetic control during positive pressure 
ventilation (Yli-Hankala et al 1993c).
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RSA depends on both central respiratory 
drive and sensory input from lung inflation 
(Gilbey et al 1984). Pagani and colleagues found 
that in awake healthy volunteers the transition 
from spontaneous breathing (15 / min) to met-
ronome controlled breathing (20 / min) was 
associated with an increase in HF, producing 
a single narrow spectral peak corresponding to 
the respiratory frequency (Pagani et al 1986).
Nakatsuka and colleagues reported that 
during 2 % sevoflurane–N2O anesthesia, apnea 
caused a reduction in HF. The authors ascribed 
this effect to reduced blood pressure variation 
in the absence of thoracic movement. During 
deeper anesthesia with an isoelectric EEG, HF 
was very low and no change in HF with apnea 
compared to mechanical ventilation was ob-
served. The respiratory pattern had no signifi-
cant effect on LF (Nakatsuka et al 2002).
Pöyhönen and colleagues investigated the 
effects of the CO2 level, tidal volume and re-
spiratory rate on HRV in awake volunteers and 
anesthetized patients. During a controlled CO2 
level and respiratory rate, an increase or de-
crease in tidal volume increased or decreased, 
respectively, the absolute and normalized HF 
power in spontaneously breathing volunteers. 
During mechanical ventilation, either awake or 
anesthetized (0.4 MAC isoflurane), the changes 
in HF power were not statistically significant. 
The authors suggested that the activity of the 
respiratory center is important in modulating 
HRV and not tidal volume per se. A decrease in 
the respiratory rate from 12 / min to 8 / min was 
associated with a decrease of normalized HF 
power and an increase of normalized LF power 
in both spontaneously breathing and mechani-
cally ventilated volunteers, as well as in anes-
thetized patients. Thus the effect of the respira-
tory rate on HRV is presumably mediated via 
afferent input from receptors inside the thorax. 
The authors concluded that in anesthetized pa-
tients, small changes in the CO2 level or tidal 
volume do not modulate HRV significantly, if 
the respiratory rate is controlled (Pöyhönen et 
al 2004).
Sleigh and Donovan found that the ability 
of HRV variables to detect the transition to 
unconsciousness during propofol induction 
was worse than that of EEG variables. The sen-
sitivity, specificity, and negative and positive 
predictive values of HRV were less than 70 % 
(Sleigh and Donovan 1999).
Pichot and colleagues observed that arousal 
from isoflurane anesthesia was associated with 
abrupt, simultaneous increases in HR, total 
HRV power, LF, and normalized LF (Pichot et 
al 2001). Similarly, Constant and colleagues re-
ported that the increase in LF and LF / HF ratio 
at emergence from anesthesia was especially 
pronounced, indicating sympathetic activation 
(Constant et al 2000).
Heart rate variability and  
noxious stimulation
Schubert and colleagues reported that maximal 
intra-abdominal surgical stimulation during 
isoflurane–N2O or enflurane–N2O anesthesia 
was associated with an increase in LF power 
and the LF / HF ratio. In that study, tracheal 
intubation and skin incision did not cause 
sympathetic activation. The authors concluded 
that HRV may be useful in the evaluation of 
the anesthetic effect relative to the magnitude 
of the stressor event. The intraindividual varia-
tion in HRV variables was large (Schubert et 
al 1997).
Latson and colleagues found that total HRV 
and normalized LF increased at skin incision 
during propofol–fentanyl anesthesia, but not 
during isoflurane–N2O–fentanyl anesthesia. 
It is possible that the overall level of anesthe-
sia was deeper in the isoflurane group in this 
study, as evidenced by lower total HRV and 
lower MAP compared to the propofol group. 
Isoflurane-anesthetized patients often dis-
played transient heart rate decelerations at skin 
incision. The authors concluded that isoflurane 
may have a particularly pronounced effect on 
sympathetic activity (Latson and O’Flaherty 
1993). Huang and colleagues demonstrated a 
transient increase in LF / HF power and HR 
with tracheal intubation after thiopentone–
fentanyl induction (Huang et al 1997). 
Wodey and colleagues found that HF power 
decreased after skin incision in children during 
sevoflurane anesthesia, consistent with sympa-
thetic activation (Wodey et al 2003).
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Toweill and colleagues found transient in-
creases in total HRV, LF, LF / HF and a measure 
of long-range correlations in the RRI signal 
at noxious stimulation during propofol anes-
thesia in children. ApEn displayed a transient 
decrease. The authors concluded that HF could 
be used as an indicator of depth of anesthesia 
and LF as an indicator of sympathetic reactions 
(Toweill et al 2003). In a study by Rantanen and 
colleagues RRI decreased and RRI SD1, SD2, 
and RRI SD increased at skin incision during 
propofol–remifentanil anesthesia. With an in-
creasing remifentanil dose, the RRI response 
was attenuated and the SD1 response was en-
hanced (Rantanen et al 2006a).
The Anemon Index (AI; MCSA, Geneva, 
Switzerland) was developed for online moni-
toring of the activity of the autonomic nervous 
system by analyzing HRV. The proprietary in-
dex ranged from 0 to 200, with increasing val-
ues indicating progressively more sympathetic 
activity. Carrasco-Jiménez and colleagues 
showed in sevoflurane-anesthetized dogs that 
the AI uniformly increased at tracheal intu-
bation, whereas no significant changes where 
observed in BIS or hemodynamic variables. 
Surgical stimuli did not induce significant 
changes in AI, BIS, or hemodynamic variables. 
The interindividual variability in both BIS and 
AI were considerable during anesthesia with a 
constant sevoflurane concentration (Carrasco-
Jiménez et al 2004). A trend toward increased 
AI at intubation was also reported in sevo-
flurane–anesthetized pigs. No changes in AI 
during mechanical test stimuli or two differ-
ent fentanyl doses were observed. No surgical 
stimulation was reported, however, and some 
of the test stimuli were of limited intensity 
(Martín et al 2003).
Pulse plethysmography
The pulse plethysmography waveform
According to the Beer-Lambert law, the ab-
sorption of light increases (i.e., the intensity of 
transmitted light decreases) exponentially as a 
function of distance and the concentration of 
dissolved substances (Szocik et al 2005). This 
is the basic principle of photoplethysmography 
(PPG), which measures the intensity of trans-
mitted (or reflected) light of a specific wave-
length in order to monitor changes in the vol-
ume of the light-absorbing structure. During 
anesthesia, pulse oximeters whose primary 
function is to produce an estimate of the relative 
concentration of oxyhemoglobin, also provide 
a photoplethysmographic waveform, related to 
the arterial pulsations of the vascular bed.
The total amount of light transmitted to 
the photodiode detector depends on the opti-
cal density of the solid tissues and the amount 
of blood in the vascular bed. The small varia-
tions in the intensity of transmitted light with 
arterial pulsations are amplified and converted 
to a voltage signal. The amplitude of the PPG 
waveform correlates with perfusion, usually 
of the fingertip or earlobe, although it does 
not provide quantitative information of the 
magnitude of arterial pulse waves (Dorlas and 
Nijboer 1985, Murray and Foster 1996). The 
blood volume changes depend on the pulse 
pressure and the distensibility of the vascular 
wall, as do the PPG amplitude changes. The 
distensibility is modulated by autonomic ner-
vous system input to the smooth muscle of the 
vessel walls (Dorlas and Nijboer 1985). The 
PPG waveform reflects the interplay of the left 
ventricular ejection and the capacitance of the 
vasculature (Murray and Foster 1996).
Both pressure and flow waves in the arterial 
system consist of a forward wave and a com-
posite backward wave, generated by reflection 
at different parts of the system where the im-
pedance changes. During increased resistance, 
the reflection (backward wave) is increased, 
and during decreased resistance it is decreased 
(Westerhof et al 1972). The steepness of the 
slope of the ascending limb of the PPG wave-
form is related to the force of left ventricular 
contraction. Changes in the stroke volume 
may produce beat-to-beat variations in the 
PPG amplitude and the area under the curve. 
If the vasculature is very elastic and the fluid 
filling is adequate, the waveform is broad and 
rounded, and the amplitude and the area un-
der the curve of the PPG waveform are large. 
During hypovolemia and vasoconstriction the 
PPG waveform becomes more narrow and 
54
peaked, and the amplitude decreases. A steep 
descending limb of the PPG waveform with a 
relatively prolonged baseline may indicate an 
inadequate stroke volume relative to the vascu-
lar compliance (Murray and Foster 1996).
The dicrotic notch on the descending limb 
of the waveform may be related to the closure 
of the aortic valve, but also to the pressure wave 
reflection. The dicrotic notch is usually situ-
ated approximately in the middle of the PPG 
waveform (figure 3). During vasoconstriction 
the dicrotic notch occurs relatively earlier and 
is situated closer to the peak of the waveform. 
With vasodilation the dicrotic notch is delayed 
and occurs relatively lower on the descending 
limb of the pulse waveform. It also becomes 
more prominent (Burch 1986, Murray and 
Foster 1996). The PPG amplitude increases 
during vasodilation, e.g. during deep anesthe-
sia (Dorlas and Nijboer 1985). During extreme 
vasodilation and an increased cardiac output 
the dicrotic notch may even be found on the 
ascending limb of the next PPG waveform. The 
origin of occasionally observed double dicrotic 
notches is not clear (Murray and Foster 1996).
Thermoregulation is an important deter-
minant of skin blood flow. During cooling, 
the PPG amplitude decreases exponentially 
in relation to the frequency of sympathetic 
vasoconstrictor bursts. The vasomotor and 
sudomotor sympathetic fibers have a ten-
dency to synchronous firing. Arousing stimuli 
evoke bursts of vasoconstrictor impulses, and 
usually sudomotor impulses also (Hagbarth 
et al 1972, Wallin and König 1976, Bini et al 
1980). Both spinal and supraspinal reflex arcs 
may be involved in the generation of these 
reflex bursts (Hagbarth et al 1972). They are 
attenuated by general and regional anesthesia 
(Wallin and König 1976, Lundin et al 1990). 
Preganglionic sympathetic fibers innervating 
the upper extremities arise from the Th2–Th7 
spinal segments. The α1-adrenergic receptors 
are involved in both maintenance of skin va-
soconstrictor tone at rest and phasic vasocon-
striction (Khan et al 1988).
In addition to respiratory frequency modu-
lation, a coherent 0.1 Hz rhythm has been 
demonstrated in both the PPG wave, RRI, and 
blood pressure. The respiratory frequency vari-
ability of PPG and blood pressure are inter-
preted as having a mainly mechanical origin, 
whereas the 0.1 Hz rhythm reflects the effect 
of the sympathetic nervous system. During 
sympathetic activation, both the power in the 
0.1 Hz range and the synchronization between 
the 0.1 Hz variability of these different cardio-
vascular signals increase. Very low frequency 
fluctuations in the PPG wave are probably due 
to local control mechanisms (Bernardi et al 
1996). An increased amplitude of the respira-
tory fluctuations in the PPG waveform may 
be associated with hypovolemia (Dorlas and 
Nijboer 1985, Murray and Foster 1996).
Pulse plethysmography and anesthesia
Induction of anesthesia causes an increase in 
the PPG amplitude, related to vasodilation 
caused by sympatholysis (Dorlas and Nijboer 
1985, Nijboer and Dorlas 1985, Luginbühl et 
al 2002). A noxious stimulus, such as tetanic 
electrical stimulation, elicits a transient va-
soconstriction in the extremities, which can 
be measured with PPG (Dorlas and Nijboer 
1985, Nijboer and Dorlas 1985, Luginbühl et 
Figure 3. A typical PPG waveform. Ypulse = PPG 
amplitude, Ynotch = dicrotic notch amplitude, Xpulse = 
pulse duration, Xnotch = latency of the dicrotic notch 
minimum from the start of the pulse upstroke. PPG 
area is defined as area under the curve. Notch relative 
amplitude = Ynotch / Ypulse. Notch relative latency = 
Xnotch / Xpulse. Reprinted from Seitsonen et al 2005; Acta 
Anaesthesiol Scand 49: 284–92, with the permission 
of the copyright holder.
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al 2006). Neuromuscular blockade slightly at-
tenuates the PPG amplitude response to elec-
trical stimulation of the ulnar nerve or muscle 
(Luginbühl et al 2002). The regulation of blood 
flow in the earlobes is different from that of 
the digits. The vasoconstrictor responses are 
much less pronounced in the ear than in the 
fingers (Nijboer and Dorlas 1985, Awad et al 
2001). Separate vasoactive reflex mechanisms, 
including a vasodilator mechanism, may exist 
for different orofacial regions. The magnitude 
of the blood flow reduction in the skin of the 
finger (and the MAP response) depends on 
the intensity of the stimulus (Kemppainen et 
al 2001).
In 1985, Nijboer and Dorlas suggested that 
the finger PPG could be used to monitor block-
ade by “stress-free” anesthesia of autonomic 
responses to surgical stimulation (Nijboer and 
Dorlas 1985). Murray and Foster noted that a 
decreased PPG amplitude, usually combined 
with an elevation of the dicrotic notch is a sig-
nal of sympathetic activity during lightening 
anesthesia (Murray and Foster 1996).
Shimoda and colleagues used laser Doppler 
flowmetry to measure the skin vasomotor re-
flex (SVmR) to tetanic electrical stimulation 
of the ulnar nerve during sevoflurane–N2O 
anesthesia. They reported that in patients 
with normal autonomic function, the SVmR 
amplitude, in response to a tetanic electrical 
stimulus immediately before laryngoscopy, 
correlated with the magnitude of the systolic 
blood pressure response to intubation, but not 
with the HR response (Shimoda et al 1998b). 
The magnitude of the SVmR correlated with 
the strength of the tetanic electrical stimulus, 
the duration of stimulation, and the depth of 
anesthesia. Sevoflurane attenuated the SVmR 
to noxious stimulation in a dose-dependent 
manner. Neuromuscular blockade did not in-
fluence the SVmR. The authors concluded that 
the SVmR may be helpful in the assessment of 
nociception and antinociception during gen-
eral anesthesia (Shimoda et al 1998a).
The absence of a significant decrease in the 
PPG amplitude in response to a tetanic electri-
cal test stimulus to the ulnar nerve may pre-
dict attenuation of significant hemodynamic 
responses to tracheal intubation better than 
the absence of the SVmR. The SVmR measures 
superficial perfusion to the depth of a few mil-
limeters. During volatile anesthesia and active 
heating of the patient the PPG, which measures 
blood volume changes in deeper vessels, may 
detect vasoconstriction responses more sensi-
tively than the SVmR. The PPG response and 
the SVmR are not directly correlated with skin 
temperature, however (Luginbühl et al 2002).
An increasing opioid concentration expo-
nentially decreases the reflex vasoconstriction 
elicited by tetanic electrical stimulation. The 
PPG amplitude response to tracheal intuba-
tion correlates with the opioid analgesic con-
centration (Luginbühl et al 2002). Nakahara 
and colleagues reported that the sevoflurane 
concentration required to block the skin vaso-
motor reflex to skin incision was 3.07 % or 1.75 
MAC in oxygen. The amplitude of the SVmR 
did not correlate with either blood pressure or 
heart rate changes at skin incision (Nakahara 
et al 2002).
Singham and colleagues investigated chang-
es in the pulse transit time (PTT, defined as 
the time from the R-wave of the ECG to the 
maximum upslope of the corresponding PPG 
waveform) during isoflurane–N2O anesthesia 
after propofol–opioid induction. The PTT in-
creased at the induction of anesthesia. A large 
decrease in PTT was observed at laryngoscopy 
and tracheal intubation. No significant changes 
in PTT were observed at the start of surgical 
stimulation. No consistent association between 
PTT and movement responses (N = 5) was 
found. The authors noted that the withdrawal 
reflexes and the autonomic responses to noci-
ceptive stimuli may be differentially affected by 
anesthesia and analgesia (Singham et al 2003). 
Dahan and colleagues reported that the PTT 
was shorter during light than during deep hyp-
notic levels, and correlated with BIS (v. 3.3) 
and HR. Noxious stimuli, movement respons-
es, and arousal were associated with decreases 
in the PTT. They noted that the PTT reflects 
changes in the arterial compliance, which is 
under autonomic control and influences the 
arterial shock wave velocity (Greenwald et al 
2002). In a study by Rantanen and colleagues 
the PPG amplitude and PTT decreased, and the 
PPG amplitude SD2 increased at skin incision 
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during propofol–remifentanil anesthesia. The 
changes in the PPG variables were similar in 
both movers (N = 5) and non-movers (N = 50) 
to skin incision (Rantanen et al 2006a).
Luginbühl and colleagues investigated the 
effect of a tetanic electrical test stimulus on 
PPG variability during propofol–remifentanil 
anesthesia. They found that the change in PPG 
amplitude SD2 differed between hemodynam-
ic responders and non-responders to tracheal 
intubation, and the change in PPG amplitude 
SD was a statistically significant predictor of 
hemodynamic response to intubation in a lo-
gistic regression model. The PPG variability re-
sponse to the test stimulus, however, conferred 
no benefit over using the predicted remifen-
tanil effect-site concentration and BIS (v. XP) 
as predictors of the hemodynamic response 
to tracheal intubation in a logistic regression 
model. No significant differences in PPG vari-
ability responses to the test stimulus were ob-
served between groups with different remifen-
tanil and propofol concentrations. The authors 
noted that inter-individual variability may 
have concealed any drug-induced differences 
in PPG variability (Luginbühl et al 2006).
Drug interactions, pharmacokinetics 
and pharmacodynamics
The equilibration of the plasma concentration 
of a drug with the effect-site concentration 
can be described with a first-order differential 
function (van Meurs et al 1998):
dCe(t) / dt = ke0 [Cp(t) – Ce(t)]
where Ce is the effect-site concentration, Cp is 
the plasma concentration, t is time, and ke0 is the 
first-order rate constant, which characterizes 
the temporal aspects of equilibration between 
plasma and effect-site. A pharmacodynamic 
(PD) model describes the physiological effect 
of a drug as a function of its concentration at 
the effect-site, the compartment where the drug 
interacts with receptors or other targets. Due 
to the time lag of plasma and effect-site equili-
bration, the display of plasma concentration vs. 
effect produces two curves, one for increasing 
and one for decreasing concentrations (a hys-
teresis loop), whereas the relationship between 
effect-site concentration vs. effect can be dis-
played in a single curve (collapsed loop). The 
hysteresis between the plasma concentration 
and effect is influenced by perfusion, diffusion, 
nonspecific binding and receptor events (Scott 
et al 1985, Egan et al 1996). The half-time of 
equilibration (T½ ke0) between the plasma and 
effect-site concentrations is given by ln2 / ke0 
(Lötsch 2005).
The hysteresis between plasma concentra-
tions and EEG effect is considerably smaller 
with alfentanil than with fentanyl. The T½ ke0 
is 0.9–1.1 min (ke0 0.63–0.77 / min) for alfen-
tanil vs. 4.7–6.4 min (ke0 0.11–0.15 / min) for 
fentanyl (Scott et al 1985, Scott and Stanski 
1987, Egan et al 1996). After a bolus dose, 
the peak alfentanil effect-site concentration is 
reached at approximately 1.4 min vs. 3.6 min 
for fentanyl (Shafer and Varvel 1991).The rapid 
initial redistribution from the effect-site is an 
important factor determining the resolution 
of alfentanil effect. With fentanyl, this rapid 
redistribution is not apparent at the effect-site. 
Instead, fentanyl has an extended effect profile 
(Ebling et al 1990).
Depending on the PK parameters and the 
EEG measure of effect used, the T½ ke0 reported 
for propofol is 1.5–3.5 min (ke0 0.20–0.46 / min) 
(Billard et al 1997, Kazama et al 1999, Schnider 
et al 1999). The time to peak effect after a bolus 
dose of propofol is 1.6–2.0 min (Schnider et al 
1999, Struys et al 2000).
A commonly used pharmacodynamic mod-
el is the sigmoid Emax model (van Meurs et al 
1998, Minto et al 2000): 
E = E0 + (Emax – E0) [Ce
γ  /  (Ce
γ + EC50
γ)]
where E is the value of the measured variable at 
the drug effect-site concentration Ce, E0 is the 
value of the measured variable in the absence of 
the drug, Emax is the value of the variable when 
the drug effect is maximal, EC50 is the effect-
site concentration that produces half of the 
maximal effect, and γ is a parameter describ-
ing the slope of the concentration-response re-
lationship. In models estimating the probabil-
ity of a certain response, E0 is 0 and Emax is the 
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maximal probability, usually assumed to be 1.
Bouillon and colleagues used a hierachical 
PD model to describe the interaction between 
an opioid, remifentanil, and a hypnotic agent, 
propofol. They found that the hierarchical 
model resulted in a considerably better fit to 
the data compared with a model introduced 
by Minto and colleagues, where each fixed 
combination (ratio) of two or more drugs is re-
garded as a “new drug” with its own response 
curve (Minto et al 2000). Also, in contrast to 
the Minto model, the hierarchical model did 
not predict that remifentanil alone can ab-
late the response to non-noxious or noxious 
stimulation. The hierarchical model estimates 
the potency of remifentanil with respect to the 
attenuation of noxious stimuli, not with re-
spect to an end-point where a hypnotic effect 
is required. Thus the EC50 of remifentanil was 
much lower in the hierarchical model than in 
the Minto model (approximately 1 ng / ml vs. 
19 ng / ml) (Bouillon et al 2004).
The authors demonstrated that remifenta-
nil alone could not suppress responsiveness to 
non-noxious or noxious stimulation in clini-
cally relevant concentrations. Modest concen-
trations of remifentanil profoundly decreased 
the propofol concentration required to sup-
press responsiveness to noxious stimulation, 
whereas high propofol concentrations were re-
quired in the absence of remifentanil. A ceiling 
effect for remifentanil was also observed. The 
interaction between propofol and remifentanil 
was synergistic for suppression of the clinical 
responses to stimulation, and additive for the 
EEG effects. At remifentanil concentrations 
less than 8 ng / ml, however, the EEG effect 
was minor. Approximate entropy was found 
to be more sensitive to opioid effect than BIS 
(v. 3.22). The combination of propofol and re-
mifentanil selected to suppress responsiveness 
had a major effect on the associated EEG state 
(Bouillon et al 2004).
Kazama and colleagues showed a synergis-
tic action between propofol and fentanyl for 
the suppression of somatic and hemodynamic 
responses to abdominal surgical stimuli. A 
50 % reduction in the propofol EC50 to suppress 
somatic responses to skin incision, peritoneum 
incision, and abdominal wall retraction was 
produced by fentanyl plasma concentrations of 
1.2, 1.8, and 2.8 ng / ml. The blood pressure re-
sponses to surgical stimuli correlated negative-
ly with the fentanyl concentration. The authors 
concluded that less than 3 ng / ml of fentanyl 
is not adequate to control the hemodynamic 
response to peritoneum incision or abdominal 
wall retraction, even when the concentration 
of propofol is sufficient to suppress somatic re-
sponses (Kazama et al 1998). Similarly, Katoh 
and colleagues showed that fentanyl attenuates 
the hemodynamic responses to tracheal intu-
bation in a dose-dependent manner. A ceiling 
effect of fentanyl for suppressing movement 
responses to tracheal intubation is achieved 
at lower doses than for suppressing hemody-
namic responses during sevoflurane anesthesia 
(Katoh et al 1999).
Westmoreland and colleagues reported that 
isoflurane MAC was reduced by 50 % with fen-
tanyl at 0.5 ng / ml or alfentanil at 29 ng / ml. 
An apparent ceiling effect for the reduction 
of isoflurane requirements was achieved with 
fentanyl above 3 ng / ml or alfentanil above 500 
ng / ml (Westmoreland et al 1994). A similar 
ceiling effect for fentanyl was also observed 
by Smith and colleagues. A 50 % reduction in 
propofol Cp50 for preventing movement due to 
skin incision was achieved with fentanyl at 0.6 
ng / ml. Increasing the fentanyl concentration 
to 3 ng / ml decreased the propofol Cp50 for skin 
incision by 89 %. Fentanyl at 3 ng / ml decreased 
the propofol Cp50 for LOC by 40 %. Thus the 
interaction between propofol and fentanyl was 
much weaker for a non-noxious stimulus than 
a noxious stimulus (Smith et al 1994).
In a study by Bruhn and colleagues, propo-
fol and remifentanil were found to interact 
synergistically with respect to somatic and he-
modynamic responses to a series of test stimu-
li, including laryngeal manipulation. Their PD 
model applied to the measured blood concen-
trations and predicted effect-site concentra-
tions resulted in PK values of 0.86, for both, for 
predicting the overall modified OAA / S score, 
0.93 and 0.92, for predicting unconsciousness, 
and 0.60 and 0.71, for predicting the response 
to laryngeal stimulation (Bruhn et al 2003).
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Sevoflurane, desflurane and 
hemodynamic responses
Ebert and Muzi reported that both the ini-
tiation of desflurane anesthesia and the 
transition from 1.0 to 1.5 MAC desflurane 
concentration resulted in hypertension, 
tachycardia, and a significant increase in the 
muscle sympathetic nerve activity. They did 
not observe these changes during isoflurane 
anesthesia (Ebert and Muzi 1993). A rapid 
increase in the end-tidal concentration of des-
flurane from 0.55 MAC to 1.66 MAC resulted 
in larger transient increases in heart rate and 
blood pressure than a corresponding increase 
in the end-tidal isoflurane concentration. 
Desflurane also induced greater increases in 
plasma catecholamine and vasopressin con-
centrations than did isoflurane. The onset of 
the sympathoadrenal response was within 30 
s after the first breath of increased desflurane 
concentration and within 60 s after the first 
breath of increased isoflurane concentration. 
The authors suggested that the increased an-
esthetic concentration stimulates medullary 
centers either via respiratory irritant receptors 
or directly, resulting in a transient increase in 
sympathetic outflow and pituitary stimulation. 
The transient increases in heart rate and blood 
pressure are caused by the release of adrenalin 
and vasopressin together with an increased 
sympathetic outflow. The rapid attenuation 
of these responses would be caused by either 
adaptation to the stimulus or direct central 
nervous system depressant effects of the anes-
thetics (Weiskopf et al 1994b).
Yli-Hankala and colleagues observed that 
a rapid increase in the end-tidal isoflurane 
concentration caused an increase in heart rate, 
blood pressure, and the mixed venous blood 
noradrenalin concentration. The authors con-
cluded that the sympathoadrenal activation 
may be due to the irritating effect of isoflurane 
on the airways, but an unknown autonomic 
control mechanism may also be involved (Yli-
Hankala et al 1993d).
In a volunteer study by Muzi and colleagues, 
a linear increase in the end-tidal concentration 
of desflurane from 3.6 % to 11 % resulted in a 
rate-dependent increase in sympathetic nerve 
activity, whereas linearly increasing end-tidal 
isoflurane from 0.6 % to 1.8 % was not associ-
ated with a significant increase in sympathetic 
nerve activity. The rate of desflurane increase 
did not significantly affect the heart rate re-
sponse, possibly due to the dependence of the 
heart rate on multiple control mechanisms. 
The effect of the rate of desflurane increase on 
the MAP response was less consistent than that 
on the sympathetic nerve activity response. 
The peak increase in MAP was greater with 
desflurane than with isoflurane, whereas peak 
increases in heart rate were similar. The thresh-
old for sympathetic nerve activation seemed to 
be slightly lower than that for the heart rate or 
MAP increase, although no single threshold 
for triggering a sympathetic or hemodynamic 
response was found (Muzi et al 1996b). Topical 
airway or systemic lidocaine administration 
does not block the neurocirculatory response 
to desflurane (Muzi et al 1996a).
In a rabbit model, a similar biphasic sym-
pathetic response as with desflurane was ob-
served with other respiratory irritant vapours, 
isoflurane, and enflurane. N2O (10 %–70 %) 
also increased renal sympathetic nerve activ-
ity (Pac-Soo et al 2000a). In an experiment on 
dogs, the increase in heart rate during deepen-
ing inhalation anesthesia was greatest for des-
flurane and least for halothane, and intermedi-
ate for sevoflurane, isoflurane, and enflurane. 
The authors suggested that the vagolytic activ-
ity of the volatile agents may be involved in the 
generation of tachycardia. Even though the in-
crease in heart rate was larger with desflurane 
than with sevoflurane, however, the decrease 
in HRV indices of vagal activity was similar for 
the two agents (Picker et al 2001).
Wajima and colleagues observed that in the 
absence of sympathetic stimulation by N2O, 
a rapid increase in the inspired sevoflurane 
concentration to 2.9 MAC was not associated 
with tachycardia or an increase in the plasma 
adrenalin concentration, in contrast to isoflu-
rane. The plasma noradrenalin concentration 
increased with rapid increases in both sevoflu-
rane and isoflurane concentrations (Wajima et 
al 2000).
Weiskopf and colleagues concluded that 
the sympathetic stimulation following a rapid 
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increase in desflurane concentration is likely 
mediated by both pulmonary and richly per-
fused systemic receptors (Weiskopf et al 1995). 
Rodig and colleagues rapidly increased the 
concentration of desflurane or sevoflurane in 
the membrane oxygenator’s gas supply line 
during mildly hypothermic cardiopulmonary 
bypass, so that concentrations corresponding 
to 1.5 MAC were measured from the exhaust 
gas within two minutes. In the desflurane 
group the systemic vascular resistance index 
initially remained unchanged, and decreased 
only after five minutes, whereas in the sevoflu-
rane group there was an immediate decrease 
in the systemic vascular resistance index. The 
endogenic plasma catecholamine concentra-
tions did not change with time in the desflu-
rane group, but decreased in the sevoflurane 
group. The authors concluded that these find-
ings suggest an extrapulmonary site mediating 
the sympathetic effects of desflurane (Rodig et 
al 1997).
Stimulation of the lower airways by des-
flurane is associated with greater increases in 
heart rate, MAP and muscle sympathetic nerve 
activity than stimulation of the upper airways. 
The muscle sympathetic nerve response may 
be linked to a systemic effector site, whereas 
the heart rate and MAP responses can be elic-
ited by local lung exposure without increas-
ing the systemic desflurane concentration. 
Alternatively, the muscle sympathetic activity 
may be less sensitive to desflurane than the 
regulation of the heart rate. The response of 
both lungs to desflurane may be a summa-
tion of the responses of the right and left lungs 
(Muzi et al 1996a).
Movement responses
Nociceptive reflexes
The motor response to a noxious stimulus 
may be a simple withdrawal reflex, or a more 
complex escape or defense pattern. Peripheral 
nociceptors synapse with second-order neu-
rons in the spinal cord dorsal horn, and these 
in turn synapse with motoneurons either di-
rectly or indirectly via interneurons or central 
pattern generators (Antognini and Carstens 
2002). Large-diameter sensory afferent fibers 
excite motoneurons directly (the monosyn-
aptic reflex). Small-diameter sensory afferents 
(Aδ- and C-fibers) excite motoneurons via 
interneurons, generating the slow ventral root 
potential associated with nociception. The spi-
nal motoneurons receive tonic inhibitory input 
as well as both feed-forward and feedback in-
hibition (Kendig 2002).
Withdrawal responses are generally pro-
duced by reflex circuits organized within the 
spinal cord or the trigeminal nucleus, although 
they can be modified by higher brain centers. 
Spinal motoneurons receive excitatory or in-
hibitory input via the reflex arc so that the net 
result is removal of the affected body part from 
the noxious stimulus. Previous injury to the 
site exciting the withdrawal reflex can induce 
facilitation of the reflex due to central sensiti-
zation. Noxious stimulation at other areas can 
cause descending supraspinal inhibition of the 
withdrawal reflex. In some instances, anesthe-
sia may attenuate this descending inhibition 
(Clarke and Harris 2004).
The development of both the pain sensation 
and the nociceptive flexor reflex seem to share 
a common spinal relay. Both the nociceptive 
reflex magnitude and the associated pain sen-
sation are attenuated by morphine in a dose-
dependent manner, most likely mainly through 
a direct spinal mechanism. In the absence of 
supraspinal influences, when their spontane-
ous activity is increased, spinal neurons may be 
even more sensitive to the effects of morphine 
(Willer 1985).
The generation of movement responses in-
volves temporal summation. Dutton and col-
leagues showed in a rat model that increasing 
the isoflurane concentration above 0.6 MAC 
increases the latency between the onset of nox-
ious stimulation and the onset of movement, 
and movement responses are abolished at con-
centrations greater than one MAC. At a given 
isoflurane concentration, increasing frequency 
of stimulation produces shorter latencies to 
EMG activation and movement. With increas-
ing frequency of stimulation, greater isoflurane 
concentrations are required to increase the la-
tency of movement and to abolish movement 
responses. Short interstimulus interval pulses 
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produce a buildup of EMG activity, resulting 
in a burst of sustained EMG activity and move-
ment. Movement responses are slightly more 
sensitive to isoflurane than the buildup of mus-
cle tone and EMG activation. During NMDA 
blockade, which interferes with temporal 
summation, the concentration of isoflurane re-
quired to suppress movement is not increased 
with shortening interstimulus intervals, and 
the MAC (to tail-clamping) is reduced. Above 
a threshold intensity, the difference between 
isoflurane concentrations required to suppress 
movement at two different interstimulus inter-
vals is independent of stimulus intensity. The 
authors suggested that isoflurane may dimin-
ish the stimulus available for temporal sum-
mation, or the downstream effect of temporal 
summation (Dutton et al 2003).
Minimum alveolar concentration 
The term MAC, defined as “the minimal alveo-
lar anesthetic concentration required to keep 
a dog from responding by gross purposeful 
movement to a painful stimulus”, was coined 
in 1963 by Merkel and Eger (Merkel and Eger 
1963). The next year MAC was defined as the 
concentration at one atmosphere at which 
50 % of patients moved in response to surgical 
incision. MAC is determined during inhaled 
monoanesthesia at equilibrium, using skin 
incision or tail clamping as the supramaximal 
stimulus. “Gross purposeful movement”, usu-
ally of the head or extremities, is considered a 
positive response. Coughing, swallowing, or 
chewing are not considered positive responses 
in the original MAC concept. The interindi-
vidual variation is usually 10 %–20 %. MAC 
decreases with age. Sex does not affect MAC 
values. Changes in CNS metabolism, such as 
may occur e.g. with changes in body tempera-
ture or CNS catecholamine release, are associ-
ated with alterations in MAC values. In clinical 
practice MAC multiples or fractions are used 
to describe different levels of CNS depression, 
assuming that the dose-response curves of dif-
ferent inhaled agents are roughly parallel. On 
the other hand, the relative toxicity of different 
agents, e.g. regarding cardiovascular depres-
sion, can be compared by using MAC multiples 
(Quasha et al 1980).
Zbinden and colleagues demonstrated 
how the end-tidal (arterial) concentration of 
isoflurane required to prevent movement re-
sponses depends on the intensity of the stimu-
lus. Intubation was the strongest stimulus, and 
evoked hemodynamic responses even when 
gross purposeful movement was inhibited 
(Zbinden et al 1994a).
In a classic study, Rampil and colleagues 
observed that the isoflurane MAC for tail 
clamping was similar in precollicular decer-
ebrate and sham-operated rats. The authors 
concluded that the mechanism by which iso-
flurane produces unresponsiveness to noxious 
stimulation is independent of the forebrain 
structures, and may include actions on the 
midbrain or spinal cord (Rampil et al 1993). 
In a subsequent study, Rampil demonstrated in 
rats that hypothermic transection of the spinal 
cord at C7 did not change isoflurane MAC for 
tail clamping in the absence of spinal shock. 
This result suggested that the site of anes-
thetic inhibition of motor response to noxious 
stimulation resides in the spinal cord (Rampil 
1994). Antognini and Schwartz showed in a 
goat model that isoflurane MAC for dew-claw 
clamping was considerably higher when iso-
flurane was delivered only to the isolated brain 
circulation as compared with delivery to the 
whole body (2.9 % vs. 1.2 %). The authors con-
cluded that unconsciousness and suppression 
movement responses during anesthesia may 
be associated with different sites of anesthetic 
action (Antognini and Schwartz 1993). Using a 
similar experimental arrangement, the authors 
found that when the isoflurane concentration 
in the cranial circulation was decreased to 
0.2 %–0.3 %, the torso MAC was decreased to 
0.8 % compared to 1.4 % during whole-body 
isoflurane administration. They suggested that 
changes in the balance of excitatory and inhibi-
tory input to the spinal cord neurons might ex-
plain the results (Borges and Antognini 1994).
Consciousness (and voluntary action) is 
lost at much lower anesthetic concentrations 
than those needed to suppress movement re-
sponses to noxious stimulation (Kazama et al 
1997, Eger 2001). Rampil and Laster found 
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in rodents that during isoflurane anesthesia, 
movement responses to noxious stimulation 
occurred in some animals simultaneously 
with substantial periods of EEG suppression. 
None of the investigated EEG variables cor-
related with movement responses (Rampil and 
Laster 1992). Similar results were found in 
goats during halothane anesthesia (Antognini 
et al 2002). Sub-MAC concentrations of isoflu-
rane (0.7 %) diminish the cortical blood flow 
responses to tactile stimulation and ablate the 
cortical blood flow responses to noxious elec-
trical stimulation. At supramaximal stimula-
tion, during 0.7 % isoflurane anesthesia, only 
subcortical blood flow responses are observed. 
At 1.3 % (1 MAC) isoflurane the subcortical 
blood flow response is also suppressed, even 
though some subjects would be expected to 
move in response to supramaximal stimulation 
at this isoflurane concentration in the absence 
of neuromuscular blockade (Antognini et al 
1997).
Mechanisms behind  
anesthetic-induced immobility
In rats, several inhaled anesthetics are hype-
ralgesic at low concentrations of 0.1 MAC, as 
measured by the hind paw withdrawal latency 
to thermal stimulation. At 0.4–0.8 MAC, they 
significantly increase hind paw withdrawal la-
tency. Isoflurane already produces an analgesic 
effect at 0.2 MAC. With the exception of N2O 
and diethyl ether, the analgesic concentra-
tion of inhaled agents overlaps that producing 
unconsciousness (Zhang et al 2000). In rats, 
sub-MAC concentrations of isoflurane seem to 
primarily diminish the number of movement 
responses to noxious stimulation. At supra-
MAC concentrations the force of movements 
is also decreased (Antognini et al 1999b).
Although clinically relevant concentrations 
of inhaled anesthetics may increase the dis-
charge activity of C-fiber nociceptors (MacIver 
and Tanelian 1990), peripheral actions of 
volatile agents are probably not important with 
respect to immobility (Antognini and Kien 
1995). Axonal transmission and the excit-
ability of postganglionic sympathetic neurons 
to direct intracellular stimulation have been 
shown to be far less sensitive to halothane than 
synaptic transmission induced by stimulation 
of preganglionic sympathetic nerves (Bosnjak 
et al 1982). Thin unmyelinated fibers may be 
more sensitive to isoflurane than myelinated 
fibers (Berg-Johnsen and Langmoen 1986).
Sevoflurane, propofol, and thiopental de-
crease the number and amplitude of indirect 
corticospinal potentials (I-waves) evoked by 
transcranial electrical stimulation. The later 
I-waves are more sensitive to anesthetics than 
the early ones, possibly reflecting longer synap-
tic chains generating the later I-waves. The com-
plex direct corticospinal potential (D-wave) is 
relatively resistant to anesthetics (Woodforth et 
al 1999). Clinical concentrations (3.7 %–7.4 %) 
of desflurane, with or without N2O, do not af-
fect either peripheral or central nerve conduc-
tion velocities or neuromuscular transmission. 
Desflurane profoundly depresses motor poten-
tials evoked by epidural spinal cord electrical 
stimulation, and dose-dependently decreases 
the amplitudes of segmental spinally relayed 
motor responses evoked by peripheral stimu-
lation. Thus it seems to act preferentially on 
central synapses (Péréon et al 1999).
Subanaesthetic concentrations of propofol 
and sevoflurane depress the transsynaptic and 
centrally mediated motor responses to both 
transcranial magnetic stimulation and pe-
ripheral stimulation. Spinal integration seems 
to be even more sensitive to anesthetic action 
than cortical excitability, as measured by BIS 
(v. 3.22) and MLAEP changes. Since both the 
spinal components of somatosensory evoked 
potentials and the brainstem auditory evoked 
potentials are relatively resistant to anesthetics, 
it seems that in both spinal and brainstem mo-
tor reflex responses the efferent part of neural 
transmission is preferentially suppressed by 
anesthetic agents (Kammer et al 2002).
Antognini and colleagues demonstrated in 
goats that isoflurane effect in the spinal cord 
depresses the spontaneous activity of noci-
ceptive dorsal horn neurons. The magnitude 
of noxious stimulus evoked activity in dorsal 
horn neurons is greater when the torso isoflu-
rane concentration is 0.3 % compared to 1.3 %. 
Very high isoflurane concentrations (around 
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9 %) in the brain attenuate the noxious stimu-
lus evoked activity in dorsal horn neurons, 
even when the torso isoflurane concentration 
is low. A brain isoflurane concentration of 3 % 
did not change dorsal horn neuronal responses 
compared to 1.3 %, during either moderate 
(1.3 %) or low (0.3 %) torso isoflurane concen-
trations. The authors concluded that very high 
brain isoflurane concentrations may influence 
descending modulatory pathways, affecting 
both sensory and motor neurons (Antognini 
et al 1998). Anesthetic doses of propofol were 
also shown to directly depress spinal dorsal 
horn neuronal responses to noxious mechani-
cal stimulation. Propofol delivered only to the 
cranial circulation was ineffective (Antognini 
et al 2000c). Isoflurane was shown to attenuate 
noxious stimulation evoked EEG and thalamic 
responses by both cranial and spinal actions 
(Antognini et al 2000a).
The same group investigated the effect 
of 0.75–1.4 MAC isoflurane and halothane 
on dorsal horn neuronal responses to nox-
ious thermal stimulation in rats. Both agents 
dose-dependently decreased the spontaneous 
activity of dorsal horn nociceptive neurons, 
although the mean spontaneous activity in 
this concentration range was larger under 
halothane than under isoflurane. Evoked dor-
sal horn activity was similar or greater with 
isoflurane than with halothane. Halothane 
dose-dependently decreased evoked dorsal 
horn neuronal responses, with simultaneous 
reductions in withdrawal force. In contrast, the 
dorsal horn neuronal responses at 1.4 MAC 
isoflurane were similar to those at 0.75–0.9 
MAC isoflurane, with a slight increase at 1.1 
MAC. The withdrawal force was dramatically 
reduced, however, at the transition from 0.9 
to 1.1 MAC isoflurane anesthesia. With both 
anesthetics, withdrawal responses were either 
markedly reduced or absent at 1.1 MAC. The 
authors concluded that depression of nocicep-
tive transmission in the dorsal horn seems to 
contribute to the immobilizing effect of halot-
hane, whereas more ventral components of the 
reflex arc are important to the immobilizing 
effect of isoflurane (Jinks et al 2003).
Antognini and colleagues showed in a goat 
model that when halothane is delivered only to 
the cranial circulation and the torso halothane 
concentration is low (0.1 %–0.2 %), the cranial 
halothane concentration required to prevent 
movement to noxious mechanical stimulation 
is 3.4 % compared to 0.9 % during whole-body 
administration. In two of five animals move-
ment responses could not be prevented even 
with a 4 % cranial halothane concentration 
(Antognini et al 2002). The corresponding 
values during cranial and systemic isoflurane 
delivery were 2.9 % and 1.2 % (Antognini and 
Schwartz 1993). The high cranial halothane 
or isoflurane concentrations resulted in pro-
nounced EEG depression with periods of burst 
suppression or isoelectricity, but movement re-
sponses still occurred. In contrast, the cranial 
thiopental concentration required to prevent 
movement to noxious mechanical stimulation 
was only twice that observed during systemic 
thiopental delivery, and the EEG remained 
active despite the suppression of movements. 
The authors concluded that whereas halothane 
(and isoflurane) suppress movement predomi-
nantly via a spinal action, thiopental may have 
an important supraspinal (subcortical) target 
with respect to immobility, perhaps medi-
ated by descending inhibition (Antognini et al 
2002).
Jinks and colleagues studied the effect of 
isoflurane and noxious thermal stimulation 
on the RVM ON- (cells which increase their 
activity with reflex movement) and OFF-cells 
(cells which are inhibited during movement) 
in rats. Isoflurane dose-dependently depressed 
the spontaneous activity of ON-cells and en-
hanced the activity of OFF-cells. It also signifi-
cantly decreased the responses of the ON-cells 
to noxious thermal stimulation at 1.15 MAC. 
The large changes in the spontaneous activ-
ity of both the ON- and OFF-cells (and in the 
evoked activity of ON-cells) at 1.15 MAC were 
associated with a nearly complete absence 
of withdrawal responses to noxious thermal 
stimulation (Jinks et al 2004).
Injection of a μ opioid agonist into the 
RVM suppressed both the spontaneous and 
the evoked activity of ON-cells in anesthetized 
rats. In cases where the μ agonist effectively in-
hibited the tail-flick reflex, the activity of OFF-
cells increased and changed from perodic to 
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continuous. The pause in the activity of OFF-
cells, which followed noxious stimulation and 
preceded the tail-flick reflex, was abolished 
(Heinricher et al 1994). Similar changes in 
OFF-cell activity were observed after intrave-
nous administration of morphine, which abol-
ished the tail-flick reflex to noxious heat (Fields 
et al 1983). The disinhibition of OFF-cells 
seems to be crucial to the antinociceptive effect 
of a μ agonist within the RVM (Heinricher et al 
1994). Application of morphine to the PAG or 
to the spinal cord also results in activation of 
RVM OFF-cells and antinociception (Cheng et 
al 1986, Heinricher and Drasner 1991).
It has been suggested that the anesthetic-
induced decrease in the excitability of spinal 
motoneurons, as measured by peripherally 
evoked and spinally relayed motor responses, 
may be involved in suppressing movement 
responses to noxious stimulation (King and 
Rampil 1994, Rampil and King 1996, Zhou et 
al 1998). The spinally relayed motor responses 
are depressed, however, at lower anesthetic 
concentrations than those required for the 
suppression of movement responses, or those 
causing EEG depression. The effect of anes-
thetics on spinally relayed motor responses 
occurs more slowly (longer T½ ke0) than the 
EEG effect (Antognini et al 1999a, Rehberg et 
al 2004a, Baars et al 2006a, Baars et al 2006b). 
The arousal caused by noxious stimulation 
transiently increases the spinally relayed mo-
tor responses during anesthesia (Rehberg et al 
2004b, Baars et al 2005, Baars et al 2006b).
Both pre- and postsynaptic mechanisms 
are probably involved in anesthetic action on 
spinal motoneurons. Spinal motoneurons re-
ceive tonic inhibition via GABAA and glycine 
receptors. Blockade of GABAA and glycine 
receptors increases volatile anesthetic require-
ments by a maximum of about 40 %. They may 
be more important for propofol and barbitu-
rates. Volatile agents can inhibit both AMPA 
and NMDA receptor mediated excitatory 
currents in spinal motoneurons, independent 
of actions on GABA or glycine gated inhibi-
tory chloride channels. Thus anesthetic ac-
tions on the motoneuron glutamate receptors 
are probably important. No specific site on the 
glutamate receptors for the volatile agents has, 
however, been identified. Anesthetic agents 
may also modulate the intrinsic excitability of 
motoneurons via various ion channels. Volatile 
anesthetic agents depress the monosynap-
tic reflex at concentrations equivalent to one 
MAC or lower, whereas it is little affected by 
i.v. anesthetic agents or opioids, at least in in 
vitro preparations. The monosynaptic reflex 
is mediated primarily via glutamate AMPA 
receptors, with a contribution from NMDA re-
ceptors. The slow ventral root potential, which 
is presumed to be associated with nociception, 
is more sensitive to anesthetic agents than the 
monosynaptic reflex. Hypnotic agents display 
some selectivity for the early component, me-
diated by the NMDA receptor. The late com-
ponent, mediated by various metabotropic 
(G-protein-coupled) receptors, is sensitive to 
opioids and α2-agonists (Kendig 2002).
In a mouse spinal cord preparation, enflu-
rane depressed motoneuron EPSCs evoked 
both by electrical stimulation (synaptic trans-
mission) and by glutamate application, when 
presynaptic mechanisms were excluded by the 
administration of tetrodotoxin. The enflurane 
effect on synaptic transmission was slightly 
larger than the direct postsynaptic effect, indi-
cating a possible contribution from presynaptic 
effects. The blockade of GABAA and glycine re-
ceptors did not significantly diminish the effect 
of enflurane on glutamate-evoked EPSCs. The 
GABAA antagonist bicuculline, however, atten-
uates enflurane effects in intact mouse spinal 
cords. The currents mediated by both AMPA 
and NMDA receptors were equally affected by 
enflurane. The authors concluded that with re-
spect to suppression of nocifensive movement, 
receptors other than GABAA or glycine are im-
portant targets of volatile anesthetics (Cheng 
and Kendig 2000).
At or close to the concentration required for 
general anesthesia, propofol and barbiturates 
depress the slow ventral root potential and 
enhance the dorsal root potential (involved in 
presynaptic inhibition) via their action on the 
GABAA receptor (Jewett et al 1992).
Sevoflurane and propofol dose-dependently 
decreased the spontaneous firing rate of rat spi-
nal cord ventral interneurons in vitro. Whereas 
high sevoflurane concentrations completely 
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suppressed the spontaneous activity, propofol 
displayed a ceiling effect near 60 % reduction. 
Based on testing in the presence of bicuculline 
and strychnine, the authors estimated that 38 % 
and 45 % of the sevoflurane effect is mediated 
by GABAA and glycine receptors, and 17 % by 
other receptors, probably including glutamate 
receptors. The effect of propofol at clinically 
relevant concentrations is mediated almost ex-
clusively by GABAA receptors (Grasshoff and 
Antkowiak 2004).
In a rodent spinal cord preparation, sevoflu-
rane markedly depressed both the motoneuron 
action potential wind-up evoked by repetitive 
stimulation of nociceptive (C-fiber) afferents 
and the underlying cumulative depolarization 
(the summation of successive slow ventral root 
potentials) already at subanesthetic concen-
trations. The effect of sevoflurane was dose-
dependent and reached its maximum at an-
esthetic concentrations. The effect of propofol 
was smaller and occurred at relatively higher 
concentrations (the cumulative depolarization 
was significantly reduced only at supraclinical 
concentrations). The monosynaptic reflex was 
depressed by sevoflurane, but not by propofol. 
Thus the effect of sevoflurane on both nocicep-
tive and non-nociceptive spinal transmission 
is considerably stronger than that of propofol 
(Matute et al 2004).
The correlation of hemodynamic variables 
and movement responses
Generally, the correlation between pre- or post-
stimulus hemodynamic variables and move-
ment responses is poor (Vernon et al 1995, 
Kazama et al 1997, Sebel et al 1997, Kochs et al 
1999). Johansen and colleagues reported that in 
a logistic regression analysis, the pre- and post-
incision heart rates emerged as significant pre-
dictors of movement responses to skin incision 
during propofol–N2O anesthesia, but the effect 
was too small to be included in the final model 
(Johansen et al 1997). Hemodynamic variables 
are also not reliable indicators of unconscious-
ness (Struys et al 2002). Subcortically medi-
ated physiological variables, such as MLAEP 
and fEMG, may reflect the arousal preceding 
movement responses better than hemodynam-
ics or surface EEG (Yli-Hankala et al 1994).
The relationship between 
electroencephalogram derived  
variables and movement responses
Sebel and colleagues investigated patients 
during isoflurane–N2O, isoflurane–opiod, or 
propofol–opioid anesthesia in a multicenter 
study. They found that BIS (v. 1.1), the estimat-
ed opioid effect-site concentration, and MAP 
were the best independent predictors of move-
ment response to skin incision according to 
logistic regression analysis. Combining infor-
mation from the BIS values and the opioid ef-
fect-site concentrations significantly improved 
the prediction performance. When isoflurane–
opioid anesthesia was used, however, the inci-
dence of movement responses was low, and no 
association between BIS values and movement 
responses appeared. With increasing opioid 
concentrations, the probability of movement 
in the presence of low isoflurane concentra-
tions and high BIS values decreased. The mod-
eled relationship between BIS values and the 
probability of movement responses was much 
closer with isoflurane or propofol than with 
opioids. Overall, the movement response rate 
to noxious stimulation was lower in patients 
whose BIS values were titrated to less than 
60, compared to the control group. The aver-
age BIS values in the control and BIS-guided 
groups were 66 and 51 (Sebel et al 1997).
Leslie and colleagues found that the pre-
stimulus BIS (v. 3.0), SEF95, MF, and relative 
β power all had PK values exceeding 0.80 for 
the movement response to tetanic electrical 
stimulation during propofol–N2O anesthe-
sia in healthy volunteers, as did the pupillary 
constriction velocity. The PK values of the pre-
stimulus relative δ power and systolic blood 
pressure were 0.79 and 0.78. The pre-stimulus 
blood and effect-site propofol concentrations 
and the pupillary reflex amplitude had PK val-
ues of 0.74–0.76. Heart rate did not predict 
movement responses. Thus, hemodynamic 
and pupillary indicators were not superior 
to surface EEG variables. The observations 
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used in calculating the prediction probabili-
ties, however, were not strictly independent. 
Individually computed PK values were even 
higher. The most pronounced change in the 
recorded variables in response to noxious 
stimulation was the rapid pupillary dilation, 
which was sustained longer in movers than in 
non-movers (Leslie et al 1996).
Singh and colleagues found that pre-incision 
BIS (v. 3.3) values were lower in non-movers 
than in movers reacting to skin incision dur-
ing propofol–fentanyl anesthesia, whereas pre-
incision SEF95 values did not differ between 
movers and non-movers. Increasing doses of 
fentanyl resulted in fewer movement responses 
(Singh et al 1999).
Dutton and colleagues found that the 
SEF95 was a statistically significant predictor 
of movement responses to surgical stimulation 
during isoflurane–N2O–fentanyl anesthesia. 
The response curves shifted to higher frequen-
cies with increasing doses of fentanyl or the use 
of N2O (Dutton et al 1996). Similarly, Schraag 
and colleagues reported that although the 
overlap in SEF95 values between responders 
and non-responders was considerable, SEF95 
was a statistically significant predictor of both 
LOC and movement responses to skin incision 
in a logistic regression model during propo-
fol–N2O–sufentanil anesthesia. No significant 
association between MF and LOC or move-
ment responses to skin incision was observed. 
The authors noted that theoretically, very low 
SEF95 values (< 7 Hz) would be required in 
order to achieve a 95 % probability of no move-
ment response to skin incision (Schraag et al 
1998).
Doi and colleagues reported that both BIS 
(v. 3.12) and SEF95 were unable to predict 
movement responses to laryngeal mask inser-
tion during propofol–alfentanil anesthesia (PK 
value 0.55 for both indices). The pre-stimulus 
hemodynamic variables and predicted blood 
propofol concentrations were also similar 
between movers and non-movers. In that 
study, the auditory evoked potential index did 
predict movement responses (PK 0.87) (Doi 
et al 1999). Similarly, Kurita and colleagues 
reported that the PK values of the auditory 
evoked potential index, end-tidal sevoflurane 
concentration, and BIS (v. 3.2) for movement 
responses to skin incision during sevoflurane 
anesthesia were 0.91, 0.86 and 0.54. It was not 
possible to relate BIS and movement responses 
with logistic regression. The presence of the 
endotracheal tube seemed to elevate the audi-
tory evoked potential index values compared 
to the values preceding intubation. The authors 
concluded that the auditory evoked potential 
index, which partly reflects the activity of sub-
cortical neuronal pathways may be an indica-
tor of arousal during anesthesia and noxious 
stimulation (Kurita et al 2001). Katoh and col-
leagues found that the PK values of the end-tidal 
sevoflurane concentration, BIS (v. 3.2), SEF95, 
and MF for movement responses to skin inci-
sion during sevoflurane anesthesia were 0.90, 
0.66, 0.57, and 0.52. None of the EEG variables 
predicted movement better than chance alone 
(Katoh et al 1998).
In a study by Kochs and colleagues a five-
second tetanic electrical test stimulus applied 
before skin incision during isoflurane–N2O 
anesthesia did not induce any significant 
changes in the EEG, MLAEP or hemodynamic 
variables, and did not predict reactions to skin 
incision. The pre-incision values of any of the 
variables were not different between movers 
and non-movers to skin incision. The increases 
in MLAEP amplitudes and EMG power and 
the decreases in α and θ EEG power after 
skin incision were larger in movers than in 
non-movers. The authors noted that in order 
to establish whether the level of anesthesia is 
sufficient to prevent movement responses to 
noxious stimulation in unparalyzed patients, 
either the level of analgesia and / or the level of 
motoneuron depression would have to be as-
sessed (Kochs et al 1999). 
Antinociception
Hypnosis, antinociception and  
the adequacy of anesthesia
Loss of consciousness cannot be achieved re-
liably by administering opioids alone (Jhaveri 
et al 1997). Similarly, opioids alone are insuf-
ficient to suppress motor and hemodynamic 
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responses to surgical stimulation (Hug et al 
1988, Lang et al 1996). Opioid analgesia re-
duces both hemodynamic and movement 
responses to noxious stimulation (Sebel et al 
1997, Katoh et al 1999, Guignard et al 2000, 
Valjus et al 2006).
In a study by Guignard and colleagues, dur-
ing propofol anesthesia, the increases in HR 
and MAP at laryngoscopy and intubation were 
inversely correlated with the target effect-site 
concentration of remifentanil. The number 
of movers to laryngoscopy and intubation 
decreased progressively as the remifentanil 
concentration increased (Guignard et al 2000). 
Supplemental doses of both propofol and alfen-
tanil were found to be effective in controlling 
the blood pressure and catecholamine respons-
es to retropubic dissection during propofol–
alfentanil anesthesia (Monk et al 1992).
The analgesic, or rather the antinocicep-
tive component of anesthesia, influences the 
hypnotic component and the state of the auto-
nomic nervous system (Kochs and Schneider 
2001). After induction of anesthesia with 
propofol, fentanyl, isoflurane, and N2O indi-
vidual patients may respond to laryngoscopy 
by increases in fEMG and HR and decreases 
in PPG amplitude even in the presence of 
30 % BSR, whereas others show no response at 
lighter levels of anesthesia (Paloheimo M, un-
published observations).
Electroencephalogram arousal responses
Wilder-Smith and colleagues suggested that 
although it is difficult to predict the responses 
to noxious stimuli based on the level of cortical 
depression before the stimulus, the elicited EEG 
arousal reactions themselves could be used for 
the assessment of nociception during anesthe-
sia (Wilder-Smith et al 1995). Guignard and 
colleagues suggested that increases in BIS (v. 
3.12) in association with noxious stimulation 
could be used as indicators of insufficient anal-
gesia during anesthesia (Guignard et al 2000).
In a volunteer study by Iselin-Chaves and 
colleagues both an increase in the concentra-
tion of propofol and the presence of alfentanil 
(50–100 ng / ml) were associated with an at-
tenuated BIS response to a noxious mechani-
cal stimulus (Iselin-Chaves et al 1998). Valjus 
and colleagues reported that during propofol–
N2O–remifentanil or propofol–N2O–esmolol 
anesthesia, some spontaneous intraoperative 
movements (occurring mostly shortly after in-
tubation or at the start of surgical stimulation) 
were associated with simultaneous and similar 
increases in RE / SE and BIS. The majority of 
movements did not elicit any changes in the 
level of hypnosis or RE values, and overall SE, 
RE, and BIS values were very similar in both 
groups. Thus in that study, RE was not more 
sensitive to arousal reactions or the level of 
intraoperative opioid analgesia than SE or BIS 
(Valjus et al 2006).
Hagihira and colleagues have introduced a 
method of employing the bispectral analysis of 
the EEG in assessing the adequacy of anesthe-
sia (Hagihira et al 2001, Hagihira et al 2002). 
In their recent work they found that skin inci-
sion during isoflurane or sevoflurane anesthe-
sia was associated with a significant reduction 
in the two peak heights (at approximately 10 
Hz and 4 Hz) of the EEG bicoherence, and 
that this reduction was counteracted by fenta-
nyl analgesia. In that study, both BIS (v. 3.4) 
and SEF95 increased, decreased or remained 
stable, depending on whether desynchroniza-
tion, δ wave arousal patterns, or mixed fast and 
slow EEG activity was elicited by the surgical 
stimulus. Because of the individual variability, 
no overall change in BIS or SEF95 values was 
observed after the skin incision. The adminis-
tration of fentanyl restored the EEG waveforms 
to patterns similar to those observed before 
skin incision. Fentanyl administration alone, 
without surgical stimulation, did not induce 
significant changes in the EEG derivatives. The 
authors speculated that the decrease in the two 
bicoherence peaks reflects the disruption of 
the EEG synchronization, associated with an-
esthesia, by sensory input to the thalamus. This 
sensory input can be blocked by sufficient an-
tinociception, either by regional anesthesia or 
opioid analgesics. In their practice, the authors 
consider reduced peak bicoherence values as 
an indication of inadequate antinociception, 
when the concentration of hypnotic agents is 
stable. Thus the bicoherence values are used 
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as a guide to the administration of analgesic 
agents (Hagihira et al 2004b).
The A-line ARX (autoregressive model-
ing with exogenous input) Index (A-AEP™, 
Alaris Medical Systems, Hampshire, UK) was 
reported to respond more sensitively than 
BIS (v. 3.1) to noxious stimulation during 
sevoflurane–N2O or propofol–N2O–fentanyl 
anesthesia, perhaps partly due to the faster 
response time of the AAI compared to BIS 
(Nishiyama and Hanaoka 2004, Nishiyama et 
al 2004). Bonhomme and colleagues observed 
that the A-Line Autoregressive Index (AAI™, 
Danmeter A / S, Odense, Denmark) increased 
in response to skin incision during sevoflurane 
anesthesia, when BIS (v. 3.4) was maintained 
between 40 and 60 by adjusting the sevoflu-
rane concentration. The increase in AAI due to 
nociceptive stimulation was attenuated by epi-
dural analgesia. Based on a logistic regression 
model, the authors suggested a threshold value 
of the AAI (20) for adjusting the antinocice-
ptive component of anesthesia during a con-
stant hypnotic level. The authors hypothesized 
that an intermittent facilitation of MLAEP by 
ascending spinoreticular or spinothalamic no-
ciceptive input might explain the increases in 
AAI despite a stable cortical level of anesthesia 
(Bonhomme et al 2006). 
Pulse plethysmography and  
heart rate variability responses
Luginbühl and colleagues found that both 
the decrease in the PPG waveform amplitude 
(pulse wave reflex, PWR) and the decrease in 
the superficial skin perfusion as measured by 
laser-Doppler flowmetry (SVmR), after a te-
tanic electrical stimulus to the forearm, were 
exponentially suppressed by increasing con-
centrations of alfentanil during sevoflurane–
N2O anesthesia. Neuromuscular blockade di-
minished the PWR to both muscle and nerve 
stimulation, and the SVmR to muscle stimula-
tion. The PWR after a tetanic stimulus was a 
more reliable predictor of the hemodynamic 
response to tracheal intubation than the SVmR 
(Luginbühl et al 2002).
Later the authors found that the variabil-
ity in the amplitude of the PPG waveform 
induced by tetanic electrical stimulation was 
similar between patients who mounted a sig-
nificant hemodynamic response to tracheal 
intubation and those who did not, except for 
SD2 derived from Poincaré analysis of the PPG 
amplitudes, which was larger in responders 
than in non-responders. Different remifentanil 
concentrations or different BIS (v. 3.3) levels 
did not influence the stimulation-induced 
PPG variability, but were significant predictors 
of the hemodynamic response to intubation 
in a logistic regression model. The ratio of the 
post- and pre-stimulus PPG amplitude SD also 
predicted the response to intubation, but did 
not significantly improve the overall accuracy 
of the logistic model compared to the model 
including the remifentanil concentration and 
BIS alone (Luginbühl et al 2006).
Analysis of HRV variables from the same 
patients revealed that generally intubation in-
duced larger HRV responses than the tetanic 
stimulus (except in RRI RMSSD and Poincaré 
SD1), but different remifentanil concentrations 
or different BIS (v. 3.3) levels did not influence 
the stimulation-induced HRV responses. A 
significant interaction between the anesthetic 
group and the stimulus type was found, how-
ever, for the mean RRI, RRI SD, RRI Poincaré 
SD2, and the RRI spectral entropy (0.04–0.4 
Hz). The tetanus-induced increases in the RRI 
SD and the Poincaré SD2 and the intubation-
induced RRI decrease were smallest in the 
group with the highest remifentanil concen-
tration (4.7 ng / ml). Both the HRV responses 
to tetanic electrical stimulation and the HRV 
variables preceding intubation were similar 
between patients who mounted a significant 
hemodynamic response to tracheal intuba-
tion and those who did not. The RRI decrease 
following intubation was larger in responders 
than in non-responders. Again, only the calcu-
lated remifentanil effect-site concentration and 
the BIS level were significant predictors of the 
hemodynamic response to intubation in a lo-
gistic regression model. The authors concluded 
that generally the hemodynamic responses dif-
fer between different levels of opioid analgesia 
only when very strong noxious stimuli are ap-
plied, and that at present the hemodynamic 
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responsiveness of an anesthetized patient is 
best evaluated by the estimated opioid concen-
tration and information from an indicator of 
the hypnotic level, such as BIS. The HRV vari-
ables are similar over a wide range of surgical 
anesthesia, and thus their value in assessing 
the hemodynamic responsiveness is limited 
(Luginbühl et al 2007).
The RRI and PPG notch amplitude respons-
es to a very strong tetanic electrical stimulus 
(30 s) during propofol–remifentanil anesthesia 
were dependent on the remifentanil concen-
tration (Rantanen et al 2004).
Response index of Nociception and  
the Surgical Stress Index
Rantanen and colleagues investigated changes 
in physiological variables at skin incision dur-
ing propofol–remifentanil anesthesia. They 
found that the RRI and PPG amplitude de-
creased, and HRV (RRI SD, Poincaré SD1 and 
SD2), PPG variability (Poincaré SD2), and RE 
increased. The relative position of the PPG 
notch changed, and PTT decreased. RE-SE 
increased in movers, but not in non-movers. 
Higher remifentanil concentrations (3 or 5 
ng / ml vs. 1 ng / ml) were associated with 
smaller decreases in the RRI, larger increases 
in the RRI SD1, smaller increases in RE, and 
larger decreases in PTT. The responses of in-
dividual variables were similar in patients with 
a large vs. a small skin incision. The authors 
developed an empirical clinical reference score 
(Clinical Signs – Stimulus – Antinociception 
score, CSSA) for estimating the nociception–
antinociception balance during general an-
esthesia. The score includes evaluation of the 
intensity of surgical stimulation (incision), the 
level of the analgesic drug concentration, and 
the presence or absence of somatic signs of in-
adequate anesthesia (Rantanen et al 2006a).
With the CSSA score as reference, they 
developed a potential online scaled index 
(Response index of Nociception, RN) of the 
nociception–antinociception balance, based 
on variables derived from the time-frequency 
balanced spectral entropy, RRI and PPG. This 
index successfully discriminated patients re-
ceiving different remifentanil concentrations 
during propofol anesthesia, movers vs. non-
movers, and patients subjected to a large vs. 
a small skin incision. RRI, and RE or RE-SE 
correlated best with the remifentanil concen-
tration and somatic responses at skin inci-
sion, respectively. The magnitude of the skin 
incision correlated best with PPG amplitude 
SD1, SD2, and SD1 / SD2. No single variable 
was associated with all three components of 
the CSSA score, but the combination of in-
formation from different signals provided an 
adequate prediction of CSSA. The PK values of 
RN for the CSSA score were 0.78 and 0.73 in 
the development and test data sets. The authors 
observed that the magnitude of skin incision 
seemed to be less important in determining 
the nociception–antinociception balance than 
the remifentanil concentration (Rantanen et al 
2006a).
Huiku and colleagues recently described the 
development of an index designed to measure 
the level of surgical stress, which is dependent 
on both the intensity of surgical stimulation 
and the level of antinociception provided by 
opioid analgesia (or neural blockade). The 
authors investigated the correlation of a large 
number of physiological variables with the 
estimated strength of surgical stimulation and 
with the concentration of remifentanil during 
propofol–remifentanil anesthesia. Different 
time- and frequency-domain measures of 
PPG amplitude and RRI variability, as well as 
measures obtained by Poincaré analysis, were 
explored. Non-invasive blood pressure, PTT, 
RE, and EEG variables were also investigated 
(Huiku et al 2007).
In order to reduce interindividual variabil-
ity in the physiological variables, a histogram 
transformation was performed. The raw values 
of the variables were mapped to a cumulative 
distribution function, which was formed by 
combining the population distribution from 
the entire development data set (54 patients) 
and the individual distribution collected dur-
ing anesthesia. When five minutes or more of 
data had been collected, the weights used for 
the population and individual distributions 
were 0.3 and 0.7. The distributions were mod-
elled as normal distributions. The mean of the 
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individual distribution was defined as that ob-
served during anesthesia for that patient, but 
the SD was fixed to the average value observed 
in the entire development population. The 
output of the histogram transformation was a 
normalized value of the variable in question, 
ranging from zero to 100, where the output 
value of 50 roughly corresponds to the indi-
vidual median value, and the values of 25 and 
75 correspond to the individual first and third 
quartile (Huiku et al 2007).
The noxious intensity of different anesthetic 
and surgical events was estimated based on 
existing data on the pharmacodynamic inter-
action between propofol and remifentanil for 
suppressing clinical responses, and the hier-
archical PD model of Bouillon and colleagues 
(Bouillon et al 2004). The total surgical stress 
(nociceptive–antinociceptive balance) was esti-
mated as TSS = (intensity of stimulation) – (ef-
fect-site remifentanil concentration / 3 ng / ml). 
The three variables which best correlated with 
the intensity of stimulation were the normal-
ized PPG amplitude (PPGamplitudenorm), the 
PTT and the systolic blood pressure. The three 
variables which best correlated with the concen-
tration of remifentanil were PPGamplitudenorm, 
the systolic blood pressure and the normalized 
heart beat interval (HBInorm), derived from the 
PPG signal. The PPGamplitudenorm explained a 
larger amount of variability in the TSS than any 
other single variable. The addition of HBInorm 
in a linear combination reduced the amount 
of unexplained variability. The performance of 
the model was slightly improved by the systolic 
blood pressure, but it was discarded due to the 
discontinuous nature of the noninvasive blood 
pressure measurement. RE or variables derived 
from the EEG did not improve the model 
performance. The optimization of the linear 
combination of PPGamplitudenorm and HBInorm 
resulted in the Surgical Stress Index (SSI): 
SSI = 100  –  (0.7   PPGamplitudenorm  +  0.3  HBInorm)
The SSI correlated positively with the esti-
mated intensity of stimulation and negatively 
with the remifentanil concentration. During 
surgery, SSI increased less in the presence of 
remifentanil at 5 ng / ml than with remifenta-
nil at 1 or 3 ng / ml, both in the development 
(N = 54) and the validation (N = 12) data sets 
(Huiku et al 2007).
Ahonen and colleagues investigated SSI 
during desflurane–N2O–remifentanil or 
desflurane–N2O–esmolol anesthesia. RE / SE 
was around 40 in both groups, and the infu-
sions of remifentanil or esmolol were adjusted 
to maintain a stable hemodynamic condition. 
At skin incision, SSI increased in the esmolol 
group, but not in the remifentanil group. After 
the insertion of troacars SSI increased in both 
groups, but remained significantly lower in the 
remifentanil group compared to the esmolol 
group. The required desflurane concentration 
was larger in the esmolol group than in the re-
mifentanil group. Two patients in the esmolol 
group moved during the procedure, whereas 
none in the remifentanil group did. The in-
traoperative movements were associated with 
high SSI values, whereas RE remained low. The 
authors observed that the autonomic changes 
related to emergence from anesthesia resulted 
in high SSI values, which were unrelated to the 
subjective sensation of pain at ROC. They con-
cluded that the SSI seems to reflect the level of 
surgical stress, and may be useful in the assess-
ment of the effect of opioid analgesics and in-
traoperative nociception (Ahonen et al 2007).
In another study, high SSI values were as-
sociated with an increased risk of intraop-
erative movement responses during propofol–
remifentanil anesthesia, although there was 
considerable overlap in SSI values between 
movers and non-movers (Uutela et al 2006). 
During laparotomy in patients anesthetized 
with propofol, SSI was higher when the effect-
site remifentanil concentration was 1 ng / ml 
compared to 5 ng / ml. This difference was 
observed despite the gradual development 
of moderate hypothermia, which potentially 
could interfere with PPG monitoring. The SSI 
had a significant negative correlation with the 
remifentanil concentration (Aho et al 2006).
Vanpeteghem and colleagues investigated 
SSI responses to a standardized tetanic electri-
cal stimulus during propofol–remifentanil an-
esthesia. SSI was independent of the propofol 
effect-site concentration. Both the baseline and 
the maximum post-stimulus SSI values were 
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significantly higher at remifentanil effect-site 
concentrations of 0–2 ng / ml than at higher 
remifentanil concentrations. At remifentanil 
concentrations above 2 ng / ml the SSI response 
to tetanic stimulation was small (Vanpeteghem 
et al 2006). Similarly, Ojala and colleagues 
found that varying propofol concentrations 
during surgery did not significantly influence 
SSI values, but were associated with different 
SE values. The SSI was higher during laparo-
tomy than before surgery, whereas SE was not 
(Ojala et al 2006).
Wennervirta and colleagues found that 
during desflurane–alfentanil anesthesia, SSI 
was significantly higher at skin incision in pa-
tients who had not received regional anesthesia 
pre-operatively, than in those with established 
regional anesthesia of the surgical site. The al-
fentanil requirement was significantly larger 
in the former group (Wennervirta et al 2006). 
Similar results were obtained during sevoflu-
rane–N2O–sufentanil anesthesia. The differ-
ence observed at skin incision in the SSI values 
between patients with and without regional 
anesthesia decreased over time (Yli-Hankala et 
al 2006).
 A visual approach toward online monitor-
ing of the nociceptive–antinociceptive balance 
during anesthesia was described by Paloheimo 
and Penttinen. They generated a two-dimen-
sional, beat-to-beat display of the PPG ampli-
tude plotted against the RRI, with a number 
of recent beats displayed in white, and the 
five most recent beats displayed in red. Rapid 
deflections of the red spot occur in response 
to noxious stimuli exceeding the antinocicep-
tive effect of balanced anesthesia. A sustained 
deviation toward short RRIs and low PPG am-
plitudes may reflect the humoral response to 
nociception (Paloheimo and Penttinen 2004).
Other approaches to the  
assessment of antinociception
Storm and colleagues investigated the changes 
in palmar skin conductance, associated with 
sympathetically mediated sweating, during 
propofol–remifentanil anesthesia. Compared 
to a clinical stress score including hypertensive 
responses, coughing, tearing, movements, and 
fEMG activation, the number of fluctuations 
in skin conductance was found to detect dis-
comfort during anesthesia with a sensitivity 
and specificity of 86 %. Generally, the number 
of fluctuations in skin conductance seemed to 
be more sensitive than the clinical stress score 
during surgical stimulation. Interestingly, one 
patient displayed a vigorous movement and 
fEMG response during intubation despite sys-
tolic hypotension, a BIS value of 40, and no in-
dication of stress by the skin conductance. The 
authors suggested that arousal with impending 
wakefulness may be differentiated from a mere 
nociceptive response by the associated skin 
conductance patterns. During arousal, the in-
crease in the number of skin conductance fluc-
tuations was accompanied by an increase in the 
mean skin conductance level and BIS (over 50). 
During noxious stimulation, without arousal, 
the number of skin conductance fluctuations 
increased, whereas the mean level of skin con-
ductance was stable and BIS remained low (less 
than 50). The amplitude of skin conductance 
fluctuations was larger during arousal than in 
the absence of arousal (Storm et al 2005).
During intubation under propofol–re-
mifentanil anesthesia, the number of skin 
conductance fluctuations was a more sensitive 
indicator of stress than either a clinical stress 
score (including muscle activity, sweating, 
tearing, and hypertensive responses) or RE-SE. 
The correlation with the clinical stress score 
was stronger for the number of skin conduc-
tance fluctuations than for RE-SE. The number 
of skin conductance fluctuations also indicated 
the stress associated with tetanic electrical 
stimulation, whereas the clinical stress score 
or RE-SE did not. In addition, the increase in 
the number of skin conductance fluctuations at 
tetanic stimulation was smaller in the presence 
than in the absence of remifentanil analgesia, 
whereas RE-SE was not sensitive to remifenta-
nil. The authors suggested that the number of 
skin conductance fluctuations may be a sensi-
tive indicator of subclinical stress during anes-
thesia, and could be used to monitor the opioid 
analgesic effect (Gjerstad et al 2007).
Alfentanil dose-dependently decreased the 
maximum amplitude of pupillary dilation in 
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response to tetanic electrical stimulation dur-
ing isoflurane anesthesia (Larson et al 1997). 
During propofol–remifentanil anesthesia, the 
pupil size decreased with an increasing re-
mifentanil concentration, reaching a plateau at 
slightly less than 2 mm (at 3 ng / ml remifenta-
nil) in the unstimulated state. A linear inverse 
correlation between the pupillary dilation to 
tetanic electrical stimulation and the target re-
mifentanil effect-site concentration was found. 
The pupillary dilation response to noxious 
stimulation was abolished at 4–5 ng / ml of re-
mifentanil (EC50 2.3 ng / ml). The authors con-
cluded that the pupil dilation response reflect-
ed the remifentanil effect more sensitively than 
did hemodynamic variables or BIS (Barvais et 
al 2003). Similarly, in children over two years 
old, reflex pupillary dilation was shown to be 
a very sensitive indicator of nociception dur-
ing 1.5 MAC sevoflurane–N2O anesthesia. A 
significant pupillary dilation was observed 
in all patients, whereas none of them moved 
in response to skin incision. A small bolus of 
alfentanil restored the pupillary diameter to 
baseline within two minutes, in parallel with 
hemodynamic variables (Constant et al 2006). 
Thus it has been suggested that the pupillary 
dilation in response to noxious stimulation 
could be used to evaluate the level of the an-
algesic component of anesthesia (Larson et al 
1997). 
The benefit of analgesia
Regional anesthetic techniques represent 
the most effective means of attenuating the 
endocrine-metabolic responses to surgical 
injury, especially with lower body procedures 
(Kehlet and Wilmore 2002, Moraca et al 2003). 
Pain relief and the prevention of the stress re-
sponse are not directly coupled. The pathways 
mediating the neuroendocrine stress response 
may be inadequately blocked despite effective 
pain control (Liu et al 1995, Carr and Goudas 
1999).
The sympathetic stress response can be 
deleterious to patients with coronary artery 
disease. Good intra- and post-operative anal-
gesia is an important factor in maintaining op-
timal hemodynamics and coronary perfusion. 
Volatile anesthetic agents and delta opioid 
receptor agonists may have direct cardiopro-
tective effects (Warltier et al 2000). Epidural 
blockade was found to reduce intraoperative 
and early post-operative myocardial ischemia, 
compared with general anesthesia alone, in pa-
tients with coronary artery disease undergoing 
upper abdominal surgery (Limberi et al 2003).
Although propofol–sufentanil–N2O anes-
thesia was associated with lower intraoperative 
cortisol and catecholamine concentrations than 
enflurane–N2O anesthesia, it did not prevent 
the post-operative metabolic stress response 
(Schricker et al 2000). An extensive epidural 
block attenuated the catecholamine response 
in radical esophagectomy patients, but did not 
prevent the cortisol or cytokine response or the 
changes in immune function (Yokoyama et al 
2005).
A meta-analysis by Rodgers and colleagues 
concluded that compared with general anes-
thesia alone, intraoperative neuraxial blockade 
was associated with a reduced overall 30-day 
mortality and reduced risks of thromboem-
bolism, bleeding, respiratory depression and 
pneumonia. The data also suggested reduced 
risks of myocardial infarction and renal failure. 
A trend towards fewer infective complications 
other than pneumonia in the neuraxial block-
ade group appeared (Rodgers et al 2000). In 
contrast, Rigg and colleagues found no differ-
ence in mortality at 30 days between high-risk 
patients assigned to intra- and post-operative 
epidural analgesia vs. general anesthesia alone. 
They did find a reduced risk of respiratory 
failure and improved analgesia in the epidural 
group compared to general anesthesia alone. 
No differences in the frequency of cardiovas-
cular events, renal failure, or infectious com-
plications were found between the groups. 
The study by Rigg and colleagues included 
abdominal and thoracic surgery and had fewer 
observed fatalities than the study by Rodgers 
and colleagues, in which the effect on mortal-
ity was most pronounced in orthopedic cases 
(Rigg et al 2002).
High dose opioid anesthesia may attenuate 
the hormonal stress response to surgery (Kono 
et al 1981, Blunnie et al 1983). Anand and col-
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leagues compared deep sufentanil-based anes-
thesia and post-operative sufentanil or fentanyl 
infusion with lighter general anesthesia (halot-
hane–ketamine–morphine) and post-operative 
intermittent morphine and diazepam boluses 
in 45 critically ill neonates undergoing cardiac 
surgery. The neuroendocrine and metabolic 
stress response was significantly decreased 
in the high dose sufentanil group compared 
with the light general anesthesia group. The 
incidences of sepsis, disseminated intravascu-
lar coagulation, persistent metabolic acidosis, 
and mortality were smaller in the high dose 
sufentanil group (Anand and Hickey 1992). 
High dose intrathecal sufentanil attenuated the 
intraoperative adrenocorticotropic hormone 
and cortisol secretion during major abdominal 
surgery more effectively than i.v. sufentanil 
(Borgdorff et al 2004). In another study, the in-
cidence of major post-operative complications 
after abdominal aortic surgery did not differ 
between patients receiving intrathecal versus 
i.v. opioid analgesia during surgery, although 
the post-operative pain relief was better and 
the consumption of morphine was less in the 
former group (Fleron et al 2003).
Ledowski and colleagues found no corre-
lation between stress hormone levels and BIS 
values, hemodynamic variables, or HRV vari-
ables during minor ear-nose-throat procedures 
with sevoflurane–remifentanil or propofol–
remifentanil anesthesia, except for a weak 
correlation between HRV LF / HF and the no-
radrenalin level. In the sevoflurane group, BIS 
values and total HRV power were lower and 
noradrenalin concentrations higher than in the 
propofol group during skin incision and maxi-
mal surgical stimulation. The overall consump-
tion of remifentanil, adjusted according to 
hemodynamic variables, was similar in the two 
groups (2.8 mg and 3.0 mg in the sevoflurane 
and propofol groups) (Ledowski et al 2005).
On the cellular level, a cascade of reactive 
changes is initiated in the spinal cord dor-
sal horn within one hour after tissue injury 
(Carr and Goudas 1999). As a result of plastic 
changes in the structure, function or electro-
chemical properties of peripheral and central 
nerve cells the response of the nociceptive 
transmission system to repeated stimuli is pro-
gressively increased (Woolf and Salter 2000). 
The level of pre-operatively existing pain may 
also influence central sensitization (Aida et al 
2000). Opioids inhibit the initial responses of 
the dorsal horn nociceptive neurons but not 
wind-up. Combined to NMDA antagonists, 
however, which directly inhibit wind-up but 
not the initial responses to incoming nocicep-
tive information, they produce profound anti-
nociception (Chapman and Dickenson 1992).
In a study of elective abdominal hysterec-
tomy patients, the patients who had received 
fentanyl intraoperatively displayed a greater 
sensory inhibition (higher pain detection and 
tolerance thresholds) at five days post-opera-
tively than those who had received ketamine or 
magnesium intraoperatively. Just after surgery 
the fentanyl group had less generalized (central) 
sensory inhibition than the other groups, but 
displayed significant multisegmental (spinal) 
inhibition not present in the other groups. With 
post-operative morphine patient-controlled 
analgesia, the pain verbal rating scale scores 
and total morphine consumption were similar 
in all groups (Wilder-Smith et al 1998). In an 
earlier study, the same authors demonstrated 
that compared with placebo, intraoperative 
fentanyl prevented segmental somatosensory 
sensitization and was associated with greater 
general sensory inhibition after isoflurane–
N2O anesthesia for elective intervertebral disc 
surgery. In that study, the post-operative pain 
verbal rating scale scores and total morphine 
consumption were also similar in both groups 
(Wilder-Smith et al 1996). Severe post-opera-
tive pain, along with long-term pre-operative 
pain, intraoperative and post-operative nerve 
damage, and psychological factors, is a predis-
posing factor to the development of chronic 
pain (Perkins and Kehlet 2000).
Isoflurane alone was far less effective than 
intrathecal morphine in attenuating central 
sensitization after subcutaneous formalin in-
jection in rats (Abram and Yaksh 1993). In ad-
dition to local anesthetics and opioids, central 
sensitization, and thus post-operative pain, 
may be reduced by other compounds such as 
gabapentidoids (Dirks et al 2002) or spinal clo-
nidine (De Kock et al 2005).
Gottschalk and colleagues compared epidu-
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ral fentanyl or bupivacaine treatment, initiated 
before surgery, with aggressive post-operative 
epidural analgesia alone, initiated before emer-
gence from isoflurane anesthesia for radical 
prostatectomy (control group). They found that 
the pre-emptive groups had lower pain ratings 
than the control group during hospitalization 
and at nine and a half weeks after discharge. 
At three and a half weeks post-operatively, 
the pre-emptive groups were more physically 
active than the control group. At nine and a 
half weeks, 86 % of patients in the pre-emptive 
groups were pain-free vs. 47 % of patients in the 
control group. Although a trend existed toward 
epidural pre-emptive bupivacaine being more 
effective than fentanyl, the difference was not 
statistically significant (Gottschalk et al 1998). 
This study is an example of “protective anal-
gesia”, aimed at preventing hypersensitivity to 
pain. As central sensitization can develop not 
only during surgery but in the post-operative 
period as well, a short “pre-emptive” analgesic 
treatment without adequate post-operative 
pain relief may not be effective (Dahl and 
Moiniche 2004).
Taken together, the above-mentioned stud-
ies indicate that the correlation between the 
hormonal stress response to surgery and indica-
tors of the adequacy of anesthesia is not always 
good. High-dose opioid administration may 
attenuate the endocrine-metabolic response to 
some degree, but regional anesthesia is more 
effective in this respect, and may be associ-
ated with a reduction in some post-operative 
complications compared to general anesthesia 
alone. Neither regional anesthesia or opioid 
analgesia is able to abolish the neuroendocrine 
stress response completely. Perhaps the great-
est significance of intraoperative antinocicep-
tion lies in the potential prevention of central 
sensitization induced by tissue injury during 
surgery, and of cardiac complications in pa-
tients with heart disease.
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Aims of the study
The aim of this thesis was threefold. First, to study aspects of EEG bispectral index 
monitoring during anesthesia. Second, to compare EEG features and heart rate re-
sponses during desflurane and sevoflurane anesthesia. Third, to explore the interac-
tion of hypnosis and antinociception, and possibilities to monitor the nociceptive–
antinociceptive balance during general anesthesia. The specific objectives were:
1. To determine whether inexpensive ECG electrodes are equally acceptable as the 
designated EEG electrodes in BIS monitoring with the A-1000 EEG monitor, in 
terms of skin-electrode impedance and measured BIS values (I).
2. To determine whether the tachycardia caused by a rapid increase in the admin-
istered desflurane concentration is associated with epileptiform EEG (II). 
3. To compare the recovery of gynecological ambulatory surgery patients after iso-
flurane and sevoflurane anesthesia, when the administration of the volatile agent 
was adjusted according to BIS values in both groups (III).
4. To compare the effectiveness of a propofol bolus of 0.7 mg / kg i.v. and an alfenta-
nil bolus of 0.5 mg i.v. in preventing the recurrence of movement during uterine 
dilatation and curettage (IV).
5. To explore which variables derived from a variety of biosignals are associated 
with the degree of intraoperative nociception, defined as the presence or absence 
of movement responses to noxious stimulation (IV, V).
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Patients and methods
Patients
The original studies (table 1) were conducted in 
the Women’s Hospital of the Helsinki University 
Central Hospital between September 1998 and 
June 2002. The patients were adult females 
classified pre-operatively as ASA physical 
status I–II (Dripps et al 1961) and scheduled 
for elective surgery under general anesthesia. 
The total number of patients analyzed was 344 
(table 2). 
All studies were approved by the local eth-
ics committee. All patients gave their written 
consent for participation after receiving both 
written and personal information of the pur-
pose and protocol of the studies.
In the second part of study I, data from one 
patient was excluded due to the short duration 
of anesthesia, with a minimal maintenance 
phase. In study II, the first ten randomized pa-
tients were considered pilot cases and were not 
included in the analysis. In study III, the surgi-
cal procedure was cancelled in two randomized 
patients, and converted from laparoscopy to 
laparotomy in two other patients, whereby the 
patients were no longer eligible for discharge 
on the same day. Two patients experienced a 
surgically complicated post-operative course. 
Table 1. Designs of the original studies and demographics of the patients. N = number of patients. 
Demographic data are median [25 % percentile; 75 % percentile]. BMI = body mass index (body mass 
divided by squared height in meters). 
I II III IV V
Design Prospective, 
controlled, 
observational
Prospective, 
randomized, 
controlled, double-
blind regarding 
EEG effects
Prospective, 
randomized, 
controlled, single-
blind
Prospective, 
randomized, 
controlled, single-
blind
Prospective, 
controlled, 
observational
N 85 31 120 82 26
Age (years) 41 [33; 52] 36 [29; 41] 35 [31; 40] 33 [29; 37] 47 [38; 54]
Height (cm) 164 [161; 170] 165 [162; 169] 166 [163; 170] 166 [162; 172] 168 [162; 173]
Body mass (kg) 62 [58; 72] 63 [52; 68] 63 [57; 70] 64 [57; 72] 66 [57; 72]
BMI (kg / m2) 23 [21; 25] 23 [20; 24] 23 [21; 25] 23 [21; 25] 23 [21; 26]
Table 2. The number of patients in the original studies.
Study Randomized patients Patients excluded from analysis Analyzed patients
I – 1 85
II 41 10 31
III 126 6 120
IV 129 47 82
V – 10 26
Total 296 74 344
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These six patients were excluded from the 
analysis. In study IV, 26 patients who moved 
in response to a non-noxious stimulus were 
given rescue medication and excluded form 
the analysis. Three patients were excluded 
because of protocol failure and nine patients 
due to missing data. The study was cancelled 
in eight cases due to logistic problems. One 
patient was excluded because removal of an 
intrauterine device, instead of uterine dilata-
tion and curettage, was performed. In study 
V, five of the originally randomized patients 
were excluded due to missing or poor quality 
data, and three patients because of spontane-
ous movement less than five minutes before 
skin incision, necessitating rescue medication. 
The study was cancelled in two cases because 
hysteroscopy, instead of laparotomy, was per-
formed. The total number of patients recruited 
but excluded from analysis in studies I–V was 
74 (table 2).
Designs and protocols of the 
original studies
The randomization in studies II–IV was per-
formed in blocks of four using the random 
numbers generator of the Excel® 97 spread-
sheet program. The group assignment codes 
were contained in sealed envelopes until re-
cruitment was complete.
Study I. In the first study, the skin-electrode 
impedance values of different electrode – skin 
pretreatment combinations, and the BIS values 
measured with different electrodes were com-
pared. The study consisted of three parts. In the 
first part, the skin-electrode impedance values 
of Zipprep® EEG electrodes, with alcohol swab 
pretreatment of the skin, and Nikomed® ECG 
electrodes, with either alcohol swab pretreat-
ment alone or both electrode paste abrasion 
and alcohol swab pretreatment of the skin 
were compared in 51 patients. The impedances 
were measured before induction and after the 
completion of the surgical procedure with 
the impedance check algorithm of the Aspect 
A-1000 EEG monitor. In the second part, the 
BIS values measured simultaneously with a 
set of four Zipprep® EEG electrodes and a set 
of four Nikomed® ECG electrodes, placed just 
cephalad of the respective Zipprep® electrodes 
on the frontotemporal area, were compared in 
26 patients. The principal outcome parameter 
was the average BIS value difference between 
the ECG and EEG electrodes. In the third part, 
BIS values measured with two sets of four 
Zipprep® EEG electrodes were compared in 
eight patients. The skin was prepared and the 
electrodes were placed in the same way as in 
the second part of the study to evaluate the ef-
fect of the location of the electrodes on the BIS 
values. The principal outcome parameter was 
the average BIS value difference between the 
two sets of EEG electrodes.
Study II. The hypothesis that tachycardia in-
duced by a rapid increase in the administered 
desflurane concentration is associated with 
epileptiform EEG activity, similarly as has 
been observed with sevoflurane, was tested. 
The principal outcome parameter was the in-
cidence of epileptiform EEG activity. A total of 
31 patients were randomized to receive either 
desflurane or sevoflurane anesthesia. After 
induction of anesthesia with propofol and 
remifentanil, and a ten-minute equilibration 
period at approximately 0.7 MAC desflurane–
N2O or sevoflurane–N2O anesthesia, the in-
spired concentration of the volatile agent was 
adjusted to the highest possible setting on the 
vaporizer (18 % and 7 %) for five minutes. A 
Bain’s circuit placed between the tracheal tube 
connector and the Y-piece of the ventilator 
was used to achieve a rapid rise in the alveolar 
anesthetic concentration. Normocapnia, as de-
fined by the end-tidal carbon dioxide concen-
tration, was maintained by adjusting fresh gas 
flow. Heart rate and non-invasive blood pres-
sure were manually recorded at one-minute 
intervals. After the five-minute study period 
the Bain’s circuit was removed and the inhaled 
concentration of the volatile agent was de-
creased to a clinically appropriate level. Three 
EEG channels and ECG lead II were recorded 
with an A-1000 EEG monitor. The EEG trac-
ings from the five-minute study period were 
classified according to the presence or absence 
of epileptiform activity by an experienced neu-
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rophysiologist who was unaware of the group 
assignment.
Study III. The hypothesis that the recovery of 
gynecological ambulatory surgery patients is 
equally fast after isoflurane–N2O anesthesia 
as after sevoflurane–N2O anesthesia, when the 
administration of the volatile agent is adjusted 
according to BIS values, was tested. In all 120 
patients were randomized to receive either 
isoflurane–N2O anesthesia or sevoflurane–
N2O anesthesia. After induction of anesthesia 
with propofol and fentanyl, the inhaled con-
centration of the volatile agent was adjusted 
so that the BIS remained between 50 and 60. 
If the heart rate or blood pressure increased 
during anesthesia by 25 % or more compared 
to the pre-induction baseline, and the level of 
hypnosis was adequate as defined by the BIS 
value, one to two doses of fentanyl 50 µg i.v. 
were given. If the hyperdynamic response per-
sisted, one to two doses of labetalol five mg 
i.v. were administered. If no hyperdynamic 
responses were present, fentanyl 50 µg i.v. was 
administered every 45 minutes. All patients re-
ceived either ketoprofen 100 mg or propaceta-
mol 2000 mg i.v. at the end of anesthesia. The 
anesthetic gases were abruptly discontinued 
when the procedure was complete. The main 
outcome parameter was the time to home-
readiness after anesthesia. Several other early 
and intermediate recovery parameters were 
registered. Psychomotor performance (DSST 
test) (Hindmarch 1980), pain, and nausea 
(VAS) were evaluated at 30, 60, 90, and 120 
minutes after anesthesia in the PACU. VAS has 
been validated as a measure of pain (Jensen et 
al 2003), and has been found useful in the as-
sessment of nausea (Boogaerts et al 2000).
Study IV. The effectiveness of an alfentanil 
bolus and a propofol bolus in preventing the 
recurrence of movement responses during 
uterine dilatation and curettage was compared. 
In addition, the association of a measure of 
HRV (Anemon-I®), heart rate, BIS, SEF95 and 
fEMG power with movement responses to 
noxious stimulation was evaluated. A total of 
82 patients were randomized to receive either 
an alfentanil bolus of 0.5 mg i.v. or a propofol 
bolus of 0.7 mg / kg i.v. in case of movement 
in response to cervical dilatation and uterine 
curettage after a propofol–alfentanil induction. 
The procedure was resumed 90 seconds after 
the group drug administration. The main out-
come parameter was the incidence of recurring 
movement after the group drug administra-
tion. If movement recurred, patients in the al-
fentanil group received a propofol bolus of 0.7 
mg / kg i.v., and patients in the propofol group 
received an alfentanil bolus of 0.5 mg i.v. After 
the second movement response, all patients 
were given a propofol bolus of 0.7 mg / kg i.v. 
in the event of recurring movement. Heart rate 
and the Anemon-I index were registered with a 
proprietary monitor. EEG and fEMG were reg-
istered with the Aspect A-2000 EEG monitor. 
The relationship between movement responses 
induced by cervical dilatation and subsequent 
surgical stimulation and HR, the Anemon-I in-
dex, EEG-derived variables, and fEMG power 
was explored. Standardized variables (relative 
to pre-stimulus values) were used to classify 
movers and non-movers.
Study V. The relationship between movement 
responses induced by skin incision and vari-
ous noninvasive cardiocirculatory variables, 
EEG-derived variables, and fEMG power was 
explored in 26 patients. After a combined in-
travenous (propofol and fentanyl) and sevo-
flurane inhalation induction, a 14-minute 
wash-in period was allowed to achieve a stable 
sevoflurane anesthesia of 0.9 MAC before skin 
incision. After skin incision, the patients were 
observed closely for two minutes to detect any 
visible somatic reactions. The ECG, PPG, EEG 
and fEMG were registered with the Datex-
Ohmeda AS / 3 Anesthesia Monitor and the 
Aspect A-2000 EEG monitor. The pre- and 
post-stimulus values of several variables cal-
culated from the aforementioned signals were 
compared. Standardized variables (relative to 
pre-stimulus values) were used to classify mov-
ers and non-movers.
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Methods
Premedication
Oral diazepam (5 mg) roughly one hour before 
anesthesia was used as premedication in stud-
ies I–II and studies IV–V. In study III, no seda-
tive premedication was given routinely, but 8 
patients received oral diazepam (2.5–10 mg) 
pre-operatively due to subjective anxiety. 
Monitoring and signal acquisition
General. Routine monitoring consisted of ECG 
(lead II), heart rate, peripheral pulse oximetry, 
noninvasive automated blood pressure mea-
surement, inspired concentration of oxygen, 
expired concentrations of carbon dioxide and 
N2O, and peak airway pressure. The expired 
concentrations of sevoflurane, desflurane and 
isoflurane were also monitored (studies I–III 
and V). The ventilatory and gas measurements 
were performed from the ventilatory circuit at 
the connection piece close to the endotracheal 
tube (studies I–III and V) or face mask (study 
IV). Datex-Ohmeda AS / 3 Anesthesia monitor 
was used in studies I–III and V. In study IV, the 
Capnomac Ultima® monitor with a Dinamap® 
device was used.
Study I. The electrode positions in the first part 
of the study were just caudal to Fpz (according 
to the international 10–20 electrode system; 
reference), Fp1 (ground), and left and right 
temporal (next to the lateral canthus of the eyes; 
active electrodes). These were also the electrode 
positions of the more caudal electrodes in the 
second and third parts of the study. Another 
set of electrodes (Nikomed® ECG electrodes 
and Zipprep® EEG electrodes in parts two and 
three, respectively) was attached just cephalad 
of the aforementioned positions. Two A-1000 
EEG monitors (Aspect Medical Systems, 
Natick, MA, USA) and two lap-top computers 
were used in the second and third parts of the 
study. The EEG was band-pass filtered (0.5–30 
Hz), amplified and digitized with a sampling 
rate of 128 Hz. Datalogger® software was used 
to collect the EEG signal. In the first part of 
the study, alcohol swab skin pretreatment was 
used for the reference and ground (Zipprep® 
EEG electrodes), and also for the left temporal 
electrode (Nikomed® ECG electrode). For the 
right temporal electrode (Nikomed® ECG elec-
trode) the skin was first abraded with electrode 
paste (Elektrodipasta comp.®, Christian Nissen 
Div., Berner Corp.), and then degreased with 
an alcohol swab. Alcohol swab skin pretreat-
ment was used for all electrodes in the second 
and third parts of the study. All electrodes were 
pressed firmly for at least 6 s after placement. 
Skin-electrode impedances below 10 kΩ were 
considered acceptable.
Study II. The EEG montage used in study II 
was F7: left mastoid, F8: right mastoid, Fpz: 
left temporal, with the ground electrode on 
the upper right forehead. The three EEG chan-
nels and ECG lead II were recorded with the 
Aspect A-1000 EEG monitor, and collected 
on a lap-top computer with Datalogger® soft-
ware. The EEG was band-pass filtered (1–50 
Hz), amplified and digitized with a sampling 
rate of 128 Hz. Alcohol swab skin pretreat-
ment was used for the pregelled silver / silver 
chloride (Ag / AgCl) Zipprep® EEG electrodes. 
Skin-electrode impedances below 5 kΩ were 
considered acceptable.
Study III. The electrode positions were just 
caudal to Fpz (according to the internation-
al 10–20 electrode system; reference), Fp1 
(ground), and left and right temporal (next 
to the lateral canthus of the eyes; active elec-
trodes). The EEG was recorded with the Aspect 
A-1000 EEG monitor, and collected on a lap-
top computer with Datalogger® software. The 
EEG was band-pass filtered (0.5–30 Hz), am-
plified and digitized with a sampling rate of 
128 Hz. Alcohol swab skin pretreatment was 
used for the pregelled Ag / AgCl Zipprep® EEG 
electrodes. Skin-electrode impedances below 5 
kΩ were considered acceptable.
Study IV. Heart rate and Anemon-I index were 
obtained from lead II with a proprietary moni-
tor via pregelled Ag / AgCl Nikomed® ECG 
electrodes. The EEG and fEMG were regis-
tered with the Aspect A-2000 EEG monitor® 
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via a BIS Standard Sensor®. Alcohol swab skin 
pretreatment and firm pressure after electrode 
placement were used. The electrode positions 
corresponded to Fpz, Fp2, and right temporal 
(next to the lateral canthus of the right eye). 
The EEG was band-pass filtered (0.5–30 Hz), 
amplified and digitized with a sampling rate 
of 128 Hz. fEMG power (in the 70–110 Hz 
range) was obtained directly from the A-2000 
monitor. The Anemon-I index, heart rate, and 
the A-2000 monitor data were collected with 
custom-made software on a lap-top computer 
at five-second intervals. Skin-electrode imped-
ances below 5 kΩ were considered acceptable.
Study V. The EEG and fEMG were registered 
with the Aspect A-2000 EEG monitor® via a 
BIS Standard Sensor®, and with a research pro-
totype of the Datex-Ohmeda AS / 3 Anesthesia 
Monitor. Alcohol swab skin pretreatment and 
firm pressure after electrode placement were 
used. The electrode positions corresponded 
to Fpz, Fp2, and right temporal (next to the 
lateral canthus of the right eye). The EEG 
was band-pass filtered (0.5–47 Hz), amplified 
and digitized with a sampling rate of 400 Hz. 
fEMG was defined as the power above 60 Hz. 
The signal from ECG lead II was sampled at 
300 Hz. The pulse plethysmography signal was 
sampled at 100 Hz. Central® and Wincollect® 
software were used to collect the data on a lap-
top computer.
Anesthesia
A fentanyl bolus of 1–2 µg / kg i.v. (studies I, III 
and V), remifentanil bolus of 1 µg / kg i.v. (study 
II), or alfentanil bolus of 0.5 mg i.v. (study IV) 
was administered before the induction of anes-
thesia. Anesthesia was induced with a propofol 
bolus of 1.5–2.5 mg / kg i.v. in studies I–IV. In 
study V, hypnotic induction with a propofol 
bolus of 1 mg / kg i.v. was supplemented with 
inhalation of sevoflurane 8 %. A rocuronium 
bolus of 30–40 mg i.v. was used to facilitate 
endotracheal intubation in studies I–III. A 
glycopyrrolate bolus of 0.2 mg i.v. was given at 
anesthetic induction in studies I and III, unless 
the pulse rate exceeded 90 / min in the absence 
of hypovolemia. It was not given routinely 
in studies II and IV–V. In study I, anesthesia 
was maintained according to clinical needs. In 
studies II and V, desflurane or sevoflurane were 
administered according to a specific protocol 
during the study period, and according to clin-
ical needs thereafter. In study III, the inhaled 
concentration of isoflurane or sevoflurane was 
adjusted so that the BIS remained between 50 
and 60 throughout the procedure. In study IV, 
anesthesia was maintained with N2O (67 %) 
and supplemented with propofol or alfentanil 
boluses. N2O (50 %–67 %) was also used as an 
adjunct in studies I–III. If the level of hypnosis 
was adequate as defined by the BIS value, hy-
perdynamic responses were treated with either 
fentanyl boluses of 50 µg i.v. or labetalol bolus-
es of five mg i.v. If no hyperdynamic responses 
were present, a fentanyl bolus of 50 µg i.v. was 
administered every 30–60 minutes. Ketoprofen 
(maximum daily dose 300 mg), ibuprofen 
(maximum daily dose 2400 mg) or paraceta-
mol (maximum daily dose 3000 mg) were used 
perioperatively as analgesic adjuncts. 
Post-operative surveillance
The patients were observed in the PACU un-
til they were alert with stable vital signs, and 
pain and nausea were controlled. If discharge 
on the operating day was considered, pain was 
treated with fentanyl bolus doses of 25–50 µg 
i.v. up to a total dose of 250–300 µg, along 
with non-steroidal anti-inflammatory agents. 
If the patient stayed in the hospital for the 
night, oxycodone boluses of 2–4 mg i.v. or 0.1 
mg / kg i.m. were used as needed. Nausea and 
vomiting were treated with a droperidol bo-
lus of 0.5–0.75 mg i.v., an ondansetron bolus 
of 4 mg i.v., or a metoclopramide bolus of 10 
mg i.v. The patients were considered home-
ready when they had stable vital signs, were 
oriented and co-operative, were able to retain 
orally consumed fluids, to walk unsupported, 
to dress and void, and had no more than mild 
nausea or pain, controllable with oral analge-
sics. For discharge, an adult escort who accom-
panied the patient overnight was also required. 
All patients received instructions for care at 
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home and a telephone number to call in case 
of problems. In studies III–V, the patients were 
interviewed in the PACU regarding memories 
of the intraoperative period. The patients in 
study III were also interviewed at 24 hours af-
ter the anesthesia.
Electroencephalogram processing
Study I. The electrode impedances were mea-
sured with the impedance check algorithm 
of the Aspect A-1000 EEG monitor. Aspect 
Medical Systems software v. 3.12 was used for 
calculation of the BIS values, obtained at five-
second intervals. 
Study II. The raw EEG tracings from the five-
minute study period were classified accord-
ing to the presence or absence of epileptiform 
activity by an experienced neurophysiologist. 
The main criteria for epileptiform activity 
were the occurrence of spikes (pointed wave-
forms standing out from the background, with 
a duration of 20–70 ms), polyspikes (spikes 
with more than two negative and positive 
deflections), rhythmic polyspikes (polyspikes 
occurring at nearly regular intervals) or peri-
odic epileptiform discharges (repetitive sharp 
waves, spikes or sharply contoured waves oc-
curring at regular intervals and without clear 
evolution in frequency or location). The cri-
teria for epileptiform EEG corresponded to 
those employed by Yli-Hankala, Vakkuri and 
colleagues (Yli-Hankala et al 1999b, Vakkuri et 
al 2000). Spectral analysis of ten-second EEG 
epochs from immediately before the rapid in-
crease in the inhaled volatile concentration, 
at two minutes after the rapid increase in the 
inhaled volatile concentration and at the end 
of the five-minute study period was performed 
with MATLAB 7® software (MathWorks Inc., 
Natick, MA, USA).
Study III. Aspect Medical Systems software v. 
3.3 was used for calculation of the BIS values, 
obtained at five-second intervals.
Study IV. Aspect Medical Systems software v. 
3.4 was used for calculation of the processed 
EEG variables (BIS, SEF95) and fEMG, ob-
tained at five-second intervals.
Study V. The EEG was analyzed in five-second 
epochs, with 50 % overlapping. Epochs with ex-
cess amplitudes were excluded. The threshold 
for rejection was defined individually by visual 
inspection. The PSD was estimated for each 
epoch with the Welch averaged periodogram 
method (Kay 1988). SEF95 and fEMG were 
computed from the PSD. EEG RE and SE were 
calculated off-line according to a published al-
gorithm (Viertiö-Oja et al 2004). 
Electrocardiogram processing
In study IV, an Anemon-I index value, along 
with a smoothed trend value, was obtained ev-
ery five seconds. The algorithm applied by the 
proprietary monitor has not been published. 
It is based on heart rate variability. The heart 
rate recording was also updated every five sec-
onds. In study V, the R-waves of the ECG were 
automatically detected. They were verified by 
visual inspection and corrected if necessary. 
A beat-to-beat RRI signal was constructed as 
a series of time differences between successive 
heart beats. RRI SD and RMSSD were used as 
time domain measures of HRV. For frequency 
domain analysis, the RRI signal was linearly 
interpolated and resampled at two Hz. The 
resulting signal was detrended, and the PSD 
was estimated with the Welch averaged peri-
odogram method (Kay 1988). LF (0.04–0.15 
Hz) and HF (0.15–0.4 Hz) spectral powers, 
and their ratio (LF / HF) were computed from 
the PSD. Poincaré plots were constructed by 
plotting the RRI interval of the current beat as 
a function of the RRI interval of the previous 
beat. The SD against the axes y = x (SD1) and 
y = (–x)+2m (SD2), where m is the mean RRI 
during the epoch of interest, as well as their 
ratio (SD1 / SD2) were calculated (Tulppo et al 
1996).
Pulse plethysmography processing
The amplitude of the PPG waveform and the 
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location of the dicrotic notch were automati-
cally detected in study V. They were verified by 
visual inspection and corrected if necessary. 
The absolute (vertical) dicrotic notch ampli-
tude was defined as the distance from pulse 
baseline to the notch minimum. The absolute 
(horizontal) dicrotic notch position was de-
fined as the distance from the beginning of 
the pulse rise to the crossing of a vertical line 
drawn through the notch minimum with the 
pulse baseline. The relative (vertical) dicrotic 
notch amplitude was defined as the ratio of 
the absolute (vertical) notch amplitude and 
the total pulse amplitude. The dicrotic notch 
latency was defined as the ratio of the absolute 
(horizontal) notch position and the total pulse 
duration. Heart beats with PPG artifacts were 
excluded from the analysis. Beat-to-beat time 
series were constructed for the PPG amplitude, 
the area under the PPG waveform, the absolute 
and relative vertical and horizontal dicrotic 
notch positions and the PPG maximum de-
rivative, i.e. the maximum slope at the rising 
edge of the waveform. For PPG amplitude, 
Poincaré analysis was carried out similarly to 
the RRI data.
Statistical analysis
General. Statistical analysis was performed 
using SPSS for Windows (SPSS Inc., Chicago, 
IL, USA), versions 9.0, 10.0, 11.0.1 and 12.0.1, 
except in study I, where NCSS 97 (NCSS, 
Kaysville, Utah, USA) and the statistical 
functions of Excel 97® software were used. 
MATLAB® (MathWorks, Natick, MA, USA) 
was used in data processing in studies II, IV 
and V.
Study I. BIS data from the maintenance phase 
of anesthesia was used in the statistical analy-
ses. In the first part of the study, the overall 
variation in impedance values between the 
three different electrode-skin preparation 
combinations was evaluated with Friedman’s 
two-way analysis of variance by ranks. Pairwise 
comparisons of impedance values between the 
different electrode-skin preparation combina-
tions and between the beginning and the end 
of surgery were made with Wilcoxon’s signed 
ranks test. In the second and third parts of the 
study, the difference between the simultane-
ous BIS values measured with the two sets of 
four electrodes was calculated at 30-second in-
tervals. Further, a grand average of individual 
mean BIS value differences was calculated. The 
hypothesis that the grand average BIS differ-
ence obtained in the second part of the study 
equals zero was tested by the one-sample t-test. 
The 95 % confidence interval for the grand av-
erage BIS value difference was calculated in the 
second and third parts of the study. The grand 
average BIS differences obtained in the second 
and third parts of the study were compared 
with the independent samples t-test, and the 
95 % confidence interval for their difference 
was calculated. In the second part of the study, 
the variation of BIS value differences over time 
was evaluated by applying Friedman’s two-way 
analysis of variance by ranks to 50 consecu-
tive BIS differences from each patient. Overall 
interindividual variation in BIS differences 
was assessed by Kruskal-Wallis nonparamet-
ric analysis of variance. In addition, the inci-
dences of BIS value differences exceeding 10 % 
in at least 50 % of the measurement points (at 
30-second intervals) in the second and third 
parts of the study were compared with Fisher’s 
exact test.
Study II. The incidence of epileptiform EEG 
activity in the two groups was compared us-
ing the χ2-test and Fisher’s exact test. The heart 
rate during the five-minute study period was 
analyzed in a six by two ANOVA for repeated 
measures, with time as a within-subjects factor 
and group assignment as the between-subjects 
factor. The paired samples and independent 
samples t-test, as appropriate, and the esti-
mated marginal means provided in the SPSS 
syntax were used for pairwise comparisons.
Study III. The means of the normally distrib-
uted variables, as defined by the Kolmogorov-
Smirnov test, were compared between the 
groups using the independent samples t-test. 
The medians of non-normally distributed vari-
ables were compared between the groups using 
the Mann-Whitney U-test. The overall change 
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with time in the VAS scores for pain and nau-
sea was analyzed by the Friedman’s two-way 
analysis of variance by ranks, and pairwise 
comparisons were made using the Wilcoxon’s 
signed ranks test within groups, and the 
Mann-Whitney U-test between groups. The 
DSST scores were analyzed in a four by two 
ANOVA for repeated measures, with time as 
a within-subjects factor and group assignment 
as a between-subjects factor.
Study IV. Anemon-I values, heart rate, BIS, 
SEF95, and EMG power were averaged over the 
periods 60 s before and 60 s after CD, RP and 
movement events using MATLAB® software. 
The means of the normally distributed vari-
ables, as defined by the Kolmogorov-Smirnov 
test, were compared using the independent 
samples or paired samples t-test. The medians 
of the non-normally distributed variables were 
compared using the Mann-Whitney U-test or 
the Wilcoxon’s signed ranks test.
Prediction probability (PK) values associat-
ed with the response (movement or no move-
ment) to noxious stimulation were calculated 
with the spread-sheet program PKMACRO®. 
The prediction probability PK is a nonpara-
metric measure of association, introduced by 
Smith and colleagues in 1996 for assessing 
the performance of anesthetic level indicators 
(Smith et al 1996b). It is a rescaled variant of 
Kim’s d y · x. The PK can be described as the prob-
ability that given two randomly selected data 
points with distinct anesthetic levels, the as-
sociated indicator values correctly predict the 
rank order of the anesthetic levels. A PK value 
of 1 reflects perfect prediction, and a PK value 
of 0.5 means that the indicator performs no 
better than chance alone. PK values between 0 
and 0.5 mean that discordances (indicator and 
anesthetic level change in opposite directions) 
are more likely than concordances (indicator 
and anesthetic level change in the same direc-
tion). The PK is independent of distribution 
assumptions, units of measurement, and the 
choice of a particular threshold value, and its 
value is asymptotically independent of sample 
size. A valid comparison of different indicators 
with PK necessitates collection of data under 
similar experimental conditions and over the 
same distribution of anesthetic levels (Smith et 
al 1996b). The PK is equal to the nonparametric 
area under the ROC curve for a dichotomous 
outcome (Smith et al 1996a).
Logistic regression models with the response 
(movement or no movement) to noxious stim-
ulation as the dependent variable were formed 
for combinations of variables which had a sta-
tistically significant PK value, unless the vari-
ables had a significant linear correlation. The 
models were evaluated by the model χ2-value, 
the overall correct classification rate and the 
area under the ROC curve associated with the 
model. The ROC curve is sensitivity plotted 
against 1-specificity. The area under the ROC 
curve represents the probability of correctly 
classifying a randomly selected positive-neg-
ative pair (in this case, a mover – non-mover 
pair). The curve itself shows all possible com-
binations of sensitivity and specificity associ-
ated with different cut-off values. The models 
were compared by the χ2-value asssociated 
with the difference in –2 log likelihood (–2LL) 
values between the models. Logistic regression 
was also used to analyze the effect of group as-
signment and the remaining procedure time 
on the recurrence of movement. Proportions 
were analysed with the Fisher’s exact test.
Study V. The RRI, EEG and PPG variables were 
averaged over the periods 120 s before and 120 s 
after skin incision with the MATLAB® software. 
Pre- and post-incision values were compared 
using Wilcoxon’s signed ranks test. The post-
incision values were normalized with respect to 
the corresponding pre-incision values by either 
dividing the post-incision value by the pre-in-
cision value or by subtracting the pre-incision 
value from the post-incision value (for those 
variables with values close to zero). The nor-
malized values of movers and non-movers were 
compared using the Mann-Whitney U-test. 
Those normalized variables, which yielded sta-
tistically significant differences between movers 
and non-movers, were used in different com-
binations to construct logistic regression equa-
tions to classify the patients into movers and 
non-movers. The models were compared by the 
overall correct classification performance, as 
defined by leave-one-out cross validation.
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Sample size and power analysis. As there 
was no previous knowledge of the end-points 
in studies I–II and V, the sample sizes were 
not based on power analysis. In study III, 
power analysis was based on data from a pre-
vious study at the same institution on similar 
patients. In that study, the range of home-
readiness times was 500 and 600 minutes 
for isoflurane- and sevoflurane-anesthesized 
patients. A sample size of 120 (60 per group) 
would give a 90 % power (with a 5 % α error 
rate) to detect a standardized difference (differ-
ence in group means divided by the standard 
deviation of the variable in question) of 0.6 
(Altman 1999). Assuming similar variability in 
home-readiness times as in the previous study, 
and that the standard deviation is roughly one 
quarter of the range, this would correspond to 
a 75–90 minute difference in the group means. 
Based on previous experience, the general inci-
dence of recurring movement in study IV was 
estimated to be 50 %. The sample size needed 
to detect a difference of 25 % in the incidence 
of recurring movement with an 80 % power 
(and a 5 % α error rate) was 110 (55 per group) 
(Pocock 1983).
84
Results
EEG electrodes (p < 0.001, Wilcoxon’s test). 
Impedance values decreased during anesthesia 
with all electrode-skin preparation combina-
tions (p ≤ 0.002, Wilcoxon’s test).
The BIS values registered with a set of ECG 
electrodes were higher than the BIS values si-
multaneously registered with a set of EEG elec-
trodes (grand average BIS value difference 5.2, 
95 % CI [3.5; 7.0], p < 0.001 vs. 0, one-sample 
t-test). The difference was stable during the 
maintenance phase of anesthesia (p = 0.22, 
Friedman’s test). The BIS values simultaneously 
registered with two sets of EEG electrodes were 
similar (grand average BIS value difference 1.7, 
95 % CI [–0.1; 3.4]; p = 0.061 vs. 0, one-sample 
t-test). The interindividual variation in BIS 
Electrocardiography electrodes  
versus designated electroencepha-
lography electrodes in bispectral 
index monitoring (Aim 1)
The skin-electrode impedance values before an-
esthetic induction and after surgery with differ-
ent electrode types and positions are shown in 
table 3. The ECG electrodes with both abrasion 
paste and alcohol swab skin pretreatment were 
superior to EEG electrodes with only alcohol 
swab skin pretreatment, in terms of the skin-
electrode impedance (p ≤ 0.001, Wilcoxon’s 
test). If only alcohol swab skin pretreatment 
was used, ECG electrodes were inferior to 
Table 3. Impedance values at the beginning and at the end of anesthesia in the three parts of study I 
with different electrode types and positions. Data are given in ohm. Both the median (interquartile range, 
IQR) and minimum and maximum values are presented. EEG = Zipprep® electrode with alcohol swab skin 
pretreatment. ECG = Nikomed® electrode with alcohol swab skin pretreatment. ECGpaste = Nikomed® elec-
trode with abrasion paste and alcohol swab skin pretreatment. Ref = reference electrode above nasion (Nz). 
A1 = active electrode at left temple. A2 = active electrode at right temple. For part III, pooled impedance 
data for the two sets of Zipprep® electrodes are presented.
Part Electrode Position
Beginning End
Median (IQR) [Minimum, 
Maximum]
Median (IQR) [Minimum, 
Maximum]
I EEG Ref (Nz) 700 (500) [200, 5500] 500 (300) [200, 4900]
ECG A1 2600 (2500) [500, 16 300] 1600 (1700) [400, 6300]
ECGpaste A2 400 (300) [200, 1200] 400 (300) [100, 1100]
II EEG Ref (Nz) 1000 (700) [400, 2200] 800 (500) [400, 2200]
EEG A1 1600 (900) [500, 2400] 1300 (1200) [400, 2300]
EEG A2 1300 (600) [400, 3400] 1100 (700) [400, 4400]
ECG Ref (Nz) 3300 (4400) [900, 17 800] 2000 (2800) [400, 9800]
ECG A1 9500 (13 300) [1400, 50 000] 4800 (4800) [1200, 15 500]
ECG A2 9600 (11 100) [900, 41 900] 5500 (8900) [1100, 23 800]
III EEG Ref (Nz) 800 (800) [200, 2000] 800 (600) [600, 1700]
EEG A1 900 (400) [500, 1600] 1000 (600) [500, 1500]
EEG A2 1000 (500) [500, 2000] 900 (600) [500, 2200]
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value differences was considerable in both the 
second and third parts of study I (p < 0.001, 
Kruskal-Wallis test) (figures 4–5). The differ-
ence between the grand average BIS value dif-
ferences from the second and third parts of the 
study was statistically significant (5.2 vs. 1.7, 
p = 0.033, independent samples t-test; differ-
ence in grand average BIS value differences 3.6, 
95 % CI [0.3; 6.9]).
Electroencephalogram features and 
tachycardia during a rapid increase 
in the administered desflurane 
concentration (Aim 2)
Epileptiform EEG activity was detected in eight 
of the 15 sevoflurane patients during the rapid 
increase in the inspired volatile concentration, 
and in none of the 16 desflurane patients (inci-
dences 0.53 vs. 0, p < 0.001, Fisher’s exact test; 
difference in incidences 0.53, 95 % CI [0.23; 
0.75]). The epileptiform phenomena were 
rhythmic polyspikes, rhythmic spiky bursts, or 
periodic epileptiform discharges. The epilepti-
form activity disappeared when the end-tidal 
sevoflurane concentration decreased after the 
study period. Nearly all subjects developed 
EEG burst suppression patterns or at least a few 
short suppression segments toward the end of 
the five-minute study period in study II.
RE / SE values calculated off-line for three 
time periods are given in table 4. The time pe-
riods are immediately before the rapid increase 
in inhaled volatile concentration (1), at two 
minutes after the increase (2), and at the end 
of the study period, i.e. at five minutes after the 
increase (3).
RE / SE values calculated off-line for the 
three time periods, separately for subjects with 
normal and epileptiform EEG in the sevoflu-
rane group, are given in table 5.
Five patients in the sevoflurane group re-
ceived a bolus of efedrin (5–10 mg i.v.), for the 
treatment of hypotension at three to four min-
Figure 4. Differences between BIS values simultane-
ously registered (at 30 s intervals) with a set of ECG 
electrodes and a set of EEG electrodes in individual 
patients during maintenance phase anesthesia in 
the second part of study I. The two sets of electrodes 
were placed adjacent to each other in a cranial 
(ECG electrodes)-caudal (EEG electrodes) orienta-
tion. Boxes represent the median (bold horizontal 
line) and quartiles. Whiskers denote the minimum 
and maximum values (outliers > 1.5 times the IQR 
excluded). The few outliers have been omitted for the 
sake of clarity.
Figure 5. Differences between BIS values simultane-
ously registered (at 30 s intervals) with two sets of 
EEG electrodes in individual patients during mainte-
nance phase anesthesia in the third part of study I. 
The two sets of electrodes were placed adjacent to 
each other in a cranial-caudal orientation. Boxes rep-
resent the median (bold horizontal line) and quartiles. 
Whiskers denote the minimum and maximum values 
(outliers > 1.5 times the IQR excluded). The few outli-
ers have been omitted for the sake of clarity. 
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utes after the start of the study period. The he-
modynamic data of these patients was excluded 
from analysis. In addition, two other patients 
in the sevoflurane group and one patient in the 
desflurane group received a bolus of efedrin 
(5–10 mg i.v.), for the treatment of hypotension 
after the study period (at five minutes). The 
heart rate increased at the initial rapid increase 
in the inhaled anesthetic concentration. In the 
desflurane group, the increase was pronounced 
[F(5,18) = 16.39, p < 0.001] and transient. In 
the sevoflurane group, the increase was slower 
and more subtle [F(5,18) = 3.05, p = 0.037]. The 
repeated measures ANOVA yielded a signifi-
cant interaction effect for the within-subjects 
factor (time) and the between-subjects factor 
(group) [F(5,18) = 3.29, p = 0.028]. In pairwise 
comparisons, heart rate was significantly lower 
in the desflurane group than in the sevoflu-
rane group at zero and at five minutes from 
the increase in inhaled anesthetic concentra-
tion (p < 0.05), although the group main ef-
fect was not significant due to the interaction 
(figure 6). In the desflurane group, heart rate 
increased significantly from zero to two min-
utes (p < 0.01) during the study period, and 
then decreased significantly from three to five 
minutes (p < 0.01). In the sevoflurane group, 
the heart rate at two minutes from the start of 
the study period was higher than at the start of 
Table 4. Values comparable to RE and SE, calculated off-line for time periods immediately before the 
increase in the inhaled anesthetic concentration (1), at two minutes after the increase (2) and at the end 
of the five-minute study period (3) in study II. Data at period 3 are given separately for patients with high 
(> 15 %) and low (< 15 %) burst suppression ratios (BSR). Data are the medians (IQR) of values averaged 
over 10 s. ** p < 0.01 vs. desflurane, Mann-Whitney U-test.
Desflurane
Period 1 (N = 13) Period 2 (N = 13) Period 3 low BSR (N = 6) Period 3 high BSR (N = 7)
RE 61 (19) 12 (11) 17 (7) 6 (7)
SE 59 (17) 12 (11) 16 (7) 5 (7)
Sevoflurane
Period 1 (N = 14) Period 2 (N = 14) Period 3 low BSR (N = 9) Period 3 high BSR (N = 5)
RE 57 (26) 26 (14) ** 20 (7) 1 (19)
SE 56 (24) 26 (15) ** 19 (7) 1 (18)
Table 5. Values comparable to RE and SE, calculated off-line for time periods immediately before the 
increase in the inhaled anesthetic concentration (1), at two minutes after the increase (2) and at the end 
of the five-minute study period (3) in study II. Data are the medians (IQR) of values averaged over 10 s. 
* p < 0.05 vs. normal EEG, Mann-Whitney U-test. 
Normal EEG (sevoflurane group, N = 6)
Period 1 Period 2 Period 3
RE 58 (27) 27 (17) 10 (19)
SE 57 (28) 26 (17) 10 (18)
Epileptiform EEG (sevoflurane group, N = 8)
Period 1 Period 2 Period 3
RE 57 (25) 26 (16) 22 (7) *
SE 56 (21) 26 (15) 20 (7) *
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the study period (p = 0.047) (figure 6).
There was no statistically significant dif-
ference in heart rate between patients with 
epileptiform EEG and those with normal EEG 
during the study period (figure 7).
Comparison of recovery of 
gynecological ambulatory surgery 
patients after isoflurane or 
sevoflurane maintenance with 
bispectral index monitoring (Aim 3)
No significant differences in the demograph-
ics, types of procedures, duration of anesthesia, 
doses of intraoperative medications, or the fre-
quencies or doses of post-operative analgesic 
and antiemetic medications between the iso-
flurane and sevoflurane groups occurred. The 
post-operative DSST scores and VAS scores for 
pain and nausea were similar in both groups.
The grand median BIS values during the 
maintenance phase were 52.1 (IQR 6.7) and 
51.3 (IQR 6.3) in the isoflurane and sevoflu-
rane groups (difference –0.2; 95 % CI [–2.0; 
1.7], p = 0.84, Mann-Whitney U-test). The 
median BIS values at the end of the procedure 
were 57.0 (IQR 11.5) and 56.1 (IQR 9.2) in 
the isoflurane and sevoflurane groups (differ-
ence –0.1, 95 % CI [–2.9; 2.6], p = 0.95, Mann-
Whitney U-test). The percentages of mainte-
nance time when BIS was outside the targeted 
range were similar between the groups.
The median end-tidal anaesthesic con-
centrations during maintenance were 0.40 % 
(95 % CI [0.40 %; 0.50 %]) and 0.80 % (95 % CI 
[0.70 %; 0.90 %]) in the isoflurane and sevo-
flurane groups. Assuming that in 35 year old 
patients the MAC values of isoflurane and 
sevoflurane in 67 % N2O are 0.45 % and 0.75 % 
(Nickalls and Mapleson 2003, Lerou 2004), the 
median MAC values during maintenance were 
0.89 MAC and 1.07 MAC in the isoflurane and 
sevoflurane groups (difference –0.13, 95 % CI 
[–0.22; 0.0], p = 0.035, Mann-Whitney U-test).
None of the patients had recall of the intra-
operative events, based on interviews both on 
the operating day and the first post-operative 
day.
Figure 6. Mean heart rate in beats per minute (bpm) 
during the rapid increase in inhaled desflurane (solid 
line; N = 14) or sevoflurane (dashed line; N = 10) 
concentration in study II. Start of the increase marked 
with 0. * p < 0.05 desflurane vs. sevoflurane, signifi-
cance test based on estimated marginal means.
Figure 7. Mean heart rate in beats per minute (bpm) 
during the rapid increase in inhaled sevoflurane 
concentration in study II. Start of the increase marked 
with 0. No statistically significant differences in heart 
rate between patients displaying epileptiform EEG 
phenomena (dashed line; N = 6) and those with a nor-
mal EEG (solid line; N = 4) at any of the time points.
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No statistically or clinically significant dif-
ference in the time to home-readiness between 
the isoflurane and sevoflurane groups emerged, 
when BIS was titrated between 50 and 60 during 
the maintenance of anesthesia. All other early 
and intermediate recovery parameters were 
also similar (table 6). The recovery times were 
also similar between the two groups among 
both the outpatients and the admitted patients. 
The incidence of slow recovery was similar in 
the two groups (home-readiness achieved in 
more than 8 hours in 22 % and 33 % of patients 
in the isoflurane and sevoflurane groups; dif-
ference –12 %, 95 % CI [–27 %; 4 %], p = 0.22, 
Fisher’s exact test). 
In study III, home-readiness was defined as 
being achieved one hour after the last dose of 
parenteral medication, when the other criteria 
were fulfilled. Applying alternative home-read-
iness criteria did not change the result of no 
difference between the two groups. If home-
readiness was defined as being able to walk, 
drink and void, it was achieved in 300 (IQR 
252) min and 294 (IQR 167) min in the iso-
flurane and sevoflurane groups (difference –22 
min, 95 % CI [–84; 31]). If the time of the last 
dose of parenteral medication was taken into 
account, home-readiness was achieved in 307 
(IQR 232) min and 327 (IQR 245) min in the 
isoflurane and sevoflurane groups (difference 
–33 min, 95 % CI [–104; 28]).
The incidence of dreaming during anes-
thesia was high in both groups, based on in-
terviews in the PACU shortly after emergence 
(table 7). The grand median BIS values during 
maintenance in non-dreaming and dreaming 
patients were 52.1 (IQR 5.1) and 51.9 (IQR 9.8) 
(difference 0.8; 95 % CI [–1.6; 3.1], p = 0.53, 
Mann-Whitney U-test). The corresponding 
grand median MAC values were 1.07 (IQR 
0.53) and 1.00 (IQR 0.30), (difference 0.00; 
95 % CI [–0.07; 0.18], p = 0.57, Mann-Whitney 
U-test). No significant differences in the grand 
median BIS (p = 0.89, Kruskal-Wallis test) or 
MAC values (p = 0.33, Kruskal-Wallis test) 
between different categories of dreaming oc-
Table 6. Early and intermediate recovery parameters in all patients in study III. Data are the medians (IQR). 
* p = 0.049 isoflurane vs. sevoflurane, Mann-Whitney U-test.
Isoflurane (N = 60) Sevoflurane (N = 60) Difference [95 % CI]
Opening of eyes (min) 5.0 (2.8) 5.3 (4.0) –0.5 [–1.4; 0.3]
Obeying commands (min) 5.8 (2.7) 6.0 (3.3) –0.6 [–1.5; 0.2]
Orientation to current date (min) 6.9 (3.2) 8.0 (3.6) –0.9 [–1.8; 0.0] *
Fluid per os (min) 32 (30) 32 (23) 0 [–4; 4]
Sitting unsupported (min) 83 (50) 80 (57) 0 [–13; 9]
Walking unsupported (min) 113 (230) 123 (253) –6 [–35; 19]
Voiding (min) 300 (239) 294 (161) –22 [–83; 31]
Home-readiness (min) 331 (254) 347 (249) –38 [–106; 29]
Table 7. The incidence of dreaming during anesthesia in study III, based on interviews in the PACU.  
No significant difference between the groups.
Isoflurane (N = 52) Sevoflurane (N = 50) Difference [95 % CI]
No dreaming 56 % 56 % 0 % [–19 %; 18 %]
Pleasant dreams 23 % 20 % 3 % [–13 %; 19 %]
Neutral dreams 19 % 22 % –3 % [–19 %; 13 %]
Unpleasant dreams 2 % 2 % 0 % [–9 %; 8 %]
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curred. One patient from each group had un-
pleasant dreams during anesthesia. The grand 
median BIS, end-tidal anesthetic, and MAC 
values in these patients were 58.6, 0.50 %, and 
1.11 MAC (isoflurane) and 43.9, 0.90 %, and 
1.20 MAC (sevoflurane).
Effectiveness of a propofol bolus 
versus an alfentanil bolus in 
preventing the recurrence of 
movement during uterine dilatation 
and curettage (Aim 4)
The demographic variables and the pre-op-
erative pain VAS values, nausea VAS values, 
and DSST scores for both groups were simi-
lar, with the exception of mean weight, which 
was larger in the propofol group than in the 
alfentanil group (67.7 kg vs. 61.5 kg, p < 0.01, 
independent samples t-test). The times from 
anesthetic induction to the start of the proce-
dure and from the administration of the group 
drug to the end of the procedure, as well as the 
duration of the procedure were comparable 
in the two groups. The median total propofol 
doses were 170 (70) and 200 (60) mg in the 
alfentanil and propofol groups (difference –25, 
95 % CI [–40; –5], p = 0.013, Mann-Whitney 
U-test). The median total alfentanil doses were 
1000 (500) and 500 (250) µg in the alfentanil 
and propofol groups (difference 500, 95 % CI 
[0; 500], p < 0.001, Mann-Whitney U-test). 
The distribution of the number of movement 
responses during the procedure is presented in 
table 8.
In the alfentanil group, the median VAS 
value for pain at 20 min after anaesthesia was 
higher than the baseline value or the values 
at 40–60 min after anaesthesia (2.9 vs. 0.0, 
p < 0.01, Wilcoxon’s signed ranks test). In the 
propofol group, the VAS values for pain were 
higher at baseline and at 20 min after anaes-
thesia compared to the values at 40–60 min 
(0.3 and 1.0 vs. 0.0, p < 0.01, Wilcoxon’s signed 
ranks test). No statistically significant differ-
ence between the two groups in the VAS values 
for pain existed at any of the time points. The 
median VAS value for nausea was zero in both 
groups at all time points.
Repeated measures ANOVA for DSST 
scores yielded a significant time main effect 
[F(3,72) = 143.9, p < 0.001] but no treatment 
group or interaction effect. That is, no signifi-
cant differences in the DSST scores between 
the two groups occurred at any of the evalu-
ated time points. The DSST values reached the 
pre-operative level by 40 min after the anaes-
thesia, and increased even further by 60 min 
after anaesthesia (figure 8). 
After the first movement response during 
uterine dilatation and curettage, a propofol 
bolus of 0.7 mg / kg i.v. was more effective than 
an alfentanil bolus of 0.5 mg i.v. in prevent-
ing further movement responses during the 
procedure. The incidences of recurring move-
ment were 73 % and 38 % in the alfentanil and 
propofol groups (difference 35 %, 95 % CI [9 %; 
56 %], p = 0.014, Fisher’s exact test).
According to logistic regression analysis, 
both the group assignment and the time from 
the administration of the group drug to the end 
of the procedure were significantly associated 
with the probability of recurring movement 
(model χ2 7.16, p = 0.007 and 12.90, p < 0.001, 
Table 8. Distribution of movement responses during the procedure in the two groups in study IV. Data are 
the number of patients (N) and the percentage of all patients within the group. p = 0.016 alfentanil vs. 
propofol group, Fisher’s exact test.
Number of movement responses Alfentanil group (N = 45) Propofol group (N = 37) Difference [95 % CI]
0 12 (27 %) 13 (35 %) –8 % [–28 %; 11 %]
1 9 (20 %) 15 (41 %) –21 % [–39 %; –1 %]
2 18 (40 %) 4 (11 %) 29 % [10 %; 45 %]
3 6 (13 %) 5 (14 %) 0 % [–16 %; 15 %]
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for group assignment and the remaining pro-
cedure time). Inclusion of both variables in 
the model (model χ2 19.23, p < 0.001) resulted 
in a significantly better fit than either variable 
alone, as judged by the –2 log likelihood cri-
terion (p < 0.001 vs. group assignment alone, 
p < 0.02 vs. remaining time alone). According 
to this model, the times associated with a 50 % 
(95 %) probability of recurring movement 
were 2.4 (7.4) min and 5.1 (10.1) min after the 
first movement in the alfentanil and propofol 
groups (figure 9). The confidence intervals 
around the probability curves of this model 
were wide, suggesting that a large amount of 
variance remained unexplained.
For the alfentanil group, the curve depicts 
the equation:
For the propofol group, the curve depicts 
the equation:
where p equals the probability of no recurring 
movement.
The association of physiological 
variables with movement responses 
during anesthesia (Aim 5)
The pre- and post-stimulus values of the inves-
tigated physiological variables in non-movers 
and movers, respectively, in studies IV and V, 
are given in tables 9–11.
In study V, the heart rate increased (RRI 
decreased) in both non-movers and movers at 
skin incision. In study IV, the changes in heart 
rate at CD and at RP were subtle. At RP, heart 
Figure 8. The mean DSST scores at baseline and at 20 
min, 40 min, and 60 min after the end of anesthesia 
in study IV, in the alfentanil group (dashed line) and 
propofol group (solid line). ## p < 0.001 vs. baseline, 
# p < 0.01 vs. baseline in the respective groups. NS 
indicates not significantly different from baseline. No 
significant differences between the groups at any of 
the time points. The significance tests are based on 
the estimated marginal means provided in the SPSS 
syntax.
Figure 9. Logistic regression curves describing the 
relationship between the remaining procedure time 
(0–15 min) after the administration of the group drug 
at the first movement (time 0), group assignment, 
and the probability of no recurring movement in 
study IV. Dashed line = alfentanil group, solid line = 
propofol group. The wide 95 % confidence intervals 
have been omitted for clarity.
p = 
1 + e 0,589 (time since first movement in min) – 1.418
1
p = 
1 + e 0,589 (time since first movement in min) – 2.993
1
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Table 9. The averaged values of the variables at the beginning of cervical dilation (CD) for non-movers 
and movers in study IV. Pre refers to values averaged over 60 s before CD. Post refers to values averaged 
over 60 s after CD. Data are the medians (IQR). For non-movers, N = 44 for HRV variables, N = 43 for EEG 
variables. For movers, N = 38. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. Pre. # p < 0.05, ## p < 0.01, ### p < 0.001 
vs. non-movers. For the abbreviations, see page 11.
Non-movers Movers
Pre Post Pre Post
Anemon Index 57.4 (43.3) 74.5 (39.3) * 61.4 (29.1) 69.0 (21.2)
Heart rate (beats / min) 66.9 (17.0) 67.2 (17.0) 68.4 (14.2) 67.9 (13.7)
fEMG power (μV2) 0.078 (0.037) 0.072 (0.032) ** 0.101 (0.054) # 0.111 (0.270) ** ### 
BIS 32.8 (10.1) 35.0 (12.1) *** 38.4 (15.7) ## 47.0 (20.7) *** ###
SEF95 (Hz) 13.3 (5.2) 14.3 (2.9) *** 14.7 (4.8) 16.6 (3.5) *** #
Table 10. The averaged values of the variables at the resumption of the procedure after the administra-
tion of the study drug (RP) for non-movers and movers in study IV. Pre refers to values averaged over 60 
s before RP. Post refers to values averaged over 60 s after RP. Data are the medians (IQR). For non-movers, 
N = 37. For movers, N = 18 for HRV variables, N = 17 for EEG variables. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. 
Pre. # p < 0.05, ## p < 0.01, ### p < 0.001 vs. non-movers. For the abbreviations, see page 11.
Non-movers Movers
Pre Post Pre Post
Anemon Index 67.3 (29.7) 70.2 (19.8) 60.4 (38.4) 80.3 (18.7) #
Heart rate (beats / min) 61.8 (14.8) 61.6 (14.9) 58.9 (10.6) 61.6 (11.8) *
fEMG power (μV2) 0.126 (0.355) 0.089 (0.095) *** 0.110 (0.267) 0.135 (0.593) #
BIS 54.5 (13.8) 47.9 (24.1) ** 61.8 (13.2) 67.1 (25.9) ##
SEF95 (Hz) 19.3 (4.1) 16.6 (3.9) *** 20.9 (4.9) 20.3 (7.4) #
rate increased in movers. In study V, RRI SD, 
RRI SD2, and RRI LF / HF increased in both 
non-movers and movers at skin incision. RRI 
HF power decreased overall and in movers, but 
not in non-movers. RRI SD1 / SD2 decreased 
in both non-movers and movers at skin inci-
sion. In study IV, the Anemon Index increased 
overall at CD. Interestingly, a statistically sig-
nificant increase was seen in non-movers, but 
not in movers. At RP, the Anemon Index did 
not change significantly in either non-movers 
or movers. These results may be partly due to 
the very large variability in Anemon-I values 
(tables 9–10). The observed HR and HRV 
changes are consistent with an increase in sym-
pathetic activity and a decrease in parasympa-
thetic activity.
In study V, the PPG amplitude, PPG area, 
and PPG maximum derivative decreased in 
both non-movers and movers as a sign of sym-
pathetic stimulation. The PPG amplitude SD2 
increased, and the PPG amplitude SD1 / SD2 
decreased in both non-movers and movers. The 
PPG notch amplitude decreased overall and in 
movers, but not in non-movers. The relative 
notch amplitude did not change overall, but 
a slight increase was seen in non-movers. The 
notch latency increased overall and in movers, 
but not in non-movers. The slightly different 
heart rate and vasoconstriction responses in 
non-movers and movers may explain the dif-
ferent changes in the configuration of the PPG 
waveform.
In study V, fEMG power and RE did not 
change overall at skin incision, but they in-
creased in movers. RE-SE increased overall 
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and in movers, but not in non-movers. In study 
IV, fEMG power did not change overall at CD, 
but increased in movers and decreased in non-
movers. At RP, fEMG power decreased in non-
movers, and remained stable in movers. These 
changes are consistent with a greater frontal 
motor activity in movers. Similarly, the abso-
lute and relative β2 power increased overall 
and in movers, but not in non-movers at skin 
incision in study V.
In study V, SE and SEF95 did not change 
significantly at skin incision either in movers 
or in non-movers. In study IV, BIS and SEF95 
increased at CD in both non-movers and mov-
ers. At RP, BIS and SEF95 decreased in non-
movers, and remained stable in movers. Thus 
the EEG arousal response was greater in mov-
ers both at CD and at RP in study IV.
In study IV, the pre-stimulus fEMG power 
and BIS values were higher in movers than in 
Table 11. The averaged values of the variables at skin incision for non-movers and movers in study V. 
Pre refers to values averaged over 120 s before skin incision. Post refers to values averaged over 120 s 
after skin incision. Data are the medians (IQR). For non-movers, N = 14 for HRV variables, N = 12 for EEG 
variables, N = 14 for PPG variables. For movers, N = 12 for HRV variables, N = 10 for EEG variables, N = 12 for 
PPG variables. The β2 band is defined as 20–47 Hz. AU = arbitrary units. * p < 0.05, ** p < 0.01, *** p < 0.001 
vs. Pre. # p < 0.05, ## p < 0.01, ### p < 0.001 vs. non-movers. For the abbreviations, see page 11.
Non-movers Movers
Pre Post Pre Post
RRI (ms) 888 (160) 761 (116) ** 911 (263) 658 (191) **
RRI SD (ms) 18.3 (9.3) 53.0 (18.9) ** 17.4 (9.5) 94.8 (75.7) ** #
RRI RMSSD (ms) 10.3 (7.1) 9.6 (6.9) 9.1 (8.2) 9.0 (7.3) 
RRI LF power (ms2) 20.2 (75.0) 10.9 (52.5) 13.8 (17.9) 5.0 (34.3)
RRI HF power (ms2) 13.3 (11.7) 2.8 (8.1) 9.3 (22.1) 1.8 (5.4) **
RRI LF / HF ratio 1.22 (5.21) 5.25 (7.77) * 1.38 (2.36) 5.58 (7.74) *
RRI SD1 (ms) 7.27 (5.02) 6.78 (4.95) 6.49 (5.85) 6.26 (5.00)
RRI SD2 (ms) 23.9 (13.5) 73.7 (26.4) ** 21.6 (12.4) 131.7 (106.9) ** #
RRI SD1 / SD2 0.287 (0.250) 0.092 (0.050) ** 0.248 (0.290) 0.046 (0.020) ** ###
RE 45 (16) 46 (11) 41 (9) 47 (20) * 
SE 43 (18) 43 (10) 39 (10) 40 (19) 
RE-SE 2.6 (5.7) 3.8 (4.1) 1.9 (1.4) 7.9 (5.3) **
SEF95 (Hz) 14.1 (4.4) 13.6 (2.4) 13.0 (2.6) 13.8 (4.4)
β2 power (μV2) 25.6 (20.6) 28.5 (25.2) 24.1 (19.6) 35.0 (24.4) **
Relative β2 power (μV2) 1.59 (2.15) 1.47 (0.89) 1.08 (0.89) 1.48 (0.80) **
fEMG power (μV2) 2.4 (14.9) 4.0 (14.0) 2.0 (2.8) 23.5 (135) * #
PPG amplitude (AU) 7.91 (4.38) 6.29 (3.19) ** 9.24 (3.25) 6.60 (2.56) **
PPG area (AU) 271 (109) 186 (85.9) ** 311 (166) 183 (87.3) **
dPPG (AU) 1.49 (0.84) 1.22 (0.60) ** 1.78 (0.55) 1.31 (0.44) **
Notch amplitude (AU) 2.37 (1.02) 2.06 (1.09) 2.82 (2.02) 1.51 (0.92) **
Notch relative amplitude ( %) 27.7 (17.1) 31.2 (24.2) * 31.7 (14.2) 28.5 (10.4)
Notch latency ( %) 30.9 (5.0) 33.1 (7.0) 32.1 (8.9) 37.2 (6.1) **
PPG amplitude SD1 (AU) 0.198 (0.068) 0.213 (0.115) 0.242 (0.179) 0.247 (0.169)
PPG amplitude SD2 (AU) 0.419 (0.197) 1.45 (0.845) ** 0.477 (0.217) 1.54 (0.966) **
PPG amplitude SD1 / SD2 0.451 (0.181) 0.137 (0.058) ** 0.486 (0.154) 0.141 (0.057) **
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non-movers at CD, but not at RP. The post-
stimulus fEMG power, BIS and SEF95 were 
higher in movers than in non-movers at CD 
and RP. The post-stimulus Anemon-I index 
was higher in movers than in non-movers at 
RP. In study V, the pre-stimulus values of the 
investigated variables were similar in movers 
and non-movers. The post-stimulus fEMG 
power was higher in movers than in non-mov-
ers. The post-stimulus RRI SD and RRI SD2 
were higher, and RRI SD1 / SD2 ratio was lower 
in movers than in non-movers. 
Significant associations between movement 
responses and RRI-, EEG-, fEMG- and PPG-
derived variables were found. In general, the 
statistically significant associations were reac-
tive, i.e. the post-stimulus value either as such 
or normalized with respect to the pre-stimulus 
value discriminated movers from non-movers. 
The variables with statistically significant PK 
values for movement to noxious stimulation in 
studies IV (at the beginning of cervical dilata-
tion and at the resumption of the procedure 
after the administration of the study drug) and 
V (at skin incision) are shown in table 12. 
The combination of two or three variables 
with logistic regression models resulted in 
better discrimination of movement responses 
compared with models using only one variable 
(table 13).
Table 12. The PK values of variables that discriminated movers from non-movers in studies IV (at the begin-
ning of cervical dilatation, CD, and at resumption of procedure, RP, after the administration of the study 
drug) and V (at skin incision). Data are PK (SE). PK values less than 0.5 indicate that the value of the variable 
decreases with increasing likelihood of movement. Pre refers to averaged values of the variable over 60 s 
(study IV) or 120 s (study V) before the stimulus. Post refers to averaged values of the variable over 60 s 
(study IV) or 120 s (study V) after the stimulus. *** p < 0.001, ** p < 0.01, * p < 0.05 vs. 0.5. For the abbrevia-
tions, see page 11.
Study IV (CD) Study IV (RP) Study V
Variable PK Variable PK Variable PK
HR / RRI HR Post / Pre 0.72 (0.08) ** RRI Post / Pre 0.18 (0.09) ***
HRV Anemon Index 
Post
0.71 (0.08) ** RRI SD Post 0.76 (0.11) *
RRI SD Post / Pre 0.82 (0.09) **
RRI SD2 Post 0.74 (0.11) *
RRI SD2 Post / Pre 0.79 (0.10) **
RRI SD1 / SD2 Post 0.07 (0.05) ***
RRI SD1 / SD2 Post / Pre 0.25 (0.10) *
EEG BIS Pre 0.68 (0.06) ** BIS Post 0.73 (0.09) * β2 power Post / Pre 0.81 (0.10) **
BIS Post 0.77 (0.06) *** BIS Post / Pre 0.69 (0.07) * Relative β2 power Post / Pre 0.88 (0.09) ***
BIS Post / Pre 0.66 (0.06) * SEF Post 0.71 (0.09) * RE Post-Pre 0.83 (0.09) **
SEF Post 0.68 (0.06) ** SEF Post / Pre 0.70 (0.08) ** RE-SE Post-Pre 0.89 (0.08) ***
fEMG fEMG Pre 0.64 (0.06) * fEMG Post 0.70 (0.08) ** fEMG Post 0.77 (0.11) *
fEMG Post 0.78 (0.05) *** fEMG Post / Pre 0.82 (0.07) *** fEMG Post / Pre 0.90 (0.08) ***
fEMG Post / Pre 0.72 (0.06) ***
PPG PPG area Post-Pre 0.23 (0.10) **
PPG notch amplitude 
Post-Pre
0.23 (0.10) **
PPG amplitude LF Post-Pre 0.74 (0.11) *
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Table 13. Performance of the logistic regression classifiers using different sets of normalized (with respect 
to values preceding the resumption of the procedure after the administration of the study drug in study IV, 
and values preceding skin incision in study V) variables in studies IV and V. The performance was evaluated 
by leave-one-out cross-validation. The variables marked with * are normalized by subtracting the pre-stim-
ulus value from the post-stimulus value. All other variables are normalized by dividing the post-stimulus 
value by the pre-stimulus value. The model χ2 value and its statistical significance are indicated. Sensitivity 
is defined as the ratio of the number of movers correctly classified as movers to the actual number of 
movers. Specificity is defined as the ratio of the number of non-movers correctly classified as non-movers 
to the actual number of non-movers. A 50 % probability of movement is used as the cut-off value in 
the calculation of overall performance, sensitivity, and specificity. The number of patients are indicated 
in parentheses (number of correctly classified cases / total number of cases). The ROC area describes the 
probability that the classifier will correctly discriminate a mover from a non-mover, taking into account all 
possible cut-off values. 
Study IV
Variables χ2 p value ROC 
area
Overall 
performance
Sensitivity Specificity
EMG 15.2 < 0.001 0.82 78 % (42 / 54) 41 % (7 / 17) 95 % (35 / 37)
HR 5.8 0.016 0.72 71 % (39 / 55) 22 % (4 / 18) 95 % (35 / 37)
SEF95 6.1 0.013 0.70 67 % (36 / 54) 18 % (3 / 17) 89 % (33 / 37)
fEMG & HR 18.9 < 0.001 0.87 81 % (44 / 54) 53 % (9 / 17) 95 % (35 / 37)
EMG & SEF95 17.4 < 0.001 0.83 74 % (40 / 54) 41 % (7 / 17) 89 % (33 / 37)
HR & SEF95 11.4 0.003 0.81 72 % (39 / 54) 41 % (7 / 17) 86 % (32 / 37)
EMG & HR & SEF95 20.7 < 0.001 0.87 74 % (40 / 54) 47 % (8 / 17) 86 % (32 / 37)
Study V
Variables χ2 p value ROC 
area
Overall 
performance
Sensitivity Specificity
RE* 8.5 0.004 0.83 77 % (17 / 22) 70 % (7 / 10) 83 % (10 / 12)
RRI 9.3 0.002 0.82 73 % (19 / 26) 58 % (7 / 12) 86 % (12 / 14)
PPG notch amplitude* 6.6 0.010 0.77 65 % (17 / 26) 50 % (6 / 12) 79 % (11 / 14)
RE* & RRI 14.6 0.001 0.91 91 % (20 / 22) 90 % (9 / 10) 92 % (11 / 12)
RE* & PPG notch amplitude* 18.4 < 0.001 0.96 91 % (20 / 22) 90 % (9 / 10) 92 % (11 / 12)
RRI & PPG notch amplitude* 11.2 0.004 0.84 73 % (19 / 26) 58 % (7 / 12) 86 % (12 / 14)
RE* & RRI & PPG notch amplitude* 21.2 < 0.001 0.97 96 % (21 / 22) 90 % (9 / 10) 100 % (12 / 12)
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Discussion
Methodology
Design 
In study II, the EEG effects were evaluated in 
a double-blind fashion and the assessment of 
the hemodynamic effects was open (single-
blinded). If a blinded observer had been used 
in studies III–IV (and in study II regarding he-
modynamic effects) the risk of investigator bias 
would have been decreased. The studies were 
conducted in a single hospital on a homog-
enous group of relatively healthy, middle-aged 
females, who had no evidence of autonomic 
dysfunction. The results may not be directly 
applicable to other, dissimilar patient groups. 
The use of placebo was not applicable in the 
study protocols. In study IV, it would have 
been unethical to give an ineffective treatment 
to patients exhibiting movement responses 
during the procedure. In addition, the aim of 
the study was to directly compare the effects of 
a hypnotic and an analgesic agent.
The level of hypnosis
The MAC-awake value is roughly 0.35 MAC 
for sevoflurane and desflurane, and 0.6 MAC 
for N2O (Eger 2001). Study II was conducted 
in the unstimulated state, before the start 
of surgery. During the first ten minutes, 0.7 
MAC sevoflurane–N2O or desflurane–N2O 
anesthesia was used. During the following five 
minutes, supraclinical concentrations of both 
anesthetic agents were used. Thus the probabil-
ity of awareness during the study was low. The 
transient epileptiform EEG activity in some 
patients in the sevoflurane group was not as-
sociated with any adverse post-operative reac-
tions.
In study IV, the incidence of movement re-
sponses either before or after the start of cervi-
cal dilatation among the recruited patients was 
65.1 % (84 / 129). The incidence of a wakeful 
response, defined by eye opening or voicing 
during the procedure was 8.5 % (11 / 129). The 
duration of a wakeful response during anes-
thesia influences the probability of memory 
formation (Dutton et al 1995). The wakeful 
responses which occurred in study IV lasted 
only a few seconds.
The BIS value associated with a 95 % prob-
ability of loss of consciousness is of the order 
50–60 (Glass et al 1997, Katoh et al 1998, Struys 
et al 2003). In studies I and III–V, rescue medi-
cation was given if BIS unexpectedly exceeded 
70. In order to exclude intraoperative aware-
ness, repeated interviews during the post-op-
erative period are recommended (Sandin et al 
2000). The patients were interviewed regarding 
possible intraoperative awareness on arrival to 
the PACU in studies III–V, and in study III 
again at 24 h post-operatively. None of the pa-
tients reported memories of the intraoperative 
period.
Measurements and outcome parameters
In study III, the primary outcome parameter 
was the time to achieving home-readiness, 
defined by the criteria presented by Korttila 
(Korttila 1995) and modified by the inclusion 
of the need for parenteral medication. These 
clinical criteria are more stringent than the 
Postanesthetic Discharge Scoring System in-
troduced by Chung (Chung 1995) and may ex-
plain the relatively prolonged home-readiness 
times observed in study III. Due to the nature 
of the surgical procedures performed, howev-
er, the patients in study III were at a high risk 
for post-operative urinary retention, and thus 
the inclusion of voiding in the home-readiness 
criteria was appropriate (Awad and Chung 
2006).
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Traditionally, movement responses during 
anesthesia have been defined as “gross and 
purposeful”, usually affecting the head or the 
extremities. Coughing, chewing, swallowing 
and grimacing have been ignored (Quasha et 
al 1980, Antognini and Schwartz 1993, Leslie 
et al 1996, Katoh et al 1998). In studies IV–V 
movement was defined as any visible somatic 
response, as has been done by other authors 
(Kearse et al 1994a, Doi et al 1999, Kurita et 
al 2001, Bruhn et al 2003). The movement 
response was also used as an indicator of sig-
nificant nociception in studies IV–V. It was 
assumed that the level of nociception was 
higher in patients exhibiting movement re-
sponses compared to those who did not move. 
Spontaneous movement during anesthesia 
may not be entirely specific for nociception. 
Increases in the level of consciousness can 
also be associated with movement responses, 
although nociception and arousal are closely 
related phenomena.
Sample size and statistical power 
Formal power analysis to estimate a sufficient 
sample size was not attempted in studies I–II 
and V. Statistically significant differences, how-
ever, were found in all three studies. In study 
I, the wide 95 % confidence interval of the 
difference in the grand average BIS values be-
tween the second and third parts of the study 
suggests that a more accurate result would 
have been obtained had the sample size been 
larger, especially in the third part of the study. 
In study II, a difference in the main outcome 
measure (incidence of epileptiform EEG activ-
ity) was shown. The logistic regression equa-
tion obtained in study V yielded a very good 
classification performance (96 %) and due to 
leave-one-out cross validation this estimate of 
classification performance was unbiased, de-
spite the restricted sample size.
In study IV, the power analysis was based 
on a presumed incidence of recurring move-
ment of 50 %. With a sample size of 55 patients 
in each group, the study would have had 80 % 
power (with a 5 % α error rate) to detect an 
absolute difference of 25 % in the incidence of 
recurring movement. Although patients were 
recruited in excess of the estimated sample size, 
we had to exclude more patients from the anal-
ysis than anticipated, leaving only 82 patients 
to be analyzed. Thus the study had less than 
80 % power to detect the originally planned dif-
ference, but had 80 % power to detect a 28.5 % 
difference (Pocock 1983). Since a statistically 
significant difference in the incidence of recur-
ring movement did emerge, statistical power is 
not crucial to study IV.
The question of statistical power is relevant 
to study III, in which no difference in the main 
outcome measure between the two groups was 
found. With a sample size of 60 patients in each 
group, the study had a 90 % power (with a 5 % 
α error rate) to detect a standardized difference 
(difference in means divided by the standard 
deviation of the variable in question) of 0.6 in 
the recovery times (Altman 1999). The variabil-
ity in the recovery times, however, was large. 
Thus the study had less than 90 % power to de-
tect differences smaller than 145 min (or less 
than 80 % power to detect differences smaller 
than 123 min, standardized difference 0.5) in 
the main outcome measure of home-readiness. 
This difference was larger than estimated in 
the original power analysis (90 min based on a 
previous study conducted at the same institu-
tion). Thus, based on power analysis it was not 
possible to reliably exclude a difference smaller 
than 123–145 min in home-readiness times. 
The 95 % confidence interval of the difference 
in all of the recovery times included zero, how-
ever, and the confidence interval was generally 
skewed in favor of isoflurane. 
The effect of the type and location 
of electrodes on bispectral index 
monitoring (Aim 1) 
According to Manberg, artifact processing, 
suppression detection, and EEG feature extrac-
tion in BIS monitoring are sensitive to electrode 
placement (Manberg 2003). In a study by Hall 
and Lockwood, BIS values (v. 2.51) registered 
with a bifrontal montage using ECG electrodes 
were on average 68 % (95 % confidence interval 
65 %–71 %) of the BIS values registered with 
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a more cranial fronto-central montage, with 
silver dome electrodes in the central loca-
tions. In a few cases, however, the agreement 
between BIS values obtained from the fronto-
central and the bifrontal montage was excel-
lent. The impedances of both electrode types 
were similar and clinically acceptable (median 
2425Ω and 2700Ω, for ECG and silver dome 
electrodes). Skin pretreatment was performed 
using alcohol and abrasion paste for the ECG 
electrodes and abrasion and adhesive paste for 
the silver dome electrodes (Hall and Lockwood 
1998).
Horiuchi and colleagues compared the BIS 
values obtained with two BIS Standard Sensors 
(A-2000 EEG monitor), one in the recom-
mended position and the other inverted and 
dislocated slightly caudally. They found that 
during stable propofol–fentanyl anesthesia, the 
bias (mean difference) between the two BIS 
values was only -1.2, with limits of agreement 
[–9.7; 7.4] (Horiuchi et al 2007). Shiraishi 
and colleagues found a good correlation be-
tween BIS (v. 3.3) values recorded from frontal 
and occipital positions in neurosurgical pa-
tients. Limits of agreement were not reported 
(Shiraishi et al 2004).
Thøgersen and Ørding found good agree-
ment between BIS values (v. 3.12) registered 
simultaneously with a set of Zipprep electrodes 
and a set of ordinary ECG electrodes using 
the A-1000 EEG monitor during both light 
and deep sevoflurane or propofol anesthesia 
(limits of agreement [–11.1; 10.1] and [–10.6; 
11.6] in the sevoflurane group). The bias was 
close to zero in all measurements. The precise 
location of the two sets of electrodes relative to 
each other was not reported. The impedances 
achieved with the ECG electrodes after alco-
hol skin pretreatment were higher than those 
measured with Zipprep electrodes and they 
decreased with time (Thøgersen and Ørding 
2000).
Hemmerling and Harvey constructed a 
custom-made connector, including a small 
proximal part of the original BIS Sensor®, in 
order to use ordinary ECG electrodes in BIS 
monitoring with the A-2000 EEG monitor. 
Crocodile connectors were used to attach the 
ECG electrodes to the custom-made connector. 
The self-test of the A-2000 monitor recognized 
this system. In that study, the ECG electrodes 
were placed caudal to the original BIS Sensor®. 
Again, the impedance values of the ECG elec-
trodes were significantly higher than those of 
the BIS Sensor. In most patients, the BIS values 
recorded with the ECG electrodes were higher 
than those recorded with the BIS Sensor, but 
generally a good agreement was achieved (bias 
–1.3, limits of agreement [–7.1; 4.4] for the 
difference between BIS values obtained with 
the BIS Sensor and ECG electrodes). The au-
thors concluded that BIS values obtained with 
either Zipprep electrodes or ECG electrodes 
can be used interchangeably (Hemmerling and 
Harvey 2002).
The impedances observed in the first part 
of study I for ECG electrodes after combined 
abrasion paste and alcohol skin pretreatment 
were lower than those reported by Hall and 
Lockwood. The reason for this is unclear, but 
may be related to the smaller number of pa-
tients in the study by Hall and Lockwood, or 
to differences in skin abrasion technique. The 
impedances of ECG electrodes after alcohol 
skin pretreatment alone were similar to those 
reported by Thøgersen and Ørding and lower 
than those reported by Hemmerling and 
Harvey, both at the temporal position in the 
first part and at the reference position in the 
second part of study I. In contrast, the imped-
ances measured at the temporal positions in 
the second part of study I were higher than 
those reported by Thøgersen and Ørding or 
Hemmerling and Harvey. The discrepancy in 
impedance values of ECG electrodes at the 
temporal position between the first and second 
parts of study I may be related to the use of a 
mixture of different electrodes in the first part 
of the study.
 Although the montage used may affect the 
BIS values obtained, the positions of the sets of 
EEG and ECG electrodes in the second part of 
study I were quite near each other. Also, in the 
study by Hemmerling and Harvey the cranio-
caudal arrangement of the electrode sets was 
opposite to that used in study I, but the direc-
tion of the difference in BIS values between the 
two sets was similar to that observed in study 
I. In study I, the bias and limits of agreement 
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(mean ± 2sd) (Bland and Altman 1986) were 
+5.5 and [–10.1; 21.1] in part 2 vs. +1.6 and 
[–7.0; 10.2] in part 3, based on 50 consecutive 
BIS differences per patient. If only one obser-
vation per patient (average BIS difference) was 
considered, the bias and limits of agreement 
were +5.2 and [–3.6; 14] in part 2 vs. +1.7 and 
[–2.5; 5.9] in part 3. Clearly, a larger positive 
bias emerged in part 2 than in part 3, contrary 
to the findings of Hemmerling and Harvey or 
Thøgersen and Ørding. It is possible that the 
specific type of ECG electrodes used in study 
I may have resulted in a larger BIS difference 
than observed by the above-mentioned au-
thors.
In the second part of study I, the scatter in 
BIS differences (shown in the Bland-Altman 
plot) between the values measured with ECG 
electrodes vs. EEG electrodes was largest at the 
high end of the clinically important BIS range 
and diminished with low BIS values. This may 
be related to the general decrease of imped-
ance values during anesthesia with all elec-
trodes, possibly related to increased skin hy-
dration (sweat secretion under the electrodes). 
Unfortunately, an experiment comparing the 
parallel BIS values measured with a set of ECG 
electrodes after abrasion paste pretreatment 
and a set of EEG electrodes after alcohol swab 
pretreatment was not performed in study I.
The electroencephalogram and 
hemodynamic effects of desflurane 
and sevoflurane (Aim 2)
The tendency of sevoflurane to induce epilep-
tiform EEG patterns during anesthesia in epi-
leptic patients is greater than that of isoflurane 
(Iijima et al 2000). Rampil and colleagues did 
not find any evidence of epileptiform EEG ac-
tivity during 6 %–15 % desflurane anesthesia, 
with or without N2O, in healthy volunteers, 
even during hypocapnia and auditory stimu-
lation (Rampil et al 1991). Even though N2O 
activates the EEG (Yli-Hankala et al 1993b), its 
epileptogenic potential seems to be low. High 
doses of opioid analgesics have been observed 
to produce seizure activity in animals, but the 
origin of abnormal movements sometimes ob-
served after opioid administration in humans 
is unclear (Modica et al 1990).
Periodic epileptiform discharges and oth-
er interictal epileptiform phenomena have 
been demonstrated during sevoflurane an-
esthesia in adults and in children, especially 
with controlled ventilation and respiratory 
alkalosis (Kaisti et al 1999, Yli-Hankala et al 
1999b, Vakkuri et al 2000, Vakkuri et al 2001, 
Jääskeläinen et al 2003). These may occasional-
ly evolve into seizures (Woodforth et al 1997). 
The occurrence and severity of epileptiform 
EEG activity depends on the sevoflurane dose 
(Jääskeläinen et al 2003). Periodic epileptiform 
discharges during sevoflurane anesthesia may 
reflect widespread neuronal hypersynchroni-
zation preceding generalized seizure activity. 
They are associated with hemodynamic accel-
eration (Vakkuri et al 2000).
Voss and colleagues recorded electrocor-
ticography in sheep during anesthesia with 
increasing concentrations of different volatile 
agents. They found that the propensity to pro-
duce electrocorticography spikes was great-
est for enflurane, followed by sevoflurane. 
Isoflurane and desflurane were associated with 
a very low spike rate. In an inhibitory sigmoid 
Emax model, the maximal spike rates during 
burst suppression level anesthesia were 17.2, 
5.3, 0.7, and 0.5 spikes / min for enflurane, 
sevoflurane, isoflurane, and desflurane (Voss et 
al 2006). Desflurane has been used in the treat-
ment of refractory status epilepticus (Sharpe et 
al 2002).
In accordance with these results, epilepti-
form EEG activity was observed in 8 / 15 pa-
tients in the sevoflurane group during the rapid 
increase in the inspired volatile concentration, 
and in none of the 16 patients in the desflurane 
group in study II.
The calculated MAC multiples (Nickalls and 
Mapleson 2003, Lerou 2004) corresponding to 
the measured end-tidal volatile concentrations 
at periods 1, 2, and 3 (immediately before the 
increase in the inhaled anesthetic concentra-
tion, at two minutes after the increase, and at 
the end of the five-minute study period) were 
0.7–0.8 MAC, 2.3–2.4 MAC, and 2.5–2.7 MAC 
for desflurane and 0.8 MAC, 3.1–3.3 MAC, 
and 3.4–3.6 MAC for sevoflurane. RE / SE 
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values at period 2, however, were higher in 
the sevoflurane group than in the desflurane 
group. The observed differences in the calcu-
lated entropy values between the two groups 
in study II probably represent the combined 
result of agent-specific EEG effects and epilep-
tiform phenomena. Patients with epileptiform 
activity had higher RE / SE values at period 3 
compared to patients with a normal EEG in 
the sevoflurane group. The data highlight the 
fact that numerical indices derived from the 
EEG are a simplified representation of EEG 
phenomena, with many confounding factors. 
Unfortunately, BIS values were not retrieved 
during study II.
 Rapid increases in the desflurane concen-
tration have been shown to induce hyperten-
sion, tachycardia, a release of catecholamines 
and vasopressin, and a rate-dependent in-
crease in sympathetic outflow (Ebert and Muzi 
1993, Weiskopf et al 1994b, Muzi et al 1996b). 
In healthy volunteers, increasing the inspired 
sevoflurane concentration from 1 % to 3 % dur-
ing anesthetic induction was not associated 
with significant changes in muscle sympathetic 
nerve activity or HR, whereas both were sig-
nificantly increased when the inspired desflu-
rane concentration increased from 3 % to 9 %. 
MAP displayed a biphasic response after a step 
change in the desflurane concentration from 
6 % to 9 % (Ebert et al 1995).
 Pac-Soo and colleagues suggested that the 
concentration-dependent sympathoexcitation 
induced by desflurane is mediated primar-
ily via pulmonary vagal afferents, with a small 
alternative extravagal afferent pathway. The 
sympathetic depression associated with high 
desflurane concentrations is likely centrally 
mediated. The authors concluded that there is 
no hard evidence for extrapulmonary receptors 
mediating the desflurane-induced sympatho-
excitation (Pac-Soo et al 2000b), although 
such receptors have been suggested by other 
authors (Weiskopf et al 1995, Rodig et al 1997). 
Weiskopf and colleagues observed that the he-
modynamic and adrenalin responses were at-
tenuated with repeated increases in end-tidal 
desflurane concentration, consistent with the 
hypothesis that rapidly adapting airway recep-
tors might produce the initial sympathoadre-
nal response (Weiskopf et al 1994a).
Tanaka and colleagues found no significant 
changes in heart rate when the inhaled concen-
tration of sevoflurane was increased from 0.9 
MAC to 2.7 MAC (Tanaka et al 1996). In con-
trast, a significant increase in heart rate dur-
ing sevoflurane induction has been reported 
by other authors (Sloan et al 1996, Constant et 
al 1999, Hall et al 2000). The cardiac, vascular 
and autonomic nervous system effects of sevo-
flurane interact. Possible mechanisms for the 
increase in heart rate during increasing sevo-
flurane concentration, even without epilepti-
form EEG activity, include the residual activity 
of the baroreceptor reflex (Ma et al 1998, Hall 
et al 2000) and the vagolytic effect of sevoflu-
rane (Constant et al 1999, Picker et al 2001), 
although at concentrations exceeding 3 MAC 
the baroreceptor reflex is likely profoundly de-
pressed (Ma et al 1998).
In study II, the rapid increase in the in-
spired desflurane concentration was associated 
with a pronounced and transient increase in 
heart rate, peaking at two minutes. A similar 
biphasic response was observed in systolic 
blood pressure, in accordance with the results 
of Ebert and colleagues (Ebert et al 1995). In 
the sevoflurane group, the heart rate increased 
gradually. The systolic blood pressure decreased 
with increasing concentrations of sevoflurane, 
reaching a plateau at three to four minutes into 
the study period. These hemodynamic results 
are in agreement with the observations of other 
authors (Constant et al 1999, Hall et al 2000). 
The difference in heart rates between the pa-
tients with and without epileptiform EEG in 
the sevoflurane group did not reach statistical 
significance, possibly due to the small number 
of patients.
The effect of bispectral index 
monitoring on the recovery of 
gynecological ambulatory surgery 
patients after isoflurane or 
sevoflurane maintenance (Aim 3)
Many studies have indicated faster early re-
covery after sevoflurane anesthesia compared 
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to isoflurane anesthesia, whereas the times to 
the recovery room or hospital discharge gener-
ally do not differ. In most of these studies the 
administraton of the volatile agents was guided 
by hemodynamic signs (Frink et al 1992, 
Eriksson et al 1995, Campbell et al 1996, Philip 
et al 1996). In these studies, a slightly higher 
isoflurane exposure, as expressed in MAC-
hours, compared to sevoflurane exposure, or 
a slightly higher isoflurane MAC fraction at 
the end of anesthesia, compared to sevoflurane 
MAC fraction, may have influenced the results. 
In some studies, the difference in early recovery 
has been less clear or absent (Sloan et al 1996, 
Karlsen et al 2000, Godet et al 2001). In the 
study by Sloan and colleagues, both anesthetics 
were administered at about 0.8 MAC concen-
tration, a relatively light anesthetic level. In the 
study by Godet and colleagues the isoflurane 
exposure may have been slightly lower than 
the sevoflurane exposure, although these were 
not precisely reported. Eriksson and colleagues 
found that intermediate recovery was similar 
after sevoflurane–N2O or isoflurane–N2O an-
esthesia (Eriksson et al 1995).
A systematic review by Gupta and col-
leagues concluded that the times to eye open-
ing, obeying commands, transfer from phase I 
recovery to phase II recovery, home-readiness 
and discharge were statistically significantly 
shorter after sevoflurane anesthesia than after 
isoflurane anesthesia. The weighted mean dif-
ferences were small, however, less than five 
minutes for the early recovery parameters 
and less than ten minutes for the intermedi-
ate recovery parameters. The result on home 
discharge (weighted mean difference 25 min) 
was based on only two studies, with a wide 
confidence interval and a marginal statistical 
significance. Drowsiness was more frequent af-
ter isoflurane than after sevoflurane anesthesia 
(Gupta et al 2004).
A meta-analysis by Robinson and col-
leagues concluded that sevoflurane anesthesia 
is associated with a faster early recovery than 
isoflurane anesthesia, but no difference in the 
times to the recovery room discharge were 
found (Robinson et al 1999). Similar results 
were reported earlier by the same authors. The 
difference in early recovery was not observed 
in cases where the duration of anesthesia was 
less than one hour. After isoflurane anesthesia, 
early recovery was progressively delayed with 
increasing case duration (Ebert et al 1998).
In study III, no difference between the sevo-
flurane and isoflurane groups in either the early 
or intermediate recovery times was found. This 
may be partly due to the use of BIS monitor-
ing, which avoided relative overdosing of anes-
thetic agents. The target BIS range in study III 
was 50–60. Several studies have found faster 
early recovery in patients with target BIS val-
ues over 45–50 compared to patients in whom 
anesthesia was adjusted based on clinical (he-
modynamic) signs (Gan et al 1997, Song et al 
1997, Johansen et al 2000, Nelskylä et al 2001, 
Luginbühl et al 2003, Recart et al 2003, White 
et al 2004). In some studies, the intermediate 
recovery has also been hastened (Gan et al 
1997, Johansen et al 2000, Recart et al 2003, 
White et al 2004). In addition, N2O was used 
in all patients in study III. The elimination of 
N2O, which diminished the total exposure to 
isoflurane or sevoflurane, is very fast. Another 
factor contributing to the similarity in recov-
ery between the two groups was the relatively 
short case duration (median less than 60 min-
utes).
The blood / gas partition coefficient of iso-
flurane (1.4) is higher than that of sevoflurane 
(0.65), whereas the tissue-blood partition co-
efficients of isoflurane are similar or slightly 
lower than those of sevoflurane (Eger 2005). 
The increase in the recovery time with either 
an increase in the delivered concentration or 
the duration of administration is steepest for 
the most soluble volatile agents. The deeper the 
anesthetic level, the more the time to recovery 
is affected by the solubility characteristics of 
the volatile agent. After light or short-term an-
esthesia the differences in recovery times be-
tween volatile agents with different solubilities 
are small (Eger and Johnson 1987). When the 
duration of anesthesia is short, only the richly 
perfused tissues are equilibrated with the par-
tial pressure of the volatile anesthetic in blood. 
Thus, after the discontinuation of anesthetic 
delivery, the more slowly equilibrating com-
partments contribute to recovery by continu-
ing to take up anesthetic (Eger 2005).
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Generally, the quality of recovery after iso-
flurane and sevoflurane anesthesia is similar, 
with no significant differences in the frequency 
of adverse events (Frink et al 1992, Eriksson et 
al 1995, Campbell et al 1996, Ebert et al 1998, 
Karlsen et al 2000). In some studies, the post-
operative sedation or confusion has been more 
pronounced after isoflurane than after sevoflu-
rane anesthesia (Philip et al 1996, Sloan et al 
1996). One study reported a higher incidence 
of PONV after isoflurane anesthesia compared 
to sevoflurane anesthesia (Philip et al 1996). 
On the other hand, another study found that 
both PONV, headache, and perioperative re-
spiratory and cardiovascular complications 
were more frequent in association with sevo-
flurane anesthesia than with isoflurane anes-
thesia (Elcock and Sweeney 2002). Some stud-
ies have suggested that the quality of recovery 
may be improved by adjusting the anesthetic 
administration according to BIS monitoring, 
as compared to clinical signs alone (Gan et al 
1997, Nelskylä et al 2001, Luginbühl et al 2003, 
Recart et al 2003).
In study III, no significant differences in the 
post-operative DSST scores, or the degree of 
pain or nausea were found. Both the frequen-
cies and doses of post-operative analgesic and 
antiemetic medications, and the incidence of 
PONV at 24 h post-operatively was similar in 
both groups. This is probably due to both the 
modest overall exposure to the volatile agents 
and the use of BIS monitoring, which allowed 
individual titration of the anesthetic agents, 
and avoided unnecessary overdosing.
The reported incidence of dreaming dur-
ing anesthesia varies between 5 %–14 % (Ranta 
et al 1998, Myles et al 2004, Sebel et al 2004, 
Huang et al 2005). It has been suspected that a 
light level of anesthesia predisposes patients to 
both dreaming and intraoperative awareness 
(Ranta et al 1998, Huang et al 2005). On the 
other hand, Hellwagner and colleagues found 
no difference in EEG MF between dreaming 
and non-dreaming patients (Hellwagner et al 
2003). Leslie and colleagues reported that the 
frequency of signs of light anesthesia in non-
dreaming patients was similar to that in dream-
ing patients (7 % and 4 %) (Leslie et al 2005). At 
present it is unclear whether dreaming repre-
sents a light level of anesthesia, corresponding 
to near-awareness (Myles et al 2004, Sebel et al 
2004). An increased incidence of dreaming has 
been reported for young and healthy individu-
als, for female patients (Ranta et al 1998, Sebel 
et al 2004, Leslie et al 2005), and for those un-
dergoing elective or ambulatory surgery (Sebel 
et al 2004). In accordance with these studies, 
the overall incidence of dreaming was high 
(43 % and 38 % in the isoflurane and sevoflu-
rane groups; difference 5 %, 95 % CI [–14 %; 
23 %]) in the patients of study III, who had all 
of the above-mentioned characteristics. None 
of the patients had recall of the intraoperative 
events. It would be interesting to compare these 
results with the incidence of dreaming during 
a deeper level of anesthesia (for example, BIS 
40–50) in a similar population.
Hypnotic versus analgesic 
supplementation during uterine 
dilatation and curettage (Aim 4)
Opioids alone are not able to suppress respons-
es to noxious or non-noxious stimulation, in 
clinically relevant concentrations (Jhaveri et al 
1997, Mertens et al 2003, Bouillon et al 2004).
Alfentanil reduces the concentration of 
propofol required for loss of consciousness 
by a synergistic interaction (Vuyk et al 1996). 
Similarly, alfentanil and propofol suppress 
responses to laryngoscopy, intubation, and 
stimuli from abdominal surgery, displaying a 
synergistic interaction (Vuyk et al 1995). The 
interaction between alfentanil and propofol 
is weaker for loss of consciousness than for 
noxious stimuli (Vuyk et al 1996). Pavlin and 
colleagues found a synergistic interaction be-
tween propofol and alfentanil for the preven-
tion of movement responses to tetanic electri-
cal stimulation in the presence of N2O (60 %). 
In their study, the EC50 of propofol alone (with 
N2O) was 6.1 µg / ml, and the EC50 of propofol 
in the presence of alfentanil at 50, 100, and 150 
ng / ml was 3.3, 2.3 and 2.2 µg / ml. A ceiling ef-
fect for the reduction of propofol requirements 
was observed with alfentanil concentrations 
above approximately 100 ng / ml (Pavlin et al 
1999).
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At least around 1 µg / ml propofol is required 
for loss of consciousness or suppression of nox-
ious stimuli, even in the presence of high alfen-
tanil concentrations (Vuyk et al 1995, Vuyk et 
al 1996). With blood propofol concentrations 
above 4 µg / ml, small amounts of alfentanil are 
very effective in obtunding responses to nox-
ious stimuli, whereas with low propofol con-
centrations (e.g. 2 µg / ml) considerably larger 
amounts of alfentanil are required, and the 
overlap between response and no response is 
more pronounced (Vuyk et al 1995).
Propofol and alfentanil also display a phar-
macokinetic interaction such that propofol 
concentrations are higher in the presence than 
in the absence of alfentanil, and alfentanil con-
centrations are higher in the presence than in 
the absence of propofol. The hemodynamic 
changes induced by the drugs may also influ-
ence the pharmacokinetics (Pavlin et al 1996, 
Mertens et al 2001, Mertens et al 2004).
Many different combinations of propofol 
and an opioid can produce unresponsiveness, 
and the specific proportions of the drugs de-
termine the associated EEG state (Bouillon 
et al 2004). The work of Vanluchene and col-
leagues illustrates the hypnotic-opioid inter-
action. During propofol anesthesia alone, BIS 
or RE / SE values around 30 (20) are required 
to suppress the response to tetanic electri-
cal stimulation in 50 % (95 %) of the patients. 
Combined to 2 ng / ml of remifentanil the cor-
responding BIS or RE / SE values are around 50 
(40) (Vanluchene et al 2004a).
In study IV, the median estimated propofol 
effect-site concentration at the start of cervi-
cal dilatation (CD) was around 4.5 µg / ml 
(Gepts et al 1987), and the median estimated 
alfentanil effect-site concentration was around 
75 ng / ml (Scott and Stanski 1987). The fre-
quency of movement responses was 46.3 %. 
Comparison of these data with those of Pavlin 
and colleagues (Pavlin et al 1999) suggests that 
cervical dilatation is a more intense noxious 
stimulus than tetanic electrical stimulation of 
the ulnar nerve.
In study IV, a propofol bolus of 0.7 mg / kg 
was more effective than an alfentanil bolus 
of 0.5 mg in preventing recurring movement 
responses. The probability of recurring move-
ment also depended on the time elapsed from 
the administration of the study drug, consis-
tent with the rapid resolution of drug effects. 
Propofol and alfentanil were administered as 
bolus doses, and the patients were young and 
healthy. Under these conditions, the level of 
hypnosis was the more critical factor deter-
mining the probability of movement respons-
es, as compared to the level of analgesia. This is 
illustrated by the median estimated effect-site 
concentrations of propofol and alfentanil at the 
resumption of the procedure after the admin-
istration of the study drug (RP) in the alfen-
tanil group (roughly 4.5 µg / ml and 130–140 
ng / ml, respectively; frequency of movement 
37.5 %) vs. in the propofol group (roughly 5.3 
µg / ml and 40–45 ng / ml, respectively; fre-
quency of movement 26.1 %). Both the bolus 
administration and the pharmacokinetic in-
teraction between propofol and alfentanil may 
have affected the accuracy of these estimations, 
however.
In the data of Vuyk and colleagues, the re-
quirement for alfentanil to suppress responses 
to intra-abdominal surgical stimulation in-
creased steeply at propofol concentrations less 
than 4 µg / ml, consistent with the results of 
study IV. In a dose-response study on young, 
healthy adults, Yu and colleagues found that 
the incidence of somatic responses to laryngeal 
mask insertion progressively decreased with an 
increasing alfentanil bolus dose, in conjunction 
with a propofol bolus of 2.5 mg / kg. Based on 
probit analysis they estimated that all somatic 
responses, including laryngospasm, would be 
abolished by 17.6 μg / kg of alfentanil in 95 % 
of patients. The ED95 of alfentanil for head 
or limb movements was predicted to be 10.7 
μg / kg (Yu et al 2006). The dose of alfentanil 
used in study IV was not adjusted according to 
the weight of the patient, and was rather mod-
est (7–10 μg / kg). The outcome might have 
been different, had a larger dose of alfentanil 
been used. 
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The possible role of physiological 
variables as indices of nociception 
during anesthesia (Aim 5)
Heart rate and  
heart rate variability responses
Similarly to studies IV and V, most studies 
have found no significant differences in the 
pre-stimulus hemodynamic variables between 
movers and non-movers or hemodynamic 
responders and non-responders to a noxious 
stimulus during anesthesia (Vernon et al 1995, 
Doi et al 1999, Kochs et al 1999, Luginbühl et 
al 2007). In a study by Leslie and colleagues, 
however, the pre-stimulus blood pressure was 
predictive of a movement response to tetanic 
electrical stimulation during propofol–N2O 
anesthesia, whereas the pre-stimulus heart 
rate was not (Leslie et al 1996). Sebel and col-
leagues found that during isoflurane or propo-
fol anesthesia, the pre-stimulus MAP was 
predictive of movement responses to skin inci-
sion in a logistic regression model (Sebel et al 
1997). Johansen and colleagues reported that 
the pre-stimulus heart rate was predictive of 
a movement response to skin incision during 
propofol–N2O–esmolol anesthesia in a logistic 
regression model (Johansen et al 1997). Thus 
in some particular circumstances the pre-stim-
ulus hemodynamic variables may be indicative 
of the overall arousal level of the patients.
Kochs and colleagues found no significant 
differences in the post-stimulus hemodynamic 
variables between movers and non-movers 
to tetanic stimulation or skin incision during 
isoflurane–N2O anesthesia. The systolic blood 
pressure response was greater in movers than 
in non-movers to skin incision, but did not 
reach statistical significance (Kochs et al 1999). 
Johansen and colleagues reported that the post-
stimulus heart rate discriminated movers and 
non-movers to skin incision during propofol–
N2O–esmolol anesthesia in a logistic regres-
sion model (Johansen et al 1997). Luginbühl 
and colleagues found a significant difference in 
the post-stimulus RRI between hemodynamic 
responders and non-responders to tracheal 
intubation during propofol–remifentanil an-
esthesia (Luginbühl et al 2007). In accordance 
with these studies, the HR and HRV responses 
were associated with movement responses in 
studies IV and V. In study IV, none of the HR 
or HRV variables discriminated movers from 
non-movers at CD, but the normalized heart 
rate and the post-stimulus Anemon Index did 
so at RP. In study V, the normalized RRI, RRI 
SD, RRI SD2, and RRI SD1 / SD2 had PK values 
significantly different from 0.5 with respect to 
movement responses at skin incision, as did 
the post-stimulus values of RRI SD, RRI SD2, 
and RRI SD1 / SD2. Of these, the normalized 
HR and the normalized RRI were included in 
the logistic regression models with the best dis-
crimination performance in studies IV and V.
Pulse plethysmogram responses
The HRV and PPG changes observed at skin 
incision in study V were similar to those re-
ported by Luginbühl and colleagues at tetanic 
electrical stimulation and at tracheal intubation 
(Luginbühl et al 2006, Luginbühl et al 2007) 
and by Rantanen and colleagues at skin inci-
sion during propofol–remifentanil anesthesia 
(Rantanen et al 2006a).
 The large interindividual differences in 
physiological variables complicate the deter-
mination of threshold values associated with 
significant nociception. In studies IV and V, 
the investigated variables were normalized 
with respect to the pre-stimulus values before 
entering them into logistic regression analysis. 
Luginbühl and colleagues observed that even 
normalized HRV and PPG responses to te-
tanic stimulation were unable to discriminate 
patients displaying a significant hemodynamic 
response to intubation from non-responsive 
patients, however, with the exception of the 
normalized PPG amplitude SD, which showed 
some classification ability. The normalized PPG 
amplitude SD2 at tetanic electrical stimulation 
was also significantly different between re-
sponders and non-responders, but did not im-
prove the prediction of the response to tracheal 
intubation in a multivariate logistic regression 
model (Luginbühl et al 2006, Luginbühl et al 
2007).
104
In study V, the normalized PPG area and the 
normalized PPG notch amplitude, and also the 
normalized PPG amplitude LF had PK values 
significantly different from 0.5 with respect to 
movement responses at skin incision. Of these, 
the normalized PPG notch amplitude was in-
cluded in the logistic regression model with 
the best discrimination performance.
Electroencephalogram and  
electromyogram responses
Yli-Hankala and colleagues observed that dur-
ing emergence from isoflurane–N2O anesthe-
sia, fEMG power and the MLAEP amplitude 
increased before spontaneous movements, 
whereas the heart rate and the EEG zero-
crossing frequency were stable during the five 
minutes preceding movement (Yli-Hankala et 
al 1994). Rampil and Laster found no signifi-
cant differences in the pre-stimulus values of 
EEG variables between rats which displayed a 
movement response to tail clamping and those 
which did not during isoflurane anesthesia 
(Rampil and Laster 1992). Similarly, Kochs 
and colleagues found no significant differences 
in the pre-stimulus values of EEG-derived 
variables between movers and non-movers to 
tetanic electrical stimulation or skin incision 
during isoflurane–N2O anesthesia (except β 
power, 12.5–30 Hz, before tetanic electrical 
stimulation) (Kochs et al 1999).
Some studies have found a significant dif-
ference in the pre-stimulus BIS values between 
movers and non-movers to noxious stimula-
tion during anesthesia (Vernon et al 1995, 
Sebel et al 1997, Singh et al 1999, Vanluchene 
et al 2004a), whereas others have not (Doi et 
al 1999, Kurita et al 2001). Thus some studies 
have found BIS to be predictive of movement 
responses to noxious stimulation during an-
esthesia (Vernon et al 1995, Leslie et al 1996, 
Sebel et al 1997). Vanluchene and colleagues 
found a significant difference in the pre-stim-
ulus RE / SE values between movers and non-
movers to tetanic electrical stimulation during 
propofol–remifentanil anesthesia (Vanluchene 
et al 2004a).
Some studies found a significant difference 
in the pre-stimulus values of SEF95 between 
movers and non-movers to noxious stimu-
lation during anesthesia, and reported that 
SEF95 was predictive of movement responses 
(Vernon et al 1995, Dutton et al 1996, Leslie et 
al 1996, Schraag et al 1998), whereas others did 
not (Kearse et al 1994a, Doi et al 1999, Singh et 
al 1999). Generally, no significant differences 
in the pre-stimulus values of MF between mov-
ers and non-movers to noxious stimulation 
during anesthesia have been found (Kearse et 
al 1994a, Vernon et al 1995, Schraag et al 1998, 
Doi et al 1999). Sebel and colleagues reported 
a significant difference in the pre-stimulus val-
ues of relative δ power between movers and 
non-movers to noxious stimulation during an-
esthesia (Sebel et al 1995), whereas others did 
not (Kearse et al 1994a, Vernon et al 1995).
Leslie and colleagues found that BIS, SEF95, 
MF, relative β power, and relative δ power pre-
dicted movement responses to tetanic electrical 
stimulation during propofol–N2O anesthesia. 
They suggested that a multivariate approach 
might improve the predictive performance. In 
their study, the differences between the pre- 
and post-stimulus values of BIS or SEF95 were 
not statistically significant (Leslie et al 1996). 
Doi and colleagues and Kurita and colleagues 
reported that the auditory evoked potential in-
dex was predictive of movement responses to 
noxious stimulation, but BIS was not (Doi et al 
1999, Kurita et al 2001).
Thus, the relationship between the pre-
stimulus values of EEG-derived variables 
and movement responses is not consistent. A 
significant difference in the pre-stimulus BIS 
values between movers and non-movers to 
noxious stimulation has generally been more 
likely to occur during propofol-based anes-
thesia than during inhalation anesthesia. The 
level of opioid analgesia may also influence the 
results. For example, in the data of Sebel and 
colleagues, a significant difference in the pre-
stimulus BIS values between movers and non-
movers to skin incision was observed during 
isoflurane or isoflurane–N2O anesthesia, but 
not during isoflurane–N2O–opioid anesthesia 
(Sebel et al 1997).
Bruhn and colleagues observed that the PK 
values of BIS (v. 3.22), EEG ApEn and SEF95 
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for unconsciousness (response to non-noxious 
stimulation) exceeded 0.90, but were only 
0.62–0.70 for the responses to noxious airway 
stimulation in healthy volunteers with varying 
concentrations of propofol and remifentanil 
(Bruhn et al 2003). Analogous results were re-
ported by Katoh and colleagues. The PK values 
of the end-tidal sevoflurane concentration, BIS 
(v. 3.2), SEF95, and MF for the OAA / S score 
were 0.97, 0.95, 0.81, and 0.62. For the move-
ment response to skin incision, however, the 
corresponding PK values were 0.90, 0.66, 0.57 
and 0.52. Only the sevoflurane concentration 
was able to predict movement responses to 
skin incision better than chance alone (Katoh 
et al 1998).
Similarly, in a study by Struys and colleagues 
the PK values of BIS (v. 3.4), AAI, and the ef-
fect-site propofol concentration for predicting 
the loss of response to tetanic electrical stimu-
lation were lower than those for predicting the 
level of sedation or the loss of consciousness, 
and deteriorated when the level of opioid anal-
gesia varied during propofol anesthesia. The PK 
values were 0.93–0.95 for the loss of conscious-
ness and 0.72–0.75 for the loss of response to 
noxious stimulation in the pooled data with 
varying remifentanil concentrations (0–4 
ng / ml) (Struys et al 2003).
During propofol monoanesthesia, the PK 
values of BIS (v. 3.4), AAI, and the effect-site 
propofol concentration for predicting the loss 
of response to tetanic electrical stimulation 
were 0.87, 0.88 and 0.82. The PK values of hemo-
dynamic variables were much worse, 0.59–0.72 
(Struys et al 2002). During propofol–remifen-
tanil anesthesia, the PK values of SE for LOC 
and for the loss of response to tetanic electrical 
stimulation were 0.81–0.86 and 0.65–0.80. The 
corresponding PK values of RE were 0.83–0.89 
and 0.67–0.85. In that study, the PK values of 
BIS (v. 4.0) for LOC and for the loss of response 
to tetanic electrical stimulation were 0.89–0.91 
and 0.69–0.77. A wide range of overlap was ob-
served between the response and no-response 
values, especially with the noxious stimulus 
(Vanluchene et al 2004a).
 With BIS, RE / SE, or AAI, sensitivities 
and specificities around 80 %–90 % can be 
obtained for LOC, vs. only 70 %–80 % for the 
loss of response to noxious stimulation (Struys 
et al 2002, Struys et al 2003, Vanluchene et al 
2004a). At 100 % sensitivity to detect the loss of 
response to tetanic stimulation the specificity 
of BIS, RE / SE and AAI are very low. The cut-
off values at the highest overall performance 
and at 100 % sensitivity are influenced by re-
mifentanil in a dose-dependent manner for 
both LOC and the loss of response to noxious 
stimulation. Generally, the difference in the 
best cut-off values is larger between remifenta-
nil at 0 and 2 ng / ml than between remifentanil 
at 2 and 4 ng / ml (Struys et al 2003, Vanluchene 
et al 2004a).
During propofol monoanesthesia, no cases 
of consciousness occur at BIS values less than 
53–58, SE values less than 37, RE values less 
than 50, or propofol effect-site concentrations 
more than 4.0 μg / ml. When remifentanil at 
2 ng / ml is combined with propofol, no cases 
of consciousness occur at BIS values less than 
65–68, SE values less than 50, RE values less 
than 62, or propofol effect-site concentrations 
more than 3.0 μg / ml. During propofol mono-
anesthesia, no cases of a response to tetanic 
electrical stimulation occur at BIS values less 
than 12–29, SE values less than 7, RE values 
less than 7, or propofol effect-site concentra-
tions more than 7.0 μg / ml. When remifentanil 
at 2 ng / ml is combined with propofol, no cases 
of a response to tetanic electrical stimulation 
occur at BIS values less than 43–57, SE values 
less than 40, RE values less than 45, or propofol 
effect-site concentrations more than 3.5 μg / ml 
(Struys et al 2002, Struys et al 2003, Vanluchene 
et al 2004a).
EEG-derived variables clearly correlate best 
with the level of sedation or hypnosis, and less 
with the responsiveness to noxious stimula-
tion. This is natural, since nociceptive reflexes 
during anesthesia are subcortically mediated. 
Table 14 illustrates the interaction between the 
level of hypnosis, EEG-derived variables, opi-
oid analgesia, and noxious stimulation.
Kochs and colleagues reported that there 
was a significant difference in the changes in 
fEMG power, MLAEP amplitudes, and EEG θ 
and α power between movers and non-movers 
to skin incision during isoflurane–N2O anes-
thesia (Kochs et al 1999). Rantanen and col-
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leagues observed that RE increased at skin 
incision during propofol–remifentanil anes-
thesia, and the increase was dose-dependently 
attenuated by remifentanil. No difference in the 
RE increase between movers and non-movers 
was observed. The RE-SE difference increased 
in movers, but not in non-movers (Rantanen 
et al 2006a). Valjus and colleagues reported 
that although some intraoperative movement 
responses were associated with increases in 
RE / SE and BIS, most of them were not (Valjus 
et al 2006). Struys and colleagues found that 
tetanic electrical stimulation caused transient 
increases in BIS and AAI with mean delays to 
maximum effect of 39 s and 20 s, respectively 
(Struys et al 2002). Experimental data con-
cerning the responses of different physiological 
variables to noxious stimulation during anes-
thesia are scarce.
Edmonds and Paloheimo found that chang-
es in the fEMG, EEG amplitude, and ZXF were 
not consistently related to changes in hemody-
namic or motor responsiveness. In some cases, 
increases in fEMG were observed during de-
creasing anesthesia, but most frequently fEMG 
increases were practically coincident with limb 
movements. Also, large interindividual vari-
ability in fEMG was observed (Edmonds and 
Paloheimo 1985).
After barbiturate induction, fEMG and ab-
dominal EMG activity increased in response 
to endotracheal intubation, despite complete 
neuromuscular blockade in the hypothenar 
muscle, in 28 / 30 and 29 / 30 patients. After 
administration of enflurane, some patients 
(8 / 30) still reacted to skin incision with an 
increase in fEMG and abdominal EMG ampli-
tude. During decreasing anesthesia, the fEMG 
increase preceded the clinical signs of arousal 
in 16 / 30 patients (Paloheimo et al 1989).
During isoflurane washout, while maintain-
ing N2O inhalation, noxious and non-noxious 
stimulation resulted in an initial persistent 
(over 30 s) increased craniofacial EMG re-
sponse in 47 % (14 / 30) and an initial combined 
EMG and movement response in 40 % (13 / 30) 
of the patients. Thus, the EMG response does 
not always herald movement before it oc-
curs. Compared to isolated EMG responses, 
combined EMG and movement responses 
were associated with more abrupt increases 
in EMG power, longer durations of increased 
voltage, and shorter latencies from the onset of 
stimulation. Isolated EMG responses occurred 
on average at 0.11 % higher isoflurane effect-
site concentrations than combined EMG and 
movement responses (Dutton et al 1998).
Chang and colleagues reported larger fEMG 
responses in patients who moved in response 
to surgical stimulation during metohexital–
N2O anesthesia compared to those who did 
not move. The fEMG responses often occurred 
almost simultaneously with movement. Large 
fEMG increases occurred more often in inad-
equately anesthetized (as defined by somatic 
or hemodynamic responses) patients than in 
adequately anesthetized patients. The interin-
dividual variability in fEMG values was con-
Table 14. The values of BIS (v. 3.4–4.0), SE and RE associated with 50 % and 95 % probability of unre-
sponsiveness (ED50 and ED95 values) to non-noxious (loss of consciousness) and noxious (tetanic electrical) 
stimulation, during propofol monoanesthesia and propofol combined with remifentanil 2 ng / ml. The data 
are observations of Struys and colleagues and Vanluchene and colleagues (Struys et al 2002, Struys et al 
2003, Vanluchene et al 2004a).
Propofol alone Propofol + remifentanil 2 ng / ml
Loss of consciousness Loss of response to tetanic 
electrical stimulation
Loss of consciousness Loss of response to tetanic 
electrical stimulation
ED50 ED95 ED50 ED95 ED50 ED95 ED50 ED95
BIS 61–71 52–55 32–41 17–29 68–80 65–66 53–72 45–56
SE 64 53 37 22 68 60 50 39
RE 70 57 39 22 74 69 53 41
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siderable. Notably, the authors were unable to 
correlate changes in the mean integrated fron-
tal EEG amplitude or ZCF with clinical signs of 
inadequate anesthesia (Chang et al 1988).
In agreement with the above-mentioned 
studies, in studies IV and V the fEMG arousal 
response, but generally not the pre-stimulus 
fEMG power discriminated movers to noxious 
stimulation from non-movers.
In study IV, the pre- and post-stimulus val-
ues and the normalized values of BIS and fEMG 
power discriminated movers from non-movers 
at CD, as did the post-stimulus value of SEF95. 
At RP, neither pre-stimulus EEG variables or 
fEMG had PK values significantly different 
from 0.5. The post-stimulus values and the 
normalized values of BIS, SEF95, and fEMG 
power discriminated movers from non-movers 
at RP. The more variable balance between hyp-
nosis and analgesia at RP compared to CD may 
have lead to the lack of predictive performance 
of EEG variables and fEMG at RP. Movement 
was associated with an EEG and fEMG arousal 
response at both CD and RP. fEMG power was 
included in the logistic regression model with 
the best discrimination performance at RP in 
study IV.
In study V, the normalized values of the 
absolute and relative β power, RE and RE-SE 
discriminated movers from non-movers at 
skin incision, as did the post-stimulus value 
and the normalized value of fEMG power. Of 
these variables, the normalized value of RE was 
included in the logistic regression model with 
the best discrimination performance.
Movement responses as  
an indicator of nociception
In studies IV and V, movement responses were 
used to investigate the relative importance of 
different physiological variables in the evalua-
tion of nociception. Autonomic responses were 
generally more pronounced in movers than 
in non-movers, consistent with greater noci-
ception in movers. Even when movement re-
sponses are blocked, hemodynamic responses 
may still occur (Zbinden et al 1994b, Kazama 
et al 1997). Kazama and colleagues observed 
that the Cp50 values of propofol with respect to 
movement responses to tetanic electrical stim-
ulation and skin incision were similar, whereas 
skin incision induced a larger hemodynamic 
response than did tetanic stimulation (Kazama 
et al 1997). Thus movement responses may be 
less sensitive indicators of nociception than 
hemodynamic responses.
In a study by Sebel and colleagues, the 
pre-stimulus opioid concentration predicted 
both the movement and the hemodynamic 
responses to skin incision during isoflurane or 
propofol anesthesia (Sebel et al 1997). The re-
mifentanil concentration predicted significant 
hemodynamic responses to tracheal intubation 
during propofol–remifentanil anesthesia in a 
logistic regression model (Luginbühl et al 2006, 
Luginbühl et al 2007). The strength of the cor-
relation between the opioid concentration and 
the heart rate or blood pressure responses to 
noxious stimulation during anesthesia is stron-
gest for the most noxious stimuli. Movement 
and blood pressure responses show a modest 
correlation with only the most noxious stimuli 
(Kazama et al 1997). 
Some studies show that the pre-stimulus 
propofol concentration predicts movement 
responses to noxious stimulation (Leslie et al 
1996, Johansen et al 1997, Struys et al 2002, 
Struys et al 2003), whereas others do not 
(Vernon et al 1995, Sebel et al 1997, Doi et al 
1999). Generally, the pre-stimulus concentra-
tions of potent volatile anesthetic agents are 
predictive of movement responses to noxious 
stimulation (Vernon et al 1995, Sebel et al 
1997, Katoh et al 1998, Kurita et al 2001).
Different anesthetic agents act preferentially 
on different parts of the central nervous system 
to suppress movement responses (Antognini 
et al 2002, Jinks et al 2003, Baars et al 2006a, 
Baars et al 2006b). For example, the effect of 
sevoflurane on both nociceptive and non-noci-
ceptive spinal neural transmission is consider-
ably stronger than that of propofol (Matute et al 
2004). Thus the extent to which EEG variables 
or measures of spinal excitability correlate 
with movement responses varies with different 
drugs. In study IV, the pre- and post-stimulus 
BIS and SEF95 values showed some association 
with movement responses to noxious stimula-
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tion, consistent with a predominant supraspi-
nal action of propofol. In contrast, in study V, 
where sevoflurane was used, no significant as-
sociations between EEG measures of hypnosis 
and movement responses emerged.
The probability of a response to noxious 
stimulation depends fundamentally on the 
prevailing combination of hypnotic and opioid 
concentrations. Because opioids have little ef-
fect on the EEG at clinically used concentra-
tions, the EEG state alone cannot predict the 
probability of response (Bouillon et al 2004). 
Cortical depression per se does not contribute 
significantly to the suppression of movement 
responses (Rampil and Laster 1992, Antognini 
et al 2002). Accordingly, the association of sub-
cortically mediated autonomic and fEMG re-
sponses with movement was stronger than that 
of EEG-derived variables in studies IV and V.
Models for discriminating  
movers and non-movers
In study IV, the performance of the normal-
ized fEMG power in classifying movers and 
non-movers at RP could not be improved, ac-
cording to the –2LL criterion, by adding other 
variables to the logistic regression model. For 
example, the comparison of the models includ-
ing the combination of fEMG power and HR 
vs. fEMG power alone did not quite reach sta-
tistical significance. The combination of fEMG 
power and HR, however, did yield slightly 
better sensitivity, overall performance, and 
ROC area than fEMG power alone. The per-
formance of weaker variables was improved by 
adding another variable to the logistic model. 
Overall the sensitivity of the acquired models 
was poor. This is probably due to the rapidly 
changing balance between drug-induced sup-
pression and surgical stimulation during the 
non-steady state conditions of uterine dilata-
tion and curettage.
In study V, two-variable combinations yield-
ed significantly better logistic regression mod-
els than did single variables (with the exception 
that the performance of RRI alone could not 
be improved by adding PPG notch amplitude). 
According to the –2LL criterion, the logistic 
model including the normalized RE, RRI and 
PPG notch amplitude was no better than the 
combination of RE and PPG notch amplitude, 
but the former did yield a better overall per-
formance and specificity. The sensitivity of the 
acquired models was much better in study V 
than in study IV, perhaps because the surgical 
stimulus was less variable, and anesthesia at the 
time of stimulation approached steady-state 
conditions during continuous administra-
tion of sevoflurane. In both studies the fEMG 
power and HR showed potential as indicators 
of significant nociception. Unfortunately, PPG 
was not investigated in study IV.
The assessment of the  
adequacy of anesthesia
When the antinociception provided by anesthe-
sia is insufficient, surgical stimuli may induce 
motor, autonomic, and humoral reactions, as 
well as changes in EEG activity. Monitoring of 
the humoral responses is impractical, and usu-
ally motor responses are blocked during anes-
thesia by hypnotic, analgesic, and neuromus-
cular blocking agents. Frontal EMG activation 
is probably more sensitive to nociception than 
visible somatic responses. Some evidence sug-
gests that the MLAEP may be more sensitive 
to nociception than other processed EEG vari-
ables during anesthesia. Different autonomic 
responses may provide a continuous measure 
of the nociceptive–antinociceptive balance 
during anesthesia, but it is unclear which of 
them is the most sensitive and robust indica-
tor of nociceptive responses. The changes in 
blood pressure and heart rate provide a crude 
measure of the autonomic state of the anesthe-
tized patient. In addition to PPG, the changes 
in palmar skin conductance or pupillary reflex 
dilation may detect more subtle nociception-
related reactions. Not only nociception, but 
also increases in the level of consciousness, and, 
for example, hemodynamic crises or seizures 
can influence the autonomic responses. In 
addition, aging and illness, as well as drugs af-
fecting the cardiovascular system, may change 
the autonomic responses to nociception. Thus 
the problem of the on-line assessment of the 
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nociceptive–antinociceptive balance during 
anesthesia is very complex.
Both consciousness and the nociceptive 
responses are simultaneously depressed by 
anesthetic agents. In 2000, Viertiö-Oja and 
colleagues concluded that the independent 
measurement of the hypnotic and analgesic 
components of general anesthesia is challeng-
ing due to their strong interactions (Viertiö-
Oja et al 2000). Wilder-Smith and colleagues 
suggested that while the EEG is of limited use 
in predicting responses to noxious stimuli, the 
EEG arousal reactions may be useful in the 
evaluation of nociception during anesthesia 
(Wilder-Smith et al 1995). Arousal, which in-
tegrates both increases in consciousness and 
autonomic nociceptive responses, could be a 
sensible end-point for the assessment of the 
adequacy of anesthesia. If EEG monitoring is 
combined with monitoring of the sympathetic 
reactions, EMG, and perhaps MLAEP, a more 
complete picture of the arousal responses may 
be obtained. In addition to new monitoring 
possibilities, the advent of new short-acting 
anesthetic agents, especially remifentanil, has 
increased the flexibility of adjusting general 
anesthesia to meet the dynamically changing 
surgical needs.
Future studies will reveal whether a reli-
able on-line estimation of the nociceptive–
antinociceptive balance can be achieved with a 
mathematical index based on a specific weight-
ed combination of different physiological 
variables, or whether the information derived 
from different sources is best integrated by the 
anesthesiologist, or perhaps a neural network. 
In any case, the description and quantifica-
tion of different sympathetic and other arousal 
responses will be useful in advancing the in-
sight into the physiology of nociception and 
anesthesia, and in providing new monitoring 
possibilities.
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Conclusions
The following conclusions can be drawn from the studies:
1. When only alcohol swab skin pretreatment is used, the skin-electrode impedance 
values of Nikomed® ECG electrodes are higher than those of Zipprep® EEG elec-
trodes. With careful skin preparation, low skin-electrode impedance values can 
be achieved with Nikomed® ECG electrodes. The BIS values (v. 3.22) registered 
with an Aspect A-1000 EEG monitor with a set of Nikomed® ECG electrodes are 
higher than those registered with a set of Zipprep® EEG electrodes, when alcohol 
swab is used as skin pretreatment. The influence of a cranial displacement of the 
electrodes by two to three centimeters on the resulting BIS values is minor.
2. The probability of epileptiform EEG activity is very low during desflurane an-
esthesia, even at high concentrations. It was confirmed that a rapid increase in 
the inspired concentration of sevoflurane is associated with epileptiform EEG 
activity in a significant portion of healthy patients. The tachycardia induced by 
a rapid increase in the inspired desflurane concentration is more pronounced 
than that induced by sevoflurane. It reaches its maximum in roughly two min-
utes.
3. When the dose of the inhaled agent is individually titrated to maintain BIS val-
ues between 50–60, the recovery profile is similar after isoflurane–N2O or sevo-
flurane–N2O anesthesia in healthy gynecological ambulatory surgery patients. 
4. When anesthesia is maintained by the inhalation of 67 % N2O and bolus doses 
of propofol or alfentanil after a propofol–alfentanil induction, in young healthy 
unparalyzed patients, a bolus of propofol (0.7 mg / kg) is more effective in pre-
venting recurring movement responses than a bolus of alfentanil (0.5 mg).
5. Several variables derived from the surface EEG, fEMG, ECG (HR / RRI or HRV), 
and PPG display mainly reactive associations with movement responses to nox-
ious stimulation during propofol–N2O–alfentanil or sevoflurane anesthesia. The 
fEMG or RE, RRI (HR), and PPG notch amplitude, normalized to their pre-
stimulus values, may be useful as indicators of nociception during anesthesia, 
but their performance needs to be validated in future studies. Combining more 
than one variable by logistic regression analysis may improve the discrimination 
of the level of nociception, as defined by the presence or absence of movement 
responses to noxious stimulation.
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Clinical considerations
1. The use of designated EEG electrodes instead of ECG electrodes in BIS monitor-
ing is recommended. The position of the electrodes should follow the instruc-
tions of the manufacturer. 
2. It may be prudent to avoid using sevoflurane, at least in high concentrations, in 
epileptic patients. Desflurane may be a safer volatile agent in this patient group. 
A rapid increase in the inspired desflurane concentration may be risky in pa-
tients with cardiac disease, due to transient sympathoexcitation. 
3. If the administration of the potent volatile agent is adjusted to maintain BIS 
at 50–60, isoflurane–N2O anesthesia is equally acceptable as sevoflurane–N2O 
anesthesia in healthy ambulatory surgery patients, in terms of the speed and 
quality of recovery. 
4. When anesthesia for a minor procedure is maintained by the inhalation of 67 % 
N2O and administration of modest bolus doses of propofol or alfentanil after 
a propofol–alfentanil induction, in young healthy unparalyzed patients, move-
ment responses are best avoided by ensuring a relatively deep hypnotic level (a 
relatively high propofol concentration).
5. Currently, all anesthesiologists can detect signs of nociception during anesthe-
sia by observing changes in heart rate, blood pressure, and the PPG waveform. 
Many also have access to EEG monitoring. Other possibilities for monitoring 
the autonomic and evoked potential responses to noxious stimulation during 
anesthesia (e.g. measurement of the palmar skin electrical conductance, pupil-
lometry, MLAEP) may become routinely available. In the future, quantification 
of the nociception-related changes in physiological variables and mathematical 
data compression may help the clinician in decision-making regarding the ad-
ministration of hypnotic and analgesic agents. The combination of information 
from different sources may improve the assessment of the nociceptive–antinoci-
ceptive balance.
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